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Abstrakt 
Nach den Ein-und Zweikomponentensystemen, stellen die extracytoplasmic function (ECF) 
σ Faktoren die dritte große Gruppe innerhalb der bakteriellen Signaltransduktion dar. Eine 
kürzlich durchgeführte phylogenetische Analyse der ECF σ-Faktoren ergab eine große 
Anzahl neuer Gruppen, deren Funktionen und Regulationsmechanismen noch nicht 
aufgeklärt sind. Diese Arbeit beschäftigt sich mit der Untersuchung und Charakterisierung 
der ECF σ-Faktoren der Gruppe 42. ECF σ Faktoren der Gruppe 42 sind stark verbreitet, 
insgesamt in 11 verschiedenen Phyla vorkommend, jedoch am häufigsten in den 
Actinobakterien zu finden. Eine Analyse des genomischen Kontextes der ECF42 σ Faktoren 
in Actinobakterien ergab, dass, im Gegensatz zu den klassischen ECF σ Faktoren, diese 
keinen Anti-σ Faktor im gleichen Operon kodieren. Stattdessen liegen die ECF42 σ Gene 
gemeinsam mit Genen, die für ein konserviertes, sogenanntes DGPF Protein kodieren, in 
einer Transkriptionseinheit. Diese DGPF Proteine sind aber offenbar nicht an der Regulation 
der Aktivität der ECF42 σ Faktoren beteiligt. Der Modellorganismus, auf dem die hier in 
dieser Arbeit gezeigten Daten basieren, ist Streptomyces venezuelae, der drei ECF42 σ 
Faktoren enthält. Zunächst wurden die Promotoren der ECF42 σ Faktoren hinsichtlich ihrer 
Erkennungssequenz TGTCGA (-35 Region) und CGA/TC (-10 Region) untersucht und es 
wurde herausgefunden, dass die Expression der ECF42 σ Faktoren positiv autoreguliert ist. 
Phänotyp Microarrays und RNA-Sequenzierungen wurden durchgeführt, um einen Einblick 
in die zelluläre Funktion der ECF42 σ Faktoren in S. venezuelae zu erlangen und um die 
Regulons dieser zu identifizieren. Dabei wurde herausgefunden, dass die ECF42 σ Faktoren 
hauptsächlich Gene regulieren, die für DGPF Proteine mit unbekannter Funktion kodieren. 
Eine Besonderheit der ECF42 σ Faktoren ist ihre lange C-terminale Verlängerung, die eine 
tetratricopeptide repeat (TPR) Domäne enthält. Diese Domäne ist in den klassischen ECF σ 
Faktoren nicht enthalten. Es wird angenommen, dass die TRP-Domäne eine bedeutende 
Funktion bei Protein-Protein Interaktionen vermittelt. In dieser Arbeit konnte gezeigt werden, 
dass eine Wechselwirkung zwischen C-Terminus und N-terminaler σ-Domäne besteht, die 
sich positiv auf die regulatorische Aktivität des ECF42 σ Faktors auswirkt. Eine Verkürzung 
des C-Terminus hat hingegen einen vollständigen Aktivitätsverlust des ECF42 σ Faktors zu 
Folge, was ebenfalls auf eine enorme Bedeutung des C-Terminus für die Aktivität des 
ECF42 σ Faktors hinweist. Zusammenfassend liefert diese Arbeit erste Einsichten in den 
Mechanismus der Aktivierung der ECF42 σ Faktoren sowie deren zelluläre Funktion. 
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Abstract  
Extracytoplasmic function (ECF) σ factors represent the third most abundant fundamental 
principle of bacterial signal transduction, outnumbered only by one- and two-component 
systems. A recent census of ECF σ factors revealed a large number of novel groups whose 
functions and regulatory mechanisms have not yet been elucidated. Here we report the 
characterization of members of the novel group ECF42. ECF42 σ factors are a highly 
abundant and widely distributed ECF group that is present in 11 phyla, but is predominantly 
found in Actinobacteria. Analysis of the genomic context conservation did not identify a 
putative anti-σ factor in the same operon of ECF σ factor as classical ones. Instead, ECF42 
genes are co-transcribed with genes encoding a conserved so-called ‘DGPF protein’, which 
is not involved in the regulation of ECF42 σ factor activity. We have experimentally verified 
the target promoter of these ECF σ factors ("TGTCGA" in the -35 region and "CGA/TC" in 
the -10 region), which was found upstream of the ECF42-encoding operons in Streptomyces 
venezuelae, suggesting that ECF42 σ factors are positively auto-regulated. ECF42 triple 
deletion mutant of S. venezuelae (Δsven_0747 Δsven_4377 Δsven_7131) was generated and 
submitted for Phenotype Microarrays to identify ECF42-related phenotypes. RNA 
sequencing (RNA-seq) was performed to define the regulons of the three ECF42 proteins in 
S. venezuelae, which identified mostly genes encode DGPF proteins with unknown function. 
In contrast to typical ECF σ factors, ECF42 σ factors are characterized by a long C-terminal 
extension containing a tetratricopeptide repeat (TPR) domain, which is postulated to mediate 
protein-protein interactions. An interaction between the C-terminal extension and the N-
terminal σ domains was hypothesized and supported by experimental evidence from a 
mutational analysis. The putative interaction, mediated by the co-variable residues, plays a 
positive regulatory role on the activity of the ECF42 σ factor. Truncations of the C-terminal 
extension of ECF42 abolished σ factor activity completely, suggesting that it is necessary 
for σ factor activity. In conclusion, this work provides the first insights into the function and 
mechanism behind ECF42 σ factors’ activation. 
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1. Introduction  
1.1 Bacterial σ factors 
The initial step for controlling of gene expression is the transcription of DNA into messenger 
RNA by the RNA polymerase (RNAP). The core RNAP is a complex multi-subunit enzyme 
of five subunits: two identical α subunits, as well as unique β, β´ and ω subunits (Ishihama, 
2000; Gruber and Gross, 2003). Another essential component of the RNAP is the σ factor, 
which binds to the core RNAP creating the RNAP holoenzyme, and is responsible for 
promoter recognition in the initiation phase of transcription (Helmann and Chamberlin, 1988; 
Gruber and Gross, 2003). 
Bacterial σ factors can be classified into two large and phylogenetically unrelated protein 
families, σ54 and σ70 (Helmann and Chamberlin, 1988; Gross et al., 1998), of which the σ70 
is by far the most abundant. This σ factor family includes the essential housekeeping σ 
factors (group 1) and three alternative σ factor groups (Helmann and Chamberlin, 1988; 
Lonetto et al., 1992; Helmann, 2002; Gruber and Gross, 2003): those including the non-
essential paralogs of the housekeeping σ factors (group 2), the flagellar, heat shock and 
sporulation-specific σ factors (group 3) and the extracytoplasmic function (ECF) σ factors 
(group 4). 
Primary σ factors (group 1). The group 1 σ factors include the E. coli σ70 and its 
orthologues (Lonetto et al., 1992). These σ factors are essential proteins responsible for most 
of the transcription in rapidly growing bacterial cells and are thus often called primary σ 
factors (Burgess and Anthony, 2001; Helmann, 2002; Murakami and Darst, 2003). Binding 
of the σ factor to the core RNAP occurs at amino acids 260 to 309 of the β´ subunit (Burgess 
and Anthony, 2001), with weaker binding also mediated by several alternate sites on the β 
and β´ subunits (Arthur and Burgess, 1998; Arthur et al., 2000; Katayama et al., 2000; 
Gruber et al., 2001; Anthony and Burgess, 2002). During transcription initiation, the 
holoenzyme, directed by the σ factor, binds to DNA thereby forming the closed complex, in 
which the DNA is still double-stranded. As the DNA is unwound and the initiation site 
exposed, the DNA/holoenzyme structure forms the open complex, allowing elongation to 
proceed. After transcription initiation, the σ factor is released from the RNAP/DNA complex 
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and can be recycled to bind additional core RNAP complexes to again mediate 
transcriptional initiation (Craig et al., 1998; Sen et al., 2000; Saecker et al., 2002).  
The primary σ factors are usually between 40 to 70 kDa in size and contain four conserved 
protein domains (σ1, σ2, σ3 and σ4) as displayed in Figure 1.1 (Lonetto et al., 1992; Wosten, 
1998; Paget, 2015). Domain σ1 acts to prevent promiscuous binding of the σ factor to DNA 
in the absence of RNAP, and is not conserved among all σ factors (Helmann and Chamberlin, 
1988). Region σ2, or specifically, σ2.1 and σ2.2, are required for binding to core RNAP, while 
region σ2.3 facilitates DNA promoter melting at the "-10" promoter site, and region σ2.4 
recognizes the "-10" consensus sequence "TATAAT", which consists of weak A-T bonds to 
facilitate DNA melting (Aiyar et al., 1994; Shuler et al., 1995; Tatti and Moran, 1995; Joo 
et al., 1997; Sharp et al., 1999; Gruber and Gross, 2003). The σ3 region of σ70 factors interacts 
with the DNA upstream of the "-10" region, which normally contain a "TG" motif located 
at approximately "-15/-14" position on the promoter (Helmann and Chamberlin, 1988; 
Helmann, 1995; Sabelnikov et al., 1995; McCracken and Timms, 1999; Bashyam and 
Hasnain, 2004). The region σ4 contains a helix-turn-helix motif, which interacts with the 
"TTGACA" consensus at the "-35" sequence of the promoter (Campbell et al., 2002; 
Murakami et al., 2002). 
Alternative σ factors (group 2-4). In addition to primary σ factors, most bacteria also 
harbor alternative σ factors, which are non-essential and recognize distinct promoter 
sequences. Alternative σ factors are usually involved in responding to changes in the 
environment and rapidly initiate changes in transcription of specific subsets of genes 
(Helmann, 2002; Paget, 2015). So far, the alternative σ factors are mainly classified into 
three distinct groups (group 2, group3 and group 4) based on structural and functional 
homology (Burgess and Anthony, 2001; Helmann, 2002; Murakami and Darst, 2003). Group 
2 σ factors are structurally very similar to group 1 and contain domains σ1 to σ4 (Fig. 1.1); 
but they are not essential (Helmann, 2002; Gruber and Gross, 2003). Group 3 consists σ 
factors involved in niche-specific regulation and can be further divided based on their 
regulation of heat shock, flagellar or sporulation genes. Structurally, proteins in this group 
typically lack the σ1 domain (Fig. 1.1) (Gruber and Gross, 2003). Group 4 consists of the 
extracytoplasmic function (ECF) σ factors, which were named due to the initial analysis of 
a small number of examples that respond to periplasmic stress and heat shock, iron transport 
or protein secretion (Lonetto et al., 1994). Structurally, proteins of group 4 contain only the 
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σ2 and σ4 domains (Helmann, 2002), which are necessary and sufficient for assembling with 
RNAP and promoter recognition. 
 
Figure 1. 1 Domain architecture of the σ70 protein family. (A) Schematic of a typical promoter, where +1 
represent the transcriptional start site (TSS) and the bent arrow indicate the direction of transcription. The -35 
and -10 sequences of the promoter are represented as grey boxes. These are recognized by the σ4 and σ2 domains, 
respectively. (B) Domain architecture (σ1, σ2, σ3 and σ4) in the four σ70 groups. The σ factors from group 1 
(primary σ factors) and group 2 possess four domains (σ1, σ2, σ3 and σ4), while the σ factors from group 3 lack 
σ1 but possess σ2, σ3 and σ4 domains. The group 4 (ECF) σ factors only contain the σ2 and σ4 domains. 
1.2 Extracytoplasmic function (ECF) σ factors 
The ability of a cell to accurately respond to changing environments and lurking competitors 
is a prerequisite to survive the struggle for suitable habitats. In order to mediate such adaption 
processes, bacteria possess different means to connect an extracellular input with an 
appropriate cellular response. ECF σ factors are the third most abundant fundamental 
principle of bacterial signal transduction, outnumbered only by one- and two-component 
systems (1CS/2CS) (Staron et al., 2009; Huang et al., 2015). This group of alternative σ 
factors regulate diverse processes, such as stress response, differentiation, secondary 
metabolism and virulence (Helmann, 2002; Gicquel et al., 2013; Haines-Menges et al., 2014; 
Luo et al., 2014; Dou et al., 2018; Lopez-Garcia et al., 2018).  
Their hallmark features are summarized in Fig. 1.2 (Helmann, 2002; Mascher, 2013): 
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(i) ECF σ factors share a characteristic protein domain architecture with only two of 
the conserved regions of σ70 proteins remaining, namely σ2 and σ4 (Fig. 1.1), 
which are sufficient for promoter recognition and binding to RNAP.  
(ii) The activity of ECF σ factors is regulated by their cognate anti-σ factors, which 
are often membrane-anchored proteins encoded in the same operon as the σ factor. 
In the absence of a signal, the anti-σ factor tightly binds the σ factor, thereby 
keeping it inactive. Once stimulated, the anti-σ factor releases the σ factor, which 
can then recruit the RNAP core enzyme to redirect transcription initiation to its 
target promoters.  
(iii) ECF σ factors recognize alternative promoter sequences typically containing an 
‘AAC’ motif in the -35 region and a ‘CGT’ in the -10 region.  
(iv) The presence of this promoter motif upstream of the ECF-encoding operon leads 
to positive autoregulation of most ECF σ factors, thereby enhancing their 
activating effect as long as inducing conditions prevail. Once the stimulus cease, 
the simultaneous upregulation of the cognate anti-σ factor then ensures a swift 
shut-off of the σ factor’s activity. 
 
Figure 1. 2 Overview of the hallmark characteristics of ECF σ factors. The ECF σ factor is represented in 
green, and the cognate anti-σ factor and associated processes are highlighted in blue. The RNAP core enzyme 
with its subunits is shown in grey. The promoter is represented by the -35 and -10 boxes; a typical ECF-
dependent promoter signature is shown below. R2/R4, conserved signature regions (regions σ2 and σ4, 
respectively) of σ70 proteins; CM, cytoplasmic membrane; TM, transmembrane region. Figure modified from 
(Mascher, 2013). 
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1.3 Classification of ECF σ factors 
The first work on ECF classification was performed in 2009 and was based on the 
comprehensive phylogenetic analysis of more than 2700 ECF σ factors derived from 369 
microbial genomes (Staron et al., 2009). This work defined 43 major groups (ECF01-ECF43, 
each containing over 10 sequences) (Fig. 1.3) and 24 minor groups (ECF101-ECF124, each 
containing less than 10 proteins). These groups have been defined based on the sequence 
similarity of the ECF σ factors and their cognate anti-σ factors, genomic context 
conservation as well as their group-specific target promoter signature. With an ever-
increasing number and diversity of completed bacterial genome sequences becoming 
available, 28 additional new groups of ECF σ factors were subsequently defined and 
described (Gomez-Santos et al., 2011; Jogler et al., 2012; Huang et al., 2015). Thus, there 
are currently 94 ECF groups described, which include 62 major groups (ECF01-ECF63) and 
32 minor groups (ECF101-ECF132). The main characteristics of each group regarding their 
genomic context conservation, taxonomic distribution, experimentally studied members, 
signaling and regulatory mechanism, and their (putative) physiological role have recently 
been summarized (Pinto and Mascher, 2016b). 
 
Figure 1. 3 Phylogenetic tree of ECF σ factors (Staron et al., 2009). The phylogenetic tree of ECF σ factors 
is based on a gapless multiple sequence alignment of regions σ2 and σ4, from the two most distant 
representatives from within each group. Each triangle represents one major group, color-coded according to 
the phylogenetic distribution of the ECFs factors. Thus, the length of the triangle’s edges reflects the overall 
sequence diversity within the group (the longer the edges, the larger the sequence diversity within this group). 
CLUSTALW (Thompson et al., 1994) was used to construct the multiple sequence alignments. The tree was 
calculated by the Least Squares method of the Phylip (Felsenstein, 1989) programs PROTDIST and FITCH, 
which are implemented in the BioEdit Sequence Alignment Editor. For reasons of clarity, only the 32 most 
important groups are shown, which contain at least 20 proteins in the data set and/or show an extended genomic 
context conservation. Figure modified from (Staroń et al., 2009). 
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1.4 Physiological function of ECF σ factors 
Although thousands of ECF σ factors have been identified and classified, only few of them 
have been characterized experimentally regarding their physiological functions. Based on 
the studies up to date, ECF σ factors in bacteria are involved in very diverse physiological 
processes, such as stress response, uptake process, secondary metabolism, virulence and the 
development or morphology of cells. The diverse functions of ECF σ factors that have 
already been characterized shall be briefly summarized in the next paragraphs. The ECF σ 
factors related functions from each ECF group have also been concluded in Table 1.1. 
Envelope stress responses. The well-studied example of ECF σ factors involved in 
envelope stress responses is the Bacillus subtilis σW that belongs to group ECF01 (Helmann, 
2006). In this case, the σW regulon was strongly induced by several antibiotics, most of which 
interfere with cell wall biosynthesis (Cao et al., 2002). Another example is the E. coli σE 
classified in group ECF02, which can be activated by heat or other stresses that generate 
unfolded envelope proteins thereby initiates the expression of genes encoding proteins for 
envelope synthesis (Alba and Gross, 2004).  
Oxidative stress responses. Numerous groups of ECF σ factors are involved in oxidative 
stress responses (Table 1.1). Disruption of these ECF σ factors coding genes rendered the 
bacterial cells more sensitive to oxidative stress. This ECF-related phenotype was founded 
by the studies on the σH (group ECF12) of Corynebacterium glutamicum (Kim et al., 2005), 
σE (ECF14) of Mycobacterium tuberculosis (Wu et al., 1997), σT (ECF15) of Caulobacter 
crescent (Alvarez-Martinez et al., 2007), σF (ECF16) of C. crescentus (Alvarez-Martinez et 
al., 2006), σO (ECF21) of Bacteroides fragilis (Ndamukong et al., 2013), σM (ECF27) of 
Corynebacterium glutamicum (Nakunst et al., 2007), σF (ECF33) of Bradyrhizobium 
japonicum (Masloboeva et al., 2012), σR (ECF39) of Streptomyces coelicolor (Paget et al., 
1998) and σJ (ECF41) of M. tuberculosis.  
Acquisition and secretion process. The well-characterized ECF σ factor involved in 
acquisition process is the E. coli σFecI, which control the transcription of the fecA operon 
coding a specific ferric citrate uptake system (Helmann, 2002). In this case, the presence of 
ferric citrate leads its binding to the outer membrane FecA protein under the Fe-limiting 
growth conditions. The signal generated by binding of ferric citrate with FecA is 
subsequently transmitted by FecA across the outer membrane into the periplasm to the anti-
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σ factor FecR, which leads the release of σFecI from FecR resulting transcription of the fecA 
operon. Such an ECF σ factors involved iron uptake system has been demonstrated in 
Pseudomonas putida, Pseudomonas aeruginosa, Serratia marcescens, Klebsiella 
pneumoniae, Aerobacter aerogenes, Bordetella pertussis, B. bronchseptica, B. avium, and 
Ralstonia solanacearum, which  has been reviewed by Braun and Mahren (Braun and 
Mahren, 2005). In contrast to acquisition, σU of S. coelicolor belongs to group ECF17, and 
has been found to be involved in protein secretion (Gordon et al., 2008). 
Biosynthesis of antibiotics and other secondary metabolite. Biosynthesis of antibiotics is 
generally a complicated process and regulated by many factors in bacteria. As a regulator, 
ECF σ factors have been demonstrated that involved in the biosynthesis of antibiotics in 
many bacterial organisms. The σMibx (ECF20) as a positive regulator is involved in the 
microbisporicin synthesis in Microbispora coralline (Foulston and Bibb, 2011). The σT 
(ECF27) of S. coelicolor (Mao et al., 2013) and σY (ECF31) of Bacillus subtilis (Mendez et 
al., 2012) are involved in the production of actinorhodin and sublancin respectively. In 
addition, σ25 (ECF39) and σ6 (ECF41) of Streptomyces avermitilis are both involved in the 
production of avermectin (Jiang et al., 2011; Luo et al., 2014). 
Pathogenicity and virulence. Virulence and virulence-associated genes are those that 
contribute to at least one aspect of bacterial disease transmission and infection processes. 
The expression of virulence and virulence-associated genes in response to particular stimuli 
is often regulated by ECF σ factors, which have been demonstrated in many cases.  The σL 
(ECF17) of Mycobacterium tuberculosis regulates polyketide synthases and secretion of 
membrane proteins that are required for virulence (Hahn et al., 2005). While  the σD (ECF40) 
of M. tuberculosis governs the expression of a small set of ribosomal genes typically 
expressed in stationary phase during in vitro growth and that loss of σD reduces macrophage 
TNF-alpha secretion as well as the lethality of M. tuberculosis infection in mice (Calamita 
et al., 2005). Other than M. tuberculosis, the virulence related ECF σ factors have been also 
found in other pathogens, such as σE of Salmonella enterica Serovar Typhimurium 
(Humphreys et al., 1999), σHrpL (ECF32) of Pseudomonas syringae (Ferreira et al., 2006) 
and σPvdS (ECF09) of Pseudomonas aeruginosa (Wilderman et al., 2001). 
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Table 1. 1 Physiological functions of characterized ECF σ factors.  
ECF group ECF name Organism Function Reference 
ECF01 Sig W B. subtilis  
Envelope stress response, antimicrobial compound resistance and 
detoxification 
(Helmann, 2006) 
ECF02 
Sig E E. coli  Envelope stress response  
(Alba and Gross, 
2004) 
Sig 22 P. aeruginosa  Cell wall stress response and alginate production 
(Wood and Ohman, 
2009) 
ECF05 Sig FpvI P. aeruginosa  Uptake of the siderophores ferrichrome and desferrioxamine 
(Mettrick and 
Lamont, 2009) 
ECF07 Sig HasI S. marcescens  Haem uptake (Biville et al., 2004) 
ECF08 Sig VreI P. aeruginosa  Adaptive response to phosphate-limiting conditions (Faure et al., 2013) 
ECF09 Sig PvdS P. aeruginosa  Iron uptake (Leoni et al., 2000) 
ECF10 Sig B. thetaiotaomicron  Mobilizing complex carbohydrates (Xu et al., 2004) 
ECF11 Sig RpoE R. sphaeroides  Response to superoxide stress (Anthony et al., 2005) 
ECF12 
Sig R S. coelicolor  Disulphide and oxidative stress response, mycothiol metabolism 
(Paget et al., 2001; 
Newton and Fahey, 
2008; Feeney et al., 
2017) 
Sig H C. glutamicum  Oxidative and heat stress (Kim et al., 2005) 
ECF13 Sig MsrAB N. gonorrhoeae  Oxidative damage response 
(Gunesekere et al., 
2006) 
ECF14 Sig E M. tuberculosis  Heat shock, acidic pH, detergent and oxidative stress (Wu et al., 1997) 
ECF15 
Sig T C. crescentus  Osmotic and oxidative stress responses 
(Alvarez-Martinez et 
al., 2007) 
Sig PhyR M. extorquens  Carbon starvation and heat shock 
(Gourion et al., 2008; 
Francez-Charlot et al., 
2009a) 
Sig RpoE S. meliloti  Heat and salt,  carbon and nitrogen starvation (Sauviac et al., 2007) 
ECF16 Sig F C. crescentus  Oxidative and heavy metal stress response 
(Alvarez-Martinez et 
al., 2006; Kohler et 
al., 2012) 
ECF17 
Sig U S. coelicolor  Protein secretion (Gordon et al., 2008) 
Sig L M. tuberculosis  Polyketide synthases and virulence (Hahn et al., 2005) 
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ECF group ECF name Organism Function Reference 
ECF18 Sig RpoT P. putida  Tolerance of toluene and other organic solvents (Duque et al., 2007) 
ECF19 Sig K M. bovis  Production of antigenetic proteins (Charlet et al., 2005) 
ECF20 Sig CnrH C. metallidurans  Nickel resistance (Grosse et al., 2007) 
ECF20 
ECF21 
Sig Mibx M. coralline  Antibiotic biosynthesis and immunity 
(Foulston and Bibb, 
2011) 
Sig O B. fragilis  Oxidative stress response 
(Ndamukong et al., 
2013) 
ECF26 Sig E S. novella  Involving thiosulfate-oxidizing pathway (Kappler et al., 2001) 
ECF26 
ECF27 
Sig Prtl P. fluorescens  Production of the germination-arrest factor (Okrent et al., 2014) 
Sig M C. glutamicum  Heat, cold and thiol-oxidant diamide stress (Nakunst et al., 2007) 
ECF27 
ECF30 
Sig T S. coelicolor  Cell differentiation and actinorhodin production 
(Feng et al., 2011; 
Mao et al., 2013) 
Sig V B. subtilis  Resistance to lysozyme (Hastie et al., 2013) 
ECF31 Sig Y B. subtilis  Sublancin producing and resistance (Mendez et al., 2012) 
ECF32 Sig HrpL P. syringae  Hypersensitive response and pathogenicity (Ferreira et al., 2006) 
ECF33 Sig F B. japonicum  Oxidative stress response 
(Masloboeva et al., 
2012)  
ECF36 Sig C M. tuberculosis  Pathogenesis and adaptive survival in the host (Karls et al., 2006) 
ECF39 Sig R S. coelicolor  Cell envelope stress response (Kang et al., 1999) 
ECF39 
ECF40 
Sig 25 S. avermitilis  Biosynthesis of avermectin and aligomycin (Luo et al., 2014) 
Sig D M. tuberculosis  Pathogenesis (Calamita et al., 2005) 
ECF41 Sig J M. tuberculosis   Oxidative stress response (Hu et al., 2004) 
ECF41 Sig 6 S. avermitilis  Production of avermectin (Jiang et al., 2011) 
ECF42 Sig 10 P. putida  Antibiotic stress response and biofilm formation 
(Tettmann et al., 
2014) 
ECF44 Sig CorE M. xanthus  Copper homeostasis 
(Gomez-Santos et al., 
2011) 
ECF52 Sig 52 S. coelicolor  Cell morphogenesis and secondary metabolism 
(Lopez-Garcia et al., 
2018) 
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Taken together, ECF σ factors are involved in very diverse physiological processes and 
functions in bacteria as we enumerated here, which include (i) cell wall stress response; (ii) 
specific oxidative stress; (iii) Acquisition and secretion process; (iv) biosynthesis of 
antibiotics and (v) pathogenicity and virulence. In addition to the known physiological 
functions of the group-define ECF σ factors captured by this classification, novel 
physiological roles of ungrouped ECF σ factors are unraveled continuously. For example, 
Myxococcus xanthus σDdvS have been revealed that involved in regulating the expression of 
the CRISPR-Cas system, thereby against invading genetic elements (Gaballa et al., 2018a). 
As more bacterial complete genomes are available, more and more diverse groups of ECF σ 
factors will be defined, meanwhile, more unknown physiological functions of ECF σ factors 
will be disclosed.  
1.5 Mechanism of ECF σ factor activation 
Most of ECF σ factors require a negative regulatory function to keep them inactive as long 
as non-inducing conditions prevail, thus, the activation of ECF σ factor is the first step for 
ECF σ factors to respond to a stimulus. Generally, the activity of ECF σ factors is inhibited 
by the association with their cognate anti-σ factors in the absence of an inducing stimulus 
(Fig. 1.2). However, the ECF classification already indicated that ECF-based signal 
transduction is far more complex and diverse than has been recognized and appreciated so 
far. This diversity in activating ECF σ factors shall be described in the following sections.  
1.5.1 Regulated proteolysis of membrane-anchored anti-σ factors 
Regulated proteolysis of membrane-anchored anti-σ factors is the best-understood 
mechanism of ECF σ factor activation. This activation mechanism was described or 
proposed for the ECF σ factors from groups ECF01-ECF04, ECF17, ECF30 and ECF40 
(Ellermeier and Losick, 2006; Wood and Ohman, 2009; Hastie et al., 2013; Jaiswal et al., 
2013) (Fig. 1.4 A). The well-studied example is that of E. coli σRpoE and its inhibitory 
regulator RseA, which is a membrane protein functions as an anti-σ factor (Helmann, 2002). 
In this case, the activity of σRpoE is primarily determined by the ratio of RseA to σRpoE. RseA 
can be rapidly degraded by the putative inner membrane serine protease (DegS) in response 
to extracytoplasmic stress of accumulation of misfolded or unfolded protein. This leads an 
increase in the free pool of σRpoE and initiates the transcription of σRpoE from its target 
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promoter (Ades et al., 1999). Another characterized example is that of B. subtilis σw 
(Helmann, 2002; Heinrich and Wiegert, 2009).  Briefly, the membrane-anchored anti-σ 
factor binds σw and inhibits its activity in the absence of an inducing stimulus. Once the 
specific stimulus is perceived, the anti-σ factor release the σw from its inhibitory grip due to 
its three successive proteolytic steps: First, the cleavage of the extracellular domain (site-1) 
of the anti-σ factor. Second, the cleavage of the transmembrane helix (site-2) regulated by 
intramembrane proteolysis. Third, the degradation of the cytoplasmic portion of the anti-σ 
factor mediated by the cytoplasmic Clp-protease complex. This leads to the release of σw its 
anti-σ factor, allowing it to assemble with the RNAP and initiate the transcription of its target 
genes.  
1.5.2 Conformational change of the anti-σ factor 
ECF σ factors can be activated by disassociation from their cognate anti-σ factor not only by 
proteolytic degradation of the anti- σ factor but also by conformational changes (Fig. 1.4 B). 
This mechanism of ECF activation has been experimentally verified or proposed for 
members of the groups ECF11-ECF14, ECF101, ECF117 and ECF126 (Kang et al., 1999; 
Zdanowski et al., 2006; Dufour et al., 2008; Barik et al., 2010; Greenwell et al., 2011). The 
best-understood paradigms are RpoE (σ)-ChrR (anti-σ) from Rhodobacter sphaeroides 
(ECF11). In this case, the soluble anti-σ factor ChrR senses redox stress through a 
mechanism involving disulfide bridge formation of the conserved cysteine residues in its C-
terminal region. This leads to the conformational change of ChrR and release of RpoE from 
the RpoE-ChrR complex. This allows for initiation of transcription from the target promoters 
of RpoE (Greenwell et al., 2011). The similar activation mechanism of ECF σ factor has also 
been demonstrated for SigR (σ)-RsrA (anti-σ) of Streptomyces coelicolor (ECF12), which 
is involved in mounting the disulfide stress response. The RsrA consist of 105 amino acids 
including 7 cysteines. In its reduced state, RsrA binds a single zinc atom (Zn-RsrA) and 
forms a 1:1 complex with SigR that suppresses its transcriptional activity (Kang et al., 1999). 
Once a “trigger disulfide” is formed in RsrA in the presence of suitable stimulus, it will drive 
the expulsion of the bound metal ion and to cause a change in protein conformation (Li et 
al., 2003). This in turn disrupts the SigR complex, releasing SigR to bind RNA polymerase.  
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Figure 1. 4 Activation mechanisms of ECF σ factors. ECF σ factors and anti-σ factors are shown in gray 
and blue, respectively. The histidine kinases, serine/threonine kinases and response regulators are shown in 
brown. “+” or “-” indicates the presence or absence of a trigger stimulus. Figure  from (Mascher, 2013). 
1.5.3 Activation of ECF σ factors by protein-protein interaction 
Activation of ECF σ factors through protein-protein interaction cascades is the third well-
described mechanism of ECF σ factor activation, which normally involves additional outer 
membrane proteins along with the σ and anti-σ proteins (Fig. 1.4 C). Such a mechanism was 
proposed for ECF σ factors of groups ECF05-ECF08, ECF10, ECF19 and ECF46 (Biville et 
al., 2004; Braun and Mahren, 2005; Mettrick and Lamont, 2009; Shukla et al., 2014). The 
best-described example is the FecI (σ)-FecR (anti-σ) pair from E. coli. In the absence of a 
stimulus, FecI is kept inactive by its cognate membrane-associated anti-σ factor, which 
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contains a N-terminal anti-σ domain and a C-terminal FecR domain. Once the inducing 
stimulus, iron-citrate, is bound to the outer membrane protein FecA. The FecA will then 
interact with the periplasmic domain of the anti-σ FecR. This interaction leads the release of 
the σ factor FecI, bound to the cytoplasmic domain of FecR, and resulting active FecI then 
initiate the transcription of the fecA operon coding a specific citrate uptake system (Helmann, 
2002).  
1.5.4 Activation of ECF σ factors through partner-switching mechanism 
The activation of ECF σ factors based on the partner-switching mechanism is achieved by a 
third partner protein, which competitively binds the anti-σ factor, thereby extricating the σ 
factor from the inhibitory grip of anti-σ factor (Fig. 1.4 D). The remarkable example of such 
a mechanism is demonstrated by σEcfG (ECF15), anti-σ (NepR) and a third partner (PhyR) in 
Alphaproteobacteria (Campagne et al., 2012). PhyR is a response regulator of a bacterial 
2CS and is unique in that it not only contains a classic receiver domain with the conserved 
phosphorylation site and catalytical motifs, but also contains an output domain that shows 
homology to ECF σ factors. The ECF σ factor-like output domain retains an ECF σ factor 
fold but lacks the σ2.4 region and degenerate in σ4.2 region (Herrou et al., 2010), thereby 
without having the DNA-binding ability. In the absence of an inducing stimulus, the σEcfG is 
sequestered by its cognate anti-σ (NepR), and the anti-σ antagonist, PhyR, remains in an 
unphosphorylated inactive state. Once triggered by a suitable stimulus, PhyR becomes 
phosphorylated and binds to NepR competitively via its ECF σ factor-like output domain. 
This leads the release of σEcfG from NepR and directs transcription of genes toward the stress 
response (Francez-Charlot et al., 2009b; Campagne et al., 2012). 
1.5.5 Transcriptional activation of ECF σ factors 
In addition to anti-σ factors, which link the input to the ECF σ factor, other regulators, such 
as two-component systems (2CS) can also play a role on the connection between signal input 
and ECF regulation, in this case at the level of transcription (Fig. 1.4 F). Such a mechanism 
was described for ECF σ factors from group ECF30, ECF32 and ECF39 (Paget et al., 1999a; 
Nizan-Koren et al., 2003; Hastie et al., 2013). In the case of σE (ECF39) from S. coelicolor, 
its expression is induced by the 2CS CseBC upon cell envelope stress. As a result of sigE 
expression, the σE-target genes – encoding the enzymes necessary for cell wall biosynthesis 
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– are upregulated (Paget et al., 1999b; Hong et al., 2002). Another example for such an ECF 
activation mechanism was also reported for σHrpL (ECF32) from Pseudomonas syringae. In 
this case, the HrpXY-like 2CS regulates the transcription of gene encoding σHrpL indirectly, 
via control of the expression of two homologous DNA-binding proteins, which induce the 
expression of σHrpL directly (Merighi et al., 2003; Lan et al., 2006). 
1.5.6 Activation of ECF σ factors by Ser/Thr protein kinases 
Based on comparative genomics analysis, a number of conserved ECF groups (ECF22, 
ECF42 and ECF43) were found to lack a recognizable anti-σ factor but instead seem to be 
co-expressed with neighboring genes encoding serine/threonine protein kinases (Staron et 
al., 2009; Jogler et al., 2012). These proteins are predominantly found in eukaryotic signal 
transducing cascade, but are also involved in regulating a number of processes in bacteria 
through phosphorylation of downstream regulators or enzymes (Dworkin, 2015). The 
conserved genomic context for these ECF groups indicates that serine/threonine kinases 
might contribute to ECF σ factor-dependent signal transduction through integrating or 
sensing the upstream signal and activating the ECF σ factor by phosphorylation (Fig. 1.4 G). 
Indeed, such a mechanism was most recently described for a member of group ECF43 from 
Xanthomonas citri (Bayer-Santos et al., 2018). 
1.5.7 Regulation of ECF σ factor activity by its C-terminal extension  
In contrast to the classical ECF σ factors, which only harbor the σ2 and σ4 domains, a number 
of ECF σ factor groups (ECF41, ECF42, ECF44, ECF45, ECF48, ECF52, ECF53, ECF56 
and ECF57) contain an additional C-terminal extension (Pinto and Mascher, 2016b) 
(Fig. 1.4 E). It has been demonstrated that small truncations of the C-terminal extension of 
ECF41 from Bacillus licheniformis increases its activity, suggesting that the C-terminal 
extension of ECF41 play an anti-σ factor-like role on the activity of ECF41. However, 
truncation of the whole C-terminal extension results in the complete loss of ECF41 activity, 
which contrarily indicates that the C-terminal extension is necessary for the activity of 
ECF41 (Wecke et al., 2012). In the case of CorE-like proteins (group ECF44), it has been 
demonstrated that binding of Cu2+ or other divalent metal ions to the Cys-rich domain (CRD) 
of the C-terminal extension of ECF44 is essential for its activity, while binding of Cu1+ 
inhibits the σ factor (Marcos-Torres et al., 2016). These studies suggest that such a C-
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terminal extension may play a dual role, contributing both for the activation and inhibition 
of ECF σ factors. However, the exact regulatory mechanism of the C-terminal extension is 
still poorly understood. 
1.6 Streptomyces venezuelae and its ECF σ factors 
Streptomycetes are high GC Gram-positive bacteria predominantly found in soil.  
Streptomyces have received tremendous scientific attention since these microorganisms are 
characterized by a complex secondary metabolism, providing over two-thirds of the 
clinically useful antibiotics of natural origin (Liu et al., 2013). In addition, Streptomyces is 
also characterized by remarkably complex developmental features, which usually grows as 
branching hyphal filaments to form a mat of fungus-like mycelium, from which emerge 
serial branches that bear chains of spores (Fig. 1.5). In brief, a germ tube emerges from the 
spore and grows by tip extension and branch formation to form the substrate mycelium. In 
response to nutrient depletion and other signals, aerial hypha breaks the surface tension and 
grow into the air to form the aerial hypha, which will further extend to a long chain that 
contains many tens of nucleoids. When aerial hypha growth stops, multiple septa subdivide 
the apical compartment into single-nucleoid pre-spore compartments. After complex 
morphological and metabolic processes such as remodeling and thickening of the cell wall, 
condensation of the chromosome and production of the spore pigment, the pre-spore 
compartments develop into mature spores. The life cycle of the most widely studied model 
organism of Streptomyces, S. coelicolor, is shown in Fig. 1.5.  
It is the complexity of their life cycle and the environment they live in that requires 
Streptomyces requires multitudinous signaling devices such as ECF σ factors. Two species 
of Streptomyces – S. coelicolor and S. griseusi (Worthen, 2008) are mostly chosen organisms 
for investigation of genetics and cell biology of Streptomyces. Besides, S. venezuelae, the 
producer of chloramphenicol, has recently been also established as a new model organism 
for studying Streptomyces development  (Bibb et al., 2012), since both S. coelicolor and 
S. griseusi fail to produce spores in liquid medium, the aerial hyphae constitute only about 
10% of the total biomass and cannot be separated from the non-differentiating vegetative 
mycelium. By contrast, S. venezuelae sporulates rapidly, synchronously and 
comprehensively in liquid culture (Glazebrook et al., 1990), which makes S. venezuelae 
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especially suitable for sensitive biochemical, cytological and molecular studies of 
developmental states.  
 
Figure 1. 5 Development life cycle of S. coelicolor. Under favorable conditions, the germ tube emerges from 
the spore and grows by tip extension and branch formation to form the vegetative hypha. In response to nutrient 
depletion and other signals, aerial hypha breaks the surface tension and grow into the air to form the aerial 
hypha. The aerial hypha further extends to a long chain that contains many tens of nucleoids. When the aerial 
hypha stops growing, multiple septa subdivide the apical compartment into single-nucleoid pre-spore 
compartments. After complex morphological and metabolic processes such as remodeling and thickening of 
the cell wall, condensation of the chromosome and production of the spore pigment, the pre-spore 
compartments develop into mature spores. Figure from (Flardh and Buttner, 2009) 
The genome sequence of S. venezuelae ATCC10712 was released in 2011 (GenBank 
Accession No. NC_018750). It has a size of 8.2 Mb and encodes 7318 proteins, including 
40 ECF σ factors from 23 distinct ECF groups (Table 1.2). This is far more than the 6 ECF 
σ factors per genome that are found on average in bacteria (Staron et al., 2009). This high 
number of ECF σ factors in the streptomycetes in general may reflect its rapid and precise 
regulation of intricate development process and diverse stress responses for adaptation in 
complex environments. To date, only ECF121 σBldN (Sven_3158) has been investigated in 
S. venezuelae and it has been shown to play a pivotal role in the developmental cascade that 
directly activates expression of the chaplin and rodlin genes encoding the hydrophobic 
sheath proteins of S. venezuelae (Bibb et al., 2012). The functions of the rest ECF σ factors 
investigated in other species of Streptomyces are listed in Table 1.2, which may provide 
useful information for future research on S. venezuelae.    
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Table 1. 2 ECF σ factors in S. venezuelae and other streptomycetes. 
Locus 
ECF 
group 
Functions in Streptomyces genus Name References 
SVEN_4513 ECF02    
SVEN_4870 ECF12 
Global regulator of redox homeostasis in 
S. coelicolor 
SigR 
(Feeney et 
al., 2017) 
SVEN_4793 ECF14    
SVEN_0063 ECF17 Protein secretion in S. coelicolor SigU 
(Gordon et 
al., 2008) 
SVEN_0399 ECF19    
SVEN_6501 ECF20    
SVEN_3668 ECF27 Actinorhodin production in S. coelicolor SigT 
(Feng et 
al., 2011)  
SVEN_6961 ECF34    
SVEN_0176 ECF36    
SVEN_2914 ECF38    
SVEN_3369 ECF38    
SVEN_6611 ECF38    
SVEN_3215 ECF39 
Cell envelope stress response in S. coelicolor;  
Biosynthesis of avermectin and oligomycin in 
S. avermitilis 
SigE 
Sig25 
(Paget et 
al., 1999b) 
(Luo et al., 
2014) 
SVEN_3278 ECF39 
SVEN_3293 ECF39 
SVEN_3759 ECF39 
SVEN_4575 ECF39 
SVEN_4454 ECF40    
SVEN_0136 ECF41 
Negative regulator of avermectin production in 
S. avermitilis 
Sig6 
(Jiang et 
al., 2011) 
SVEN_0858 ECF41 
SVEN_3295 ECF41 
SVEN_3475 ECF41 
SVEN_3480 ECF41 
SVEN_3821 ECF41 
SVEN_3859 ECF41 
SVEN_1176 ECF41 
SVEN_0747 ECF42    
SVEN_4377 ECF42    
SVEN_7131 ECF42    
SVEN_0980 ECF50    
SVEN_0015 ECF51    
SVEN_3871 ECF52 
Secondary metabolism and morphogenesis in 
S. coelicolor 
Sig52 
(Lopez-
Garcia et 
al., 2018)  
SVEN_0434 ECF53    
SVEN_6745 ECF53    
SVEN_4562 ECF56    
SVEN_4974 ECF118    
SVEN_3185 ECF121 
Cell development and morphogenesis in 
S. venezuelae 
SigBldN 
(Bibb et al., 
2012)  
SVEN_4540 ECF123    
SVEN_4229 ECF126    
SVEN_4487 Ungrouped    
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1.7 Aims of this study 
This study focuses on a novel group of ECF σ factors, ECF42, which is characterized by a 
long C-terminal extension. These extensions contain a tetratricopeptide repeat (TPR) domain 
(Staron et al., 2009), which is postulated to be important for protein-protein interaction 
(D'Andrea and Regan, 2003). Genes encoding ECF42 proteins are not genomically 
associated with obvious anti-σ factor-encoding genes. Instead, the large majority is 
associated with genes encoding DGPF proteins of unknown function. So far, none of the σ 
factors belonging to ECF42 has been experimentally studied, with the exception of ECF-10 
from Pseudomonas putida, which was found to be involved in stress resistance and biofilm 
formation (Tettmann et al., 2014). ECF42 proteins are particularly widely distributed in the 
Actinobacteria and the genome of S. venezuelae encodes three σ factors of this group 
(Table 1.1). 
The aims and approaches of my thesis are summarized below: 
Aim 1 (Target promoter determination): ECF σ factors perform their functions by 
regulating transcription of their target genes, which normally harbor an ECF group- specific 
target promoter. Identification of ECF target promoters enables the prediction of their target 
regulons, thereby providing a direct access to the physiological role of ECF-dependent 
regulation. As part of this thesis, the target promoter of ECF42 shall be predicted by 
bioinformatics analysis and subsequently experimentally verified.  
Aim 2 (Physiological roles): The phylogenetic distribution analysis shows that ECF42 σ 
factors are highly abundant in Actinobacteria, especially in the genus Streptomyces. The 
physiological role of ECF42 in S. venezuelae shall be investigated by phenotypically 
screening ECF42-mutants and by defining the target regulons of ECF42 σ factors. 
Aim 3 (Regulatory mechanism): ECF42 genes lack obvious anti-σ factor-encoding genes 
in their vicinity, as do classical ECF σ factors, but instead, are associated with genes 
encoding DGPF proteins. Additionally, ECF42 σ factor harbor a conserved C-terminal 
extension domain (TPR), which may be involved in mediating protein-protein interactions. 
Thus, the regulatory role of the DGPF protein and the C-terminal extension on the activity 
of ECF42 σ factor shall be investigated in this study by in vivo and in vitro approaches, in 
order to unravel the signaling mechanism of ECF42 σ factors. 
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2. Materials and methods 
2.1 Bioinformatics analysis 
2.1.1 Phylogenetic distribution of ECF42 σ factors 
The protein sequence of ECF42 σ factor from S. venezuelae (Sven_4377) was submitted to 
NCBI blastp and run against the non-redundant protein sequences database. The sequences 
of the complete 10,010 hits were extracted in December 2017. False positives (i.e., proteins 
that did not belong to the ECF42 group) and proteins from more than one sequenced strain 
per species were removed leaving 2661 protein sequences for further analysis. Multiple 
sequence alignments were performed using ClustalW (Thompson et al., 1994) and the 
phylogenetic tree was generated from the gapless multiple alignments using the Neighbor-
Joining method and Jukes-Cantor protein distance model, as implemented in CLC Main 
Workbench (Qiagen). 
2.1.2 Genomic context analysis of ECF42 encoding genes 
Genomic context analysis of the ECF42 family (COG4941) was performed by applying the 
multidendrogram approach to create the context tree using the database MicrobesOnline 
(Alm et al., 2005) at http://www.microbesonline.org/. 
2.1.3 Domain architecture analysis of ECF42 σ factors 
Protein domain architecture and alignment of ECF42 σ factors with classical ECF σ factors 
was analyzed using the DNAMAN software package (Lynnon BioSoft, Vaudreuil, Quebec, 
Canada). Classical ECF σ factors were included: RpoE from Streptomyces coelicolor A3(2) 
and Pseudomonas putida KT2440; SigE from Streptomyces avermitilis and S. coelicolor 
A3(2); SigM from S. coelicolor A3(2); SigL from Mycobacterium bovis and S. avermitilis; 
SigK from Mycobacterium sp. JLS and S. avermitilis. The protein sequences of ECF42 σ 
factors were extracted from Xanthomonas campestris pv. Campestris, Rhodopirellula 
baltica, Bacillus cereus, Planctopirus limnophila, S. coelicolor A3(2), S. avermitilis MA, 
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Streptomyces lydicus, Streptomyces griseus, Streptomyces albus and Streptomyces 
venezuelae. 
2.1.4 Identification of the putative target promoter motif of ECF42 σ factors 
Eighteen operons encoding ECF42 σ factors and DGPF proteins were selected and the 250 
base pairs upstream of the starting codon of the first gene of the operon were extracted for 
promoter motif analysis. The presence of a putative promoter motif was investigated with 
the MEME motif discovery tool of the MEME Suite (Bailey et al., 2009), which is available 
at http://meme-suite.org/. Settings are listed in Table 2.1.  
Table 2. 1 Settings used in MEME discovery tool for the identification of ECF42 
putative target promoter motifs. 
Parameter Setting 
Select the motif discovery mode: Normal model 
Select the sequence alphabet: DNA, RNA or Protein 
Select the site distribution: Zero or one occurrence per sequence  
Select the number of motifs: 3 
How wide can motif be: 60 to 50 
Can motif sites be on both strands:  Search given strand only 
 
2.2 Medium, supplements and antibiotics  
2.2.1 Medium and supplements 
Lysogeny broth (LB) broth: 
Tryptone  10 g 
Yeast extract  5 g 
NaCl  10 g 
 H2O   Ad 1 L 
(Agar)  15 g (for LB agar plates) 
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MYM: 
Maltose  4 g 
Yeast extract 4 g 
Malt extract 10 g 
 H2O  Ad 1 L 
Agar 20 g (for MYM agar plates) 
 
R2 trace elements (500x): 
ZnCl2 20 g 
FeCl3·6H2O 100 g 
CuCl2·2H2O 5 g 
 MnCl2·4H2O 5 g 
Na2B4O7·10H2O 5 g 
(NH4)6Mo7O24·6H2O 
 
5 g 
H2O Add to 1 L 
(When needed 2 ml of R2 trace elements was added per liter of MYM medium) 
 
MS (SFM): 
Mannitol 20 g 
Soya flour  4 g 
Malt extract 10 g 
 Tap H2O  Ad 1 L 
Agar 20 g (for MYM agar plates) 
 
III'-Salts:  
MnSO4·4 H2O 0.232 g 
MgSO4·7 H2O 12.3 g 
H2O Add to 1 L 
 
 
                                                                                                                                                 
Materials and methods 
22 
10 x MOPS solution (1 L), adjusted to pH 7 with 10 M KOH: 
MOPS 83.72 g 
KH2PO4 (1M) 3.85 ml 
K2HPO4 (1M) 6.15 ml 
(NH4)2SO4 33 g 
H2O Add to 1 L 
 
MOPS-based chemically defined medium (MCSE): 
10× MOPS solution 10 ml 
Tryptophan (5 mg/ml) 1 ml 
Ammonium ferric citrate (2,2 mg/ml) 1 ml 
III’-Salts 1 ml 
Potassium glutamate (40%) 2 ml 
Sodium succinate (30%) 2 ml 
Fructose (20%) 1 ml 
 
 
 
 
H2O Add to 100 ml 
 
10 x MN-Medium:  
K2HPO4·3H2O         136 g 
KH2PO4 60 g  
Na3C6H5O7 ·2 H2O              10 g 
H2O Add to 1 L 
 
MNGE-Medium (10 ml):  
1 x MN-Medium in H2O 9.2 ml 
Glucose (20%) 1 ml 
KC5H9NO4 (40%) 50 µl 
C6H8O7·Fe·NH3 (2,2 mg/ml) 50 µl 
Tryptophan (5 mg/ml) 100 µl 
MgSO4 (1M) 30 µl 
                                                                                                                                                 
Materials and methods 
23 
Expression Mix: 
Yeast extract (5%) 500 µl 
Casamino-acids (CAA) (10%) 250 µl 
Tryptophan (5 mg/ml) 50 µl 
H2O 250 µl 
 
BioLog metal ion cocktail: 
ZnCl2·7H2O 68 mg 
FeCl2·6H2O 135 mg 
MnCl2·4H2O 99 mg 
CaCl2·2H2O 74 mg 
H2O Add to 100 ml 
 
BioLog inoculating fluid: 
IF-0a medium (Biolog): 6 ml 
Dye mix D, G (Biolog): 72 µl 
Glucose (500 mM): 72 µl 
Metal ion cocktail: 72 µl 
Cell suspension:  696 µl 
H2O: 288 µl 
2.2.2 Antibiotics used for bacterial selection 
Antibiotics used for selection of mutant strains are listed in Table 2.2.  
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Table 2. 2 Antibiotics used for selection of mutant strains. 
Strain Antibiotic 
Working concentration 
(μg/ml) 
B. subtilis 
 
Chloramphenicol 5 
 MLS selection:  
 Erythromycin 1 
 Lincomycin 25 
E. coli Ampicillin 100 
 
 
 
Kanamycin 50 
 Chloramphenicol 50 
 Apramycin  50 
 Hygromycin  50 
S. venezuelae Apramycin  50 
 Thiostrepton  25 
 Hygromycin  50 
 Nalidixic acid  25 
2.3 Bacterial strains, plasmids and oligonucleotides 
Bacterial strains used in this study are listed in Table 2.3. Used vectors and generated 
plasmids are listed in Table 2.4. Oligonucleotides used in this study are listed in appendices 
Table A1.  
Table 2. 3 Strains used in this study. 
Strains Genotype/Description Reference 
E. coli  
DH10ß F-, mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 endA1 araD139 Δ(ara leu) 7697 galU galK rpsL nupG λ– 
Invitrogen 
ET12567 F-, dam-13::Tn9, dcm-6, hsdM, hsdR 
(MacNeil 
et al., 
1992) 
ET12567/pUZ8002 
E. coli ET12567 harboring pUZ8002, a not self-transmissible plasmid which 
can mobilize oriT-containing plasmids by conjugation 
(Flett et 
al., 1997) 
MK01 
F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, Δ(araH-araF)570(::FRT), 
ΔaraEp532::FRT, φPcp8-araE535, rph-1, Δ(rhaD-rhaB)568, hsdR514, 
lacI::cat 
(Kogenaru 
and Tans, 
2014) 
BL21 (DE3) pLys  F-, ompT hsdSB (rB–, mB–) gal dcm (DE3) pLysS (CamR) Invitrogen 
BTH101 F-, cya-99, araD139, galE15, galK16, rpsL1 (Str r), hsdR2, mcrA1, mcrB1 (Karimova 
et al., 
1998) 
TME3007 MK01 Level_M_QL001  (3xflag_ ecf42_4454  + Pecf42_4454_luxCDABE) This work 
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Table 2.3 Strains used in this study (continued). 
Strains Genotype/Description Reference 
E. coli  
TME3008 MK01 Level_M_QL004  (3xflag _ecf42_4454 M01 + Pecf42_4454_luxCDABE) This work 
TME3009 MK01 Level_M_QL005  (3xflag _ecf42_4454 M02 + Pecf42_4454_luxCDABE) This work 
TME3010 MK01 Level_M_QL006  (3xflag _ecf42_4454 M03 + Pecf42_4454_luxCDABE) This work 
TME3011 MK01 Level_M_QL007  (3xflag _ecf42_4454 M04 + Pecf42_4454_luxCDABE) This work 
TME3012 MK01 Level_M_QL008  (3xflag _ecf42_4454 M05 + Pecf42_4454_luxCDABE) This work 
TME3013 MK01 Level_M_QL010  (3xflag _ecf42_4454  T1 + Pecf42_4454_luxCDABE) This work 
TME3014 MK01 Level_M_QL010  (3xflag _ecf42_4454  T2 + Pecf42_4454_luxCDABE) This work 
TME3015 MK01 Level_M_QL010  (3xflag _ecf42_4454  T3 + Pecf42_4454_luxCDABE) This work 
TME3016 MK01 Level_M_QL010  (3xflag _ecf42_4454  T4 + Pecf42_4454_luxCDABE) This work 
TME3017 MK01 Level_M_QL004  (3xflag _ecf42_4454 M07 + Pecf42_4454_luxCDABE) This work 
S. venezuelae  
TMS0001 S. venezuelae ATCC10712 wild type Lab strain 
TMS0039 Δsven_7131 This work 
TMS0044 Δsven_7131 Δsven_4377 This work 
TMS0050 Δsven_0747 Δsven_4377 Δsven_7131 This work 
TMS0112 
Δsven_0747 Δsven_4377Δsven_7131 
attBϕBT1::pIJ10257_N_3xflag_sven_0747 
This work 
TMS0113 
Δsven_0747 Δsven_4377Δsven_7131  
attBϕBT1::pIJ10257_N_3xflag_sven_4377 
This work 
TMS0114 Δsven_0747 Δsven_4377Δsven_7131 
attBϕBT1::pIJ10257_N_3xflag_sven_7131 
This work 
TMS0174 attBϕC31::pGUS This work 
TMS0175 Δsven_0747 Δsven_4377Δsven_7131 attBϕC31::pGUS This work 
TMS0176 
Δsven_0747 Δsven_4377Δsven_7131 
attBϕBT1::pIJ10257_N_3xflag_sven_0747 attBϕC31::pGUS 
This work 
TMS0177 
Δsven_0747 Δsven_4377Δsven_7131  
attBϕBT1::pIJ10257_N_3xflag_sven_4377  attBϕC31::pGUS 
This work 
TMS0178 Δsven_0747 Δsven_4377Δsven_7131  
attBϕBT1::pIJ10257_N_3xflag_sven_7131 attBϕC31::pGUS 
This work 
TMS0179 attBϕC31::pGUS_NP_0747 This work 
TMS0180 Δsven_0747 Δsven_4377 Δsven_7131    attBϕC31::pGUS_NP_0747 This work 
TMS0181 
Δsven_0747 Δsven_4377Δsven_7131 
attBϕBT1::pIJ10257_N_3xflag_sven_0747 attBϕC31::pGUS_NP_0747 
This work 
TMS0182 
Δsven_0747 Δsven_4377Δsven_7131  
attBϕBT1::pIJ10257_N_3xflag_sven_4377  attBϕC31::pGUS_NP_0747 
This work 
TMS0183 
Δsven_0747 Δsven_4377Δsven_7131  
attBϕBT1::pIJ10257_N_3xflag_sven_7131 attBϕC31::pGUS_NP_0747 
This work 
TMS0184 ATCC10712 attBϕC31::pGUS_NP_4377 This work 
TMS0185 Δsven_0747 Δsven_4377 Δsven_7131 attBϕC31::pGUS_NP_4377 This work 
TMS0186 Δsven_0747 Δsven_4377Δsven_7131 
attBϕBT1::pIJ10257_N_3xflag_sven_0747 attBϕC31::pGUS_NP_4377 
This work 
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Table 2.3 Strains used in this study (continued). 
Strains Genotype/Description Reference 
S. venezuelae  
TMS0187 Δsven_0747 Δsven_4377 Δsven_7131  
attBϕBT1::pIJ10257_N_3xflag_sven_4377  attBϕC31::pGUS_NP_4377 
This work 
TMS0188 
Δsven_0747 Δsven_4377Δsven_7131  
attBϕBT1::pIJ10257_N_3xflag_sven_7131 attBϕC31::pGUS_NP_4377 
This work 
TMS0189 attBϕC31::pGUS_NP_7131 This work 
TMS0190 Δsven_0747 Δsven_4377 Δsven_7131    attBϕC31::pGUS_NP_7131 This work 
TMS0191 
Δsven_0747 Δsven_4377Δsven_7131 
attBϕBT1::pIJ10257_N_3xflag_sven_0747 attBϕC31::pGUS_NP_7131 
This work 
TMS0192 
Δsven_0747 Δsven_4377Δsven_7131  
attBϕBT1::pIJ10257_N_3xflag_sven_4377  attBϕC31::pGUS_NP_7131 
This work 
TMS0193 
Δsven_0747 Δsven_4377Δsven_7131  
attBϕBT1::pIJ10257_N_3xflag_sven_7131 attBϕC31::pGUS_NP_7131 
This work 
TMS0036 Δsven_4377::apr pGUS _NP_4377 This work 
TMS0051 Δsven_4377::apr attBϕC31::pGUS _NP_4377 attBϕBT1::pIJ10257_3xflag_ 
sven_4377_T1 (1-179aa) 
This work 
TMS0052 
Δsven_4377::apr attBϕC31::pGUS _NP_4377 attBϕBT1::pIJ10257_3xflag_ 
sven_4377_T2 (1-230aa) 
This work 
TMS0053 
Δsven_4377::apr attBϕC31::pGUS _NP_4377 attBϕBT1::pIJ10257_3xflag_ 
sven_4377_T3 (1-287aa) 
This work 
TMS0054 Δsven_4377::apr attBϕC31::pGUS _NP_4377 
attBϕBT1::pIJ10257_3xflag_sven_4377_T4 (1-353aa) 
This work 
B. subtilis strains   
W168 B. subtilis wild-type trpC Lab strain 
1A774 JH642 rpoC::(6xHis-tag) SpecR 
BGSC (C. 
Moran) 
TMB2572 W168 sacA::pQL3Clux01 (pBS3Clux-NP_sven_0747) This work 
TMB2573 W168 sacA::pQL3Clux01 (pBS3Clux-AP_sven_0747) This work 
TMB2574 W168 sacA::pQL3Clux01 (pBS3Clux-NP_sven_4377) This work 
TMB2575 W168 sacA::pQL3Clux01 (pBS3Clux-AP_sven_4377) This work 
TMB2576 W168 sacA::pQL3Clux01 (pBS3Clux-NP_sven_7131) This work 
TMB2577 W168 sacA::pQL3Clux01 (pBS3Clux-AP_sven_7131) This work 
TMB2650 
W168 lacA::erm PxylA_3xflag-sven_4377 sacA::cat NP_sven_4377 
luxABCDE This work 
TMB2653 
W168 lacA::erm PxylA_3xflag-sven_4377 sacA::cat NP_sven_7131 
luxABCDE 
This work 
TMB2656 
W168 lacA::erm PxylA_3xflag-sven_4377 sacA::cat AP_sven_4377 
luxABCDE 
This work 
TMB2659 
W168 lacA::erm PxylA_3xflag-sven_4377 sacA::cat AP_sven_7131 
luxABCDE 
This work 
TMB2727 1A774 rpoC::(6xHis-tag) SpecR lacA::PxylA_3xflag_ sven_4377) This work 
TMB2728 1A774 rpoC::(6xHis-tag) SpecR lacA::PxylA_3xflag_ sven_7131) This work 
                                                                                                                                                 
Materials and methods 
27 
Table 2. 4 Plasmids used in this study. 
Plasmids Description Reference 
Plasmids for S. venezuelae 
pIJ10257 
Protein overexpression vector, HygR, integrates into the ΦBT1 
attachment site of Streptomyces spp. ermEp* promoter cloned into 
pMS82 
(Hong et al., 
2005) 
pGUS 
AprR, conjugative and Φ31-integrative vector, gus reporter gene without 
promoter 
(Myronovsk
yi et al., 
2011) 
pIJ12738 
pKC1132 with multiple cloning site and I-SceI site from pUC57-
Simple_SceI 
(Fernandez-
Martinez 
and Bibb, 
2014) 
pIJ12742 pGM1190 with ermE*p-I-SceI gene, ThiR 
(Fernandez-
Martinez 
and Bibb, 
2014) pQLS001 pIJ12738 derivative carrying up- and downstream regions of sven_0747  This work 
pQLS002 pIJ12738 derivative carrying up- and downstream regions of sven_4377  This work 
pQLS003 pIJ12738 derivative carrying up- and downstream region of sven_7131  This work 
pQLS004 pIJ10257 derivative carrying 3xflag_sven_0747  This work 
pQLS005 pIJ10257 derivative carrying 3xflag_sven_4377  This work 
pQLS006 pIJ10257 derivative carrying 3xflag_sven_7131  This work 
pQLS007 pGUS derivative carrying putative target promoter of sven_0747  This work 
pQLS008 pGUS derivative carrying putative target promoter of sven_4377  This work 
pQLS009 pGUS derivative carrying putative target promoter of sven_7131 This work 
pQLS010 pIJ10257 derivative carrying 3xflag_sven_4377_T1 (1-537 bp) This work 
pQLS011 pIJ10257 derivative carrying 3xflag_sven_4377_T2 (1-690 bp) This work 
pQLS012 pIJ10257 derivative carrying 3xflag_sven_4377_T3 (1-861 bp) This work 
pQLS013 pIJ10257 derivative carrying 3xflag_sven_4377_T4 (1-1059 bp) This work 
Plasmids for E. coli 
pETDuet-1 Vector designed for co-expression of two target genes Invitrogen 
Level 0-1  MoClo cloning vector (Werner et 
al., 2012) 
Level 0-9  MoClo cloning vector (Werner et 
al., 2012) 
Level 0-15  MoClo cloning vector (Werner et 
al., 2012) 
Level 0-1 L MoClo cloning vector (Werner et 
al., 2012) 
Level 1-1 R  MoClo cloning vector (Werner et 
al., 2012) 
Level 0-11_001 0-11 derivative carrying terminator 01 (Pinto et al., 
2018) 
Level 0-11_002 0-11 derivative carrying terminator 02 (Pinto et al., 
2018) 
Level 1-3 L  MoClo cloning vector (Pinto et al., 
2018) 
Level 1-2 L 
insulator 
MoClo cloning vector (Pinto et al., 
2018) 
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Table 2.4 Plasmids used in this study (continued). 
Description 
Reference 
Plasmids Description Reference 
Plasmids for E. coli 
Level M end-
linker 03  
MoClo cloning vector (Pinto et al., 
2018) 
Level M 
medium copy 
plasmids 
MoClo cloning vector (Pinto et al., 
2018) 
Level 0-1_PBad 0-1 derivative carrying arabinose inducible promoter PBad (Pinto et al., 
2018) 
Level 0_1_Pecf42 0-1 derivative carrying the target promoter of ECF42_4454  (Pinto et al., 
2018) 
Level 0-9_RBS 0-9 derivative carrying ribosome binding site  (Pinto et al., 
2018) 
Level 0-15_lux  0-15 derivative carrying luxCDABE operon (Pinto et al., 
2018) 
Level 0-15 
ECF42_4454 
0-15 derivative carrying ecf42_4454 gene (Locus tag: XCC3792) (Pinto et al., 
2018) 
pQLE001 0-15 derivative carrying 3xflag_ecf42_4454 gene This work 
pQLE002 0-15 derivative carrying 3xflag truncated ecf42_4454 gene T1 (1-180aa) This work 
pQLE003 0-15 derivative carrying 3xflag truncated ecf42_4454 gene T2 (1-232aa) This work 
pQLE004 0-15 derivative carrying 3xflag truncated ecf42_4454 gene T3 (1-294aa) This work 
pQLE005 0-15 derivative carrying 3xflag truncated ecf42_4454 gene T4 (1-355aa) This work 
pQLE006 0-15 derivative carrying gene coding for a mutated ECF42_4454 M01 
(S191A) 
This work 
pQLE007 0-15 derivative carrying gene coding for a mutated ECF42_4454 M02 
(V195A) 
This work 
pQLE008 0-15 derivative carrying gene coding for a mutated ECF42_4454 M03 
(I199A) 
This work 
pQLE009 0-15 derivative carrying gene coding for a mutated ECF42_4454 M04 
(N201A) 
This work 
pQLE010 0-15 derivative carrying gene coding for a mutated ECF42_4454 M05 
(R214A) 
This work 
pQLE011 0-15 derivative carrying gene coding for a mutated ECF42_4454 M07 
(S191A, V195A, I199A, N201A) 
This work 
pQLE012 1-1 R derivative carrying PBAD promoter driving the expression of  3xflag 
ecf42_4454  
This work 
pQLE013 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 T1 (1-182aa) 
This work 
pQLE014 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 T2 (1-235aa) 
This work 
pQLE015 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 T3 (1-295aa) 
This work 
pQLE016 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 T4 (1-370aa) 
This work 
pQLE017 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 M01 (S191A) 
This work 
pQLE018 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 M02 (V195A) 
This work 
pQLE019 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 M03 (I199A) 
This work 
pQLE020 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 M04 (N201A) 
This work 
pQLE021 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 M05 (R214A) 
This work 
pQLE022 1-1R derivative carrying PBAD promoter driving the expression of 3xflag 
ecf42_4454 M07 (S191A, V195A, I199A, N201A) 
This work 
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Table 2.4 Plasmids used in this study (continued). 
Description 
Reference 
Plasmids Description Reference 
Plasmids for E. coli 
pQLE023 1-1R derivative carrying Pecf42_4454 promoter driving luxCDABE  This work 
pQLE024 Level M derivative carrying PBAD_ ecf42_4454_T1 and 
Pecf42_4454_luxCDABE  
This work 
pQLE025 Level M derivative carrying PBAD_ ecf42_4454_T1 and 
Pecf42_4454_luxCDABE  
This work 
pQLE026 Level M derivative carrying PBAD_ ecf42_4454_T2 and 
Pecf42_4454_luxCDABE  
This work 
pQLE027 Level M derivative carrying PBAD_ ecf42_4454_T3 and 
Pecf42_4454_luxCDABE 
This work 
pQLE028 Level M derivative carrying PBAD_ ecf42_4454_T4 and 
Pecf42_4454_luxCDABE 
This work 
pQLE029 Level M derivative carrying PBAD_ ecf42_4454_M01 and 
Pecf42_4454_luxCDABE  
This work 
pQLE030 Level M derivative carrying PBAD_ ecf42_4454_M02 and 
Pecf42_4454_luxCDABE  
This work 
pQLE031 Level M derivative carrying PBAD_ ecf42_4454_M03 and 
Pecf42_4454_luxCDABE  
This work 
pQLE032 Level M derivative carrying PBAD_ ecf42_4454_M04 and 
Pecf42_4454_luxCDABE  
This work 
pQLE033 Level M derivative carrying PBAD_ ecf42_4454_M05 and 
Pecf42_4454_luxCDABE  
This work 
pQLE034 Level M derivative carrying PBAD_ ecf42_4454_M07 and 
Pecf42_4454_luxCDABE  
This work 
pQLE035 pUT18C derivative carrying sven_4376  This work 
pQLE036 pUT18C derivative carrying sven_7130  This work 
pQLE037 pUT18C derivative carrying sven_7131  This work 
pQLE038 pKT25 derivative carrying sven_4376  This work 
pQLE039 pKT25 derivative carrying sven_4377  This work 
pQLE040 pKT25 derivative carrying sven_7130  This work 
pQLE041 pKT25 derivative carrying sven_7131  This work 
pQLE042 pKT25 derivative carrying ecf42_4454 sigma region (1-543 bp)  This work 
pQLE043 pKNT25 derivative carrying ecf42_4454 sigma region (1-543 bp) This work 
pQLE044 pUT18 derivative carrying ecf42_4454 sigma region (1-543 bp) This work 
pQLE045 pUT18C derivative carrying ecf42_4454 sigma region (1-543 bp) This work 
pQLE046 pKT25 derivative carrying ecf42_4454 C-terminal extension (544-1269 bp)  This work 
pQLE047 pKNT25derivative carrying ecf42_4454 C-terminal extension (544-1269 bp) This work 
pQLE048 pUT18 derivative carrying ecf42_4454 C-terminal extension (544-1269 bp) This work 
pQLE049 pUT18C derivative carrying ecf42_4454 C-terminal extension (544-1269 bp) This work 
pQLE050 0-15 derivative carrying gene encoding DGPF protein (Locus tag: 
XCC3790) protein  
This work 
pQLE051 1-1R derivative carrying PTet  promoter driving the expression of 
3xflag_DGPF 
This work 
pQLE052 pETDuet-1 derivative carrying ecf42_4454 σ region (1 to 543 bp)  This work 
pQLE053 pETDuet-1 derivative carrying ecf42_4454 C-terminal extension (544-
1269 bp)  
This work 
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Table 2.4 Plasmids used in this study (continued). 
Description 
Reference 
Plasmids Description Reference 
Plasmids for E. coli 
pQLE054 pETDuet-1 derivative carrying ecf42_4454 σ region (1 to 543 bp) and C-
terminal extension (544 to 1269 bp) for separately expression 
This work 
pQLE055 pETDuet-1 derivative carrying gene encoding RibD (Sven_1041)  This work 
pQLE056 pETDuet-1 derivative carrying gene encoding DGPF (Sven_3806)  This work 
pQLE057 pETDuet-1 derivative carrying genes encoding RibD and DGPF for co-
expression 
This work 
Plasmids for B. subtilis 
pBS3Clux B. subtilis BioBrick vector (Radeck et 
al., 2013) 
pBS2E_PxylA Integration at lacA, ampR, mlsR, PxylA 
Daniela 
Pinto, 
unpublished 
pQL3Clux01 pBS3Clux-NP_sven_0747 This work 
pQL3Clux02 pBS3Clux-AP_sven_0747 This work 
pQL3Clux03 pBS3Clux-NP_sven_4377 This work 
pQL3Clux04 pBS3Clux-AP_sven_0747 This work 
pQL3Clux05 pBS3Clux-NP_sven_7131 This work 
pQL3Clux06 pBS3Clux-AP_sven_7131 This work 
pQL2E-Pxyl 02 pBS2E_PxylA_3xflag-tag_sven_4377 This work 
pQL2E-Pxyl 05 pBS2E_PxylA_3xflag-tag_sven_7131 This work 
 
2.4 Nucleic acid manipulations 
2.4.1 Synthesis of genes and oligonucleotides  
Oligonucleotides were synthesized by Sigma (International AG, Germany). The lyophilized 
pellets were resuspended to a final concentration of 100 μM in H2O and stored at -20 °C. 
Genes for heterologous expression were codon optimized and synthesized through the 
GeneArt Strings DNA fragments service from ThermoFisher (International AG, Germany).  
2.4.2 Polymerase chain reaction (PCR) 
PCR reactions were performed by using DNA polymerases from New England Biolabs 
(NEB) according to the manufacturer’s instructions. OneTaq DNA Polymerase (M0480) was 
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used for confirming insertions, deletions or colony PCR, Q5 High-Fidelity DNA 
Polymerases (M0491) was used for creating fragments for cloning.  
2.4.3 Agarose gel electrophoresis of DNA  
Electrophoresis was performed using the 1% agarose gel containing ethidium bromide (Carl 
Roth) in 1 × TAE buffer (40 mM Tris, 20 mM Acetic acid, 1 mM EDTA). Samples were 
mixed with 6 × loading dye prior to loading. The voltage used for electrophoresis was 6 volts 
per cm.  
2.4.4 Restriction endonuclease digestion  
The restriction endonuclease digestion of DNA fragments and plasmids was performed by 
using the restriction enzymes from NEB according to their manufacturer’s instructions.  
2.4.5 Ligation of DNA fragments 
The ligation of DNA fragments was performed by using the T4 DNA ligase (M0202) from 
NEB according to the recommended protocol and the reaction was incubated for 8 hours at 
16 °C. 
2.4.6 Purification of DNA fragments and preparation of plasmids 
The DNA fragments from PCR products or DNA agarose gel were cleaned and concentrated 
by using the Hi-Yield Gel/PCR DNA Fragment Extraction Kits from Süd-Laborbedarf 
GmbH (SLG, Germany) according to the manuals. The plasmids extraction from E. coli was 
carried out by using the Hi-Yield Plasmid Mini DNA Isolation Kit (SLG, Germany) 
according to the manufacturer’s instruction. 
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2.4.7 DNA sequencing  
Sequencing of DNA fragments or plasmids was performed by Eurofins Genomics (Germany) 
using the Mix2Seq Kits according to the manufacturer’s protocol.  
2.4.8 Fusion PCR for the site mutagenesis of ECF42 σ factor 
The single or multiple amino acids mutation at the C-terminal extension of ECF42 σ factor 
(Locus tag: XCC3792) from Xanthomonas campestris were generated by fusion PCR. A 
DNA fragment encoding N-terminus of ECF42_4454 was amplified from plasmid 
Level 0_15_ECF42_4454 by using primers TM5670 and TM5671. The DNA fragments 
encoding different mutated versions of the C-terminal extension were amplified from 
plasmid Level 0-15 _ECF42_4454 by using primers TM5672 and TM5620 for M01 (S191A), 
TM5673 and TM5620 for M02 (V195A), TM5674 and TM5620 for M03 (I199A) and 
TM5675 and TM5620 for M04 (N201A). Then, DNA fragments encoding the N-terminus 
and the C-terminal extension were joined together by fusion PCR using Q5 High-Fidelity 
DNA Polymerases to generate different full ecf42_4454 genes encoding different mutated 
ECF42 σ factors M01 (S191A), M02 (V195A), M03 (I199A) and M04 (N201A). For M05 
(R214A), The N-terminal σ and the C-terminal extension encoding regions were amplified 
from plasmid Level 0-15_ecf42_4454 using the primer pairs TM5670-TM5676, TM5677-
TM5620, respectively. For M07 (S191A, V195A, I199A, N201A), fragments encoding the 
N-terminal σ regions and the C-terminal extensions were amplified from plasmid pQLE010 
using the primer pairs TM5670-TM5856 and TM5857-TM5620, respectively. All fused 
fragments of mutated ECF42 coding genes were cloned into MoClo vector 0-15 using the 
MoClo cloning strategy. 
2.4.9 MoClo cloning assemble 
For the analysis of the interaction between the N-terminal σ domain and C-terminal 
extension of the ECF42 σ factor (XCC3792) from Xanthomonas campestris, all genetic 
constructs (Table 2.4) were generated using the MoClo cloning method, which is based on 
the golden gate cloning strategy (Werner et al., 2012). The general assembly was performed 
accordingly to the following protocol: 50 ng of backbone vector, 50 ng of insert or insert-
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containing plasmids, 1 μl of BbsI or BsaI, 1 μl of T4 DNA ligase and 2 μl 10 × T4 DNA 
ligase buffer were mixed in a final reaction volume of 20 μl. The mixture was incubated at 
37 °C for 3 hours; at 50 °C for 10 min and at 80 °C for 10 min. Then, 10 μl of the reaction 
mix was used for E. coli transformation. The scheme for DNA assembly from level 0 to level 
M constructs is illustrated (Fig. 2.1).  
Level 0 plasmids containing the arabinose inducible promoter PBAD (0-1_PBAD), ECF42 
target promoter (0-1_Pecf42_4454), the anhydrotettracycline inducible promoter PTet (0-1_PTet), 
the RBS (0-9_RBS), the luxCDABE reporter cassette (0-15_luxCDABE) and the terminators 
01, 02 and 03 (0-11_01, 0-11_02, and 0-11_03) (Fig. 2.1 A) were a kind gift from Georg 
Fritz. DNA fragments encoding different C-terminally truncated ECF42 alleles - T1 (1-180 
aa), T2 (1-232 aa), T3 (1-294 aa) and T4 (1-355 aa) were amplified from plasmid pQLE001 
by using the primer pairs TM5590 and TM5714, TM5590 and TM5715, TM5590 and 
TM5716, TM5590 and TM5717, respectively. The amplified fragments were cloned into 0-
15 vector to generate the plasmids pQLE002, pQLE003, pQLE004 and pQLE005. The 
fragments encoding mutated ecf42 genes (see section 2.4.8) encoding M01 (S191A), M02 
(V195A), M03 (I199A), M04 (N201A), M05 (R214A) and M07 (S191A, V195A, I199A, 
N201A) were cloned into 0-15 vector to generate plasmids pQLE006, pQLE007, pQLE008, 
pQLE009, pQLE010 and pQLE011. The DGPF coding gene was synthesized and cloned 
into 0-15 vector to generate the plasmid pQLE050. A 3xflag tag coding sequence was 
introduced at the N-terminal position of all C-terminally truncated ECF42 or DGPF proteins 
by PCR.  
For level 1 plasmids (Fig. 2.1 B), different truncated or mutated ecf42 genes were placed 
under the control of the arabinose inducible promoter PBAD in the MoClo vector 1-1R. The 
target promoter sequences of ECF42_4454 σ factor was placed upstream of the luxCDABE 
reporter in vector 1-3L. The gene encoding the DGPF protein (XCC3790) was placed under 
the control of the anhydrotettracycline inducible promoter PTet in the vector 1-5L to generate 
the plasmid pQLE051. The level M plasmids were generated by combining different 
transcriptional units from level 1 plasmids (Fig. 2.1 C). Each transcriptional unit was 
insulated to avoid transcriptional interference. The generated level M plasmid was 
transformed into E. coli MK01 for further assessment. 
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Figure 2. 1 Illustration of MoClo cloning and assemble strategy. (A) Level 0 plasmids. The anhydrotetra-
cycline-inducible promoter PTet, the arabinose-inducible promoter PBAD and the target promoter of ECF42 
Pecf42_4454 were cloned into the 0-1 vector to generate the promoter- containing level 0-1 plasmids. The ribosome 
binding site (RBS) was cloned into the 0-9 plasmid. Genes encoding ECF42 σ factor wild type (WT), C-
terminally truncated alleles (T1, T2, T3 and T4), point mutated ECF42 (M01, M02, M03, M04, M05 and M07) 
and the DGPF protein were cloned into the 0-15 plasmid to generate the coding sequence containing level 0-
15 plasmids. Three different terminators (01, 02 and 03) were cloned into 0-11 vectors. (B) Level 1 plasmids. 
All fragments encoding ECF42 alleles and mutants were assembled in 1-1R vector under the control of the 
arabinose inducible promoter PBAD. The luxCDABE reporter operon was assembled in the 1-3L vector under 
the control of the target promoter of the ECF42 σ factor. The gene encoding the DGPF protein was assembled 
in 1-5L vector under the control of the anhydrotetracycline inducible promoter PTet. (C) Level M plasmids. 
Transcriptional units containing each ECF42 version were assembled with the luxCDABE transcriptional unit 
or both luxCDABE and DGPF transcriptional units. 
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2.5 Protein methods 
2.5.1 SDS PolyAcrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-polyacrylamide gels at a concentration of 12.5% were prepared by using the Mini-
PROTEAN® Tetra Handcast System (Bio-Rad, USA) as described in Table 2.5. 
Electrophoresis was performed in 1 × SDS-PAGE running buffer (25 mM Tris, 192 mM 
glycine, 0.1% SDS) at 220 V until the dye-front arrived at the bottom of the gel. 
Table 2. 5 Composition of the SDS-PAGE gels. 
For 2 separating gels:  For 2 stacking gels: 
30% acrylamide 4.2 ml  30% acrylamide 0.67 ml 
1.5 M Tris, pH8.8 2.5 ml  1.5 M Tris, pH6.8 0.4 ml 
10% SDS 100 μl  10% SDS 50 μl 
dH2O 3.2 ml  dH2O 3.85 ml 
10% APS 75 μl  10% APS 50 μl 
TEMED 10 μl  TEMED 8 μl 
2.5.2 Coomassie staining  
The proteins in the SDS-PAGE gels were stained by Coomassie Brilliant blue R-250 staining 
solution (45% methanol, 10% acetic acid, 0.25% Coomassie Brilliant Blue R-250) at room 
temperature with gentle shaking for 2 hours. The gel was destained by using the destaining 
solution (45% methanol, 10% acetic acid) for 30 minutes. The destaining solution was 
removed and new one was added three or four times until the bands of proteins were clearly 
distinguishable. 
2.5.3 Overexpression of N-terminal σ region and C-terminal extension of an ECF42 σ 
factor in E. coli 
The DNA fragment encoding the N-terminal sigma domain (181 aa) of ECF42 σ factor 
(XCC3792) was amplified from plasmid pQLE001 using primers TM6068 and TM6069 and 
cloned into vector pETDuet-1 with NcoI and BamHI to generate the overexpression plasmid 
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pQLE052. The fragments encoding the C-terminal extension was amplified from plasmid 
pQLE001 with primers TM6070 and TM6071 and cloned into vector pETDuet-1 with NdeI 
and KpnI to generate the overexpression plasmid pQLE053. Additionally, both fragments 
encoding the N- and C-terminal domains were simultaneously cloned into the positions 1 
and 2 of pETDuet-1 to generate the co-expression plasmid pQLE054. For purification 
purposes of the N- and C-terminal regions of ECF42 σ factor, the N-terminal of ECF42 was 
tagged with a 10 × His tag at the N-terminus and the C-terminal extension of ECF42 was 
tagged with a Strep tag at the C-terminus. 
Constructed overexpression plasmids were transformed into E. coli BL21 (DE3) pLysE to 
generate the overexpression strains. Day cultures of the overexpression strains were prepared 
by diluting the overnight cultures 1:1000 in fresh LB medium with antibiotics and incubated 
at 37 °C with agitation. Once the optical density at 600 nm (OD600) of the culture reached 
0.6, the production of the proteins was induced by addition of 0.5 mM IPTG and incubation 
was continued at 37 °C for 3 hours. The cells were harvested by centrifugation and 
resuspended in lysis buffer (100 mM, Tris-HCl, pH8.0, 100 mM NaCl) before sonication 
with 50% power for 3 minutes with pulse durations of 5 sec on and 5 sec off (GM70 sonicator 
from BANDELIN, Germany). Expression and solubility of the proteins was checked by 
SDS-PAGE and Western blot.  
2.5.4 Refolding of ECF42 fragments in vitro 
Since both N-terminal 10×His_ and C-terminal_Strep-tagged ECF42 proteins in E. coli were 
expressed as insoluble inclusion bodies, they needed to be refolded in vitro before 
purification as described previously (Eiamphungporn and Helmann, 2008). The production 
of the N- and C-terminal domain of ECF42 σ factor was induced by 1 mM IPTG at 37 °C 
for 3 hours when the optical density at 600nm (OD600) of the culture reached 0.6. Cells from 
500 ml of culture were collected by centrifugation and resuspended in 20 ml of disruption 
buffer (50 mM Tris-HCl pH 8.0, 2 mM EDTA, 0.1 mM DTT, 1mM β-mercaptoethanol, 233 
mM NaCl, 10% (v/v) glycerol] for sonication as described in section 2.5.3. The pellet was 
collected and washed twice with 10 ml TEDG buffer (10 mM Tris-HCl pH 8.0, 10 mM 
EDTA, 0.1 mM DTT, 10% glycerol) containing 0.5% (v/v) Triton X-100 and was then 
dissolved in 10 ml of the same buffer with 1% (v/v) of Sarkosyl. After centrifugation to 
remove the insoluble fraction, the supernatant was gradually diluted (1 ml per min) with 
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TEDG buffer containing 0.01% Triton X-100 to a final volume of 100 ml, to allow 
renaturation of the N- or C-terminus of the ECF42 σ factor. Purification of the refolded 
proteins was carried out using the ÄKTA start protein purification system (GE Healthcare). 
2.5.5 Purification of ECF42 σ factor fragments 
HisTrap HP columns (5ml, GE Healthcare) was used for the purification of 10 × His_sigma 
region. Briefly, the solution of refolded N-terminal σ region was loaded onto the column 
equilibrated with TEDG-0.01% (v/v) Triton X-100. After washing with 50 ml of TEDG 
containing 0.15 M NaCl and 0.01% Triton X-100, 10 × His_sigma region was eluted using 
20 ml elution buffer (20 mM HEPES pH8.0, 0.15 M NaCl, 1 mM β-mercaptoethanol, 10% 
glycerol) with a linear gradient concentration of imidazole from 20 mM to 500 mM. 
Fractions containing the target protein were collected and stored at -80 °C until use. Protein 
concentration was determined by using the Pierce™ BCA Protein Assay Kit (ThermoFisher, 
Germany). 
Purification of the C-terminal extension_Strep-tag of ECF42 σ factor was performed by 
using the 1 ml Strep-Tactin XT Superflow cartridge (IBA, Germany) according to the 
manufacturer’s instructions. Briefly, the refolded C-terminal extension_Strep-tag protein 
solution was loaded onto the column equilibrated with TEDG-0.01% (v/v) Triton X-100. 
After washing with 50 ml of TEDG containing 0.15 M NaCl and 0.01% Triton X-100, C-
terminus_Strep-tag was eluted using 20 ml elution buffer (20 mM HEPES pH8.0, 150 mM 
NaCl, 1 mM EDTA, 50 mM biotin, 10% glycerol). Fractions containing the C-
terminus_Strep-tag were collected and stored at -80 °C until use. 
2.5.6 Pull-down assay of DGPF protein with RibD 
Genes encoding RibD (sven_1041) and DGPF (sven_3806) from S. venezuelae were codon 
optimized for E. coli by using the GeneArt Strings DNA Fragments service from 
ThermoFisher. The DNA fragment encoding RibD was amplified using primers TM6134 
and TM6135 and cloned into vector pETDuet-1 with NcoI and BamHI to generate the 
plasmid pQLE055 and the fragment encoding DGPF protein was amplified using primers 
TM6136 and TM6137 and cloned into plasmid pQLE055 with NcoI and BamHI to generate 
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the plasmid pQLE057. A 10×His and Strep tags were introduced into the N-terminus of 
RibD and C-terminus of DGPF, respectively. The plasmid pQLE057, co-expressing RibD 
and DGPF under the control of the IPTG inducible promoter, was transformed into E. coli 
BL21 (DE3) pLysE and the expression was induced by 0.4 mM IPTG at 25 °C for 4 hours, 
when the optical density at 600 nm (OD600) of the culture reached 0.6. The cells were 
harvested by centrifugation and resuspended in lysis buffer (20 mM Tris pH 8.0, 5 mM 
EDTA, 50 mM NaCl, 1× EDTA-free protease inhibitors (Roche)] for sonication as described 
in section 2.5.3. The Strep tagged DGPF protein was purified from the cell lysate as 
described before, and the 10× His tagged RibD protein potentially interacted  and co-purified 
with Strep tagged DGPF protein was confirmed by Western blot using an anti-His tag 
antibody. 
2.5.7 Protein crosslinking  
The interaction between the N-terminal σ region and the C-terminal extension of ECF42 was 
analyzed by crosslinking using glutaraldehyde as the crosslinking agent. Ten microgram of 
purified 10×His_σ region and equal molar amount of C-terminal extension_Strep-tag were 
mixed in the final volume of 50 µl 20 mM HEPES buffer (pH8.0). After incubated at room 
temperature for 5 min, the mixture was treated with 5 µl of 2.3% freshly prepared solution 
of glutaraldehyde and incubated at room temperature for 10 minutes. The reaction was 
terminated by addition of 10 µl of 1 M Tris-HCl pH8.0. Then, 10 µl of 6× SDS protein 
loading buffer (ThermoFisher, Germany) was added into the reaction mixture and the cross-
linked proteins were checked by electrophoresis conducted in 12% SDS-polyacrylamide gels. 
The alcohol dehydrogenase from Thauera aromatic (ThaADH), which is known to form 
homodimers, was used as positive control.  
2.5.8  Immunoprecipitation of RNAP from E. coli 
The RNAP immunoprecipitation (IP) was carried out to investigate the interaction of the 
RNAP with the C-terminally truncated ECF42-T1 (1-180 aa) in E. coli by using the anti-E. 
coli RNAP ImmunoAffinity Resin (BioLegend). The C-terminally truncated ECF42-T1 (1-
180 aa) was overexpressed in E. coli (TME3013) by induction with 0.2% arabinose at 30 °C 
for 4 hours. Cells were collected by centrifugation at 5000 g for 10 min at 4 °C. The 
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supernatant was discarded and immediately 800µl of ice-cold lysis buffer [20 mM Tris pH 
8.0, 5 mM EDTA, 50 mM NaCl, 1× EDTA-free protease inhibitors (Roche)] was added to 
the cells. After incubation on ice for 30 min, the cells were subjected to sonication as 
described in the section 2.5.3. Lysates were centrifuges at 12,000 g in a pre-cooled centrifuge 
for 10 min and the supernatant was kept for further analysis.  
The anti-E. coli RNAP ImmunoAffinity Resin beads were washed three times with cell lysis 
buffer as used above. The antibody concentration was adjusted to 5 µg/ml in PBS buffer 
(pH8.0) and 500 µl of diluted antibody were transferred to a new 1.5 ml tube for each sample. 
The protein concentration of the cell lysates was adjusted to 1 mg/ml with lysis buffer. Five 
hundred microliters of cell extract was added to the tube containing 500 µl of diluted 
antibody resin beads and incubated at 4 °C for 2 hours with gentle agitation.  
The agarose beads were collected by centrifugation and washed 3 times with ice-cold cell 
lysis buffer. After the final wash step, the supernatant was removed and 20 µl of 6× SDS 
protein loading buffer (ThermoFisher) were added. The samples were incubated for at 95 °C 
5 min and centrifuged at 14,000 g in for 5 min at room temperature. The immunoprecipitated 
RNAP was checked by SDS-PAGE by loading 20 µl of the sample, and the C-terminally 
truncated 3×Flag_ECF42-T1 (1-180 aa) potentially co-immunoprecipitated with RNAP was 
checked by Western blot using anti-FLAG antibody. 
2.5.9 Western blot analysis 
2.5.9.1 Western blotting analysis of ECF42 σ factor in S. venezuelae.  
ECF42 overexpression strains TMS0112, TMS0113 and TMS0114 (Table 2.3) were 
inoculated in 50 ml MYM medium supplemented with R2 trace elements and incubated at 
30 °C with agitation. Cells from 10 ml of culture were harvested by centrifugation after 
growing for 8, 10 and 12 hours and resuspended in 1 ml ice-cold sonication buffer [20 mM 
Tris pH 8.0, 5 mM EDTA, 50 mM NaCl, 1 x EDTA-free protease inhibitors (Roche)] for 
sonication. Lysates were then centrifuged at 14,000 g for 15 min at 4 °C to remove cell debris. 
The protein concentration of the clear lysate was determined using Pierce™ BCA Protein 
Assay Kit (ThermoFisher, Germany). Twenty microgram of proteins from each sample was 
submitted for 12.5% SDS-PAGE. After electrophoresis, transfer was carried out to a 
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polyvinylidene difluoride (PVDF) membrane (Sigma) using a wet transfer cell from Bio-
Rad according to the manufacture instruction. The membrane was then incubated in blocking 
buffer [2.5% milk powder in TBS buffer (50 mM Tris PH 7.6, 150 mM NaCl)] for 1 hour at 
room temperature. Afterwards, the membrane was incubated with the primary Monoclonal 
ANTI_FLAG M2 antibody produced in mouse (Sigma, F3165) at room temperature for 1 
hour. After four washing steps (10 min per step) with blocking buffer, the membrane was 
incubated with a secondary Goat Anti-Mouse IgG (H+L) HRP conjugated antibody at room 
temperature for 1 hour. After four washing steps with block buffer, the membrane was 
washed with TBS buffer before the signals were detected with a LumiImager (Alpha 
Innotech) using AceGlow (VWR, Germany) as the chemiluminescence substrate.  
2.5.9.2 Western blot analysis of ECF42 σ factor in E. coli.  
The expression of different C-terminally truncated or mutated ECF42 σ factors was detected 
by Western blot analysis by using an anti-FLAG antibody. An overnight culture of E. coli 
MK01 strain harboring ECF42 overexpression plasmid (Table 2.4) was diluted (1:100) into 
LB medium (10 ml) and grown at 37 °C with shaking until OD600 reached 0.5. Arabinose to 
a final concentration of 0.2% was then added to the culture to induce the expression of the 
ecf42 genes and incubated for another 2 hours. 
Cells were then harvested by centrifugation with 5,000 g at 4 °C for 10 min and resuspended 
in 1.5 ml of lysis buffer (100 mM Tris-HCl pH8.0, 100 mM NaCl) and lysed by sonication 
as described in the section 2.5.3. Protein concentration was quantified by using Pierce™ 
BCA Protein Assay Kit (ThermoFisher), and 20 µg of protein from each sample was used 
for SDS-PAGE analysis. Proteins were then transferred to a PVDF membrane as described 
above. The membrane was then incubated in blocking buffer for 1 hour at room temperature 
after which it was incubated with Direct-Blot™ HRP anti-DYKDDDDK Tag Antibody 
(BioLegend) diluted in block buffer at room temperature for 1 hour. After four washing steps 
with block buffer, the membrane was washed with TBS buffer before the signal was detected 
by a LumiImager (Alpha Innotech) using AceGlow (VWR) as the chemiluminescence 
substrate. 
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2.6 Manipulation of S. venezuelae 
2.6.1 Preparation of S. venezuelae spores 
S. venezuelae was plated out for a confluent lawn on a MYM agar plate and grown at 30 °C 
for 4 days, when sporulation has already occured. Two microliters of sterile 20% glycerol 
solution was pipetted onto the surface of the plate and gently rub with a sterile cotton bud to 
dislodge the spores. The surface of the plate was washed with another 1 ml of 20% glycerol 
solution then the spore solution was pipetted into a sterile 2 ml microfuge tube. The spores 
were stored at -20 °C until use. 
2.6.2 Total DNA preparation of S. venezuelae 
Fifty microliters of S. venezuelae spores were inoculated into 10 ml MYM liquid medium 
supplemented with R2 trace elements and grown at 30 °C with agitation for 14 hours. Cells 
were harvested by centrifugation and the pellet was washed with 10% sucrose and 
resuspended in 2 ml SET buffer (75 mM NaCl, 25 mM EDTA pH8.0, 20 mM Tris pH7.5). 
Two microliters of RNase (10 mg/ml) and 40 μl of lysozyme (50 mg/ml) were added to the 
cell suspension and incubated at 37 °C for 1 hour. Sixty microliters of proteinase K (20 
mg/ml) and 240 μl of 10% SDS were added and incubated with cell lysate at 55 °C for 2 
hours. Eight hundred microliters of 5M NaCl and 2 ml of chloroform were added after the 
cell lysate was cooled down to room temperature and then mixed gently for 30 min. After 
centrifugation at 6,000 g, 4 °C for 15 min, the supernatant was transferred to a new tube to 
be mixed with 0.6 volumes of isopropanol gently for 30 min. After centrifugation at 12,000 
g, 4 °C for 20 min, the supernatant was removed and the DNA pellet was collected and 
washed with 70% ethanol. Total DNA was dissolved in 200 μl TE buffer (10 mM Tris, pH 
8.0, 1.0 mM EDTA) and stored at -20 °C until use.  
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2.6.3 Conjugation of S. venezuelae 
Plasmids were transferred to S. venezuelae by conjugation using E. coli ET12567/ pUZ8002. 
An overnight culture of E. coli ET12567/pUZ8002 harboring the target plasmid was 
prepared in LB liquid medium supplemented with the appropriate antibiotics. On the next 
day, the overnight culture was diluted 1:100 in 10 ml of fresh LB medium supplemented 
with the appropriate antibiotics. When the OD600 of the culture reached a value between 0.4 
and 0.6, cells were harvested by centrifugation and washed twice with fresh LB medium. 
Cells were then resuspended in 100 μl LB medium and mixed with approximately 108 spores 
of S. venezuelae. The mixed suspension was plated on a MS (SFM) plate supplemented with 
50 mM MgCl2 without antibiotics and incubated overnight at 30 °C. Nalidixic acid (0.5 mg) 
and other appropriate antibiotics to select for the conjugated plasmid in S. venezuelae were 
mixed in 1 ml water and overlaid on the plate. The plate was incubated at 30 °C for 3 to 5 
days until S. venezuelae colonies were visible. The exconjugants of S. venezuelae were then 
streaked on a fresh DNA agar plate supplemented with nalidixic acid and additional 
antibiotics for selection of the transferred plasmid three times and the colonies were then 
tested by colony PCR for the presence of the transferred plasmid. 
2.6.4 Generation of ECF42 σ factors triple deletion mutant  
S. venezuelae harbors three genes encoding ECF42 σ factors (sven_0747, sven_4377 and 
sven_7131). The markerless triple deletion mutant (Δsven_0747 Δsven_4377 Δsven_7131) 
was generated based on the I-SceI Meganuclease-mediated method (Fig. 2.2) (Fernandez-
Martinez and Bibb, 2014). Approximately 2 kb fragments upstream of genes sven_0747, 
sven_4377 and sven_7131 were amplified using the primer pairs TM4364-TM4365, 
TM4368-TM4369 and TM4452-TM4453 (Table 2.5), respectively. The 2 kb fragments 
downstream of genes sven_0747, sven_4377 and sven_7131 were amplified using the primer 
pairs TM4366-TM4367, TM4370-TM4371 and TM4454-TM4455, respectively (Table A1).  
The up- and down fragments of each ECF42 gene were pairwise cloned into the delivery 
vector pIJ12738 (that contains the I-SceI recognition site) with HindIII and KpnI resulting 
in the constructs pQLS001, pQLS002 and pQLS003 (Table 2.4). 
As shown in Fig. 2.2, plasmid pQLS003 was introduced into S. venezuelae wild type by 
conjugation to generate the single cross-over mutant of sven_7131. Single cross-over 
                                                                                                                                                 
Materials and methods 
43 
mutants were selected on the basis of apramycin resistance and confirmed by colony PCR. 
The plasmid encoding the I-SceI Meganuclease (pIJ2742) was then conjugated into the 
single cross-over strain and selected on the basis of thiostrepton resistance.  
 
Figure 2. 2 Illustration of the meganuclease I-SceI mediated ecf42 gene deletion. Approximately 2 kb 
fragments, upstream (FA) and downstream (FB) of the genes encoding Sven_7131 ECF42 σ factor, were 
amplified and cloned into the vector pIJ12738 containing the I-SceI recognition site. The resulting plasmid was 
transformed into S. venezuelae WT by conjugation. The plasmid integrated into the chromosome DNA at the 
FA or FB region (FA used as the example here). Single cross-over mutants were selected by apramycin 
resistance, which was on the basis of the resistance of the introduced plasmid pIJ12738. The correct genotype 
was confirmed by colony PCR by using primers located up- (P1) and downstream (P2) of the ECF42 coding 
gene. The plasmid pIJ12742 encoding I-SceI Meganuclease was then conjugated into the single cross-over 
strain and conjugants were selected on the basis of thiostrepton resistance from pIJ12742. The constitutively 
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expressed I-SceI caused the double strand breaks at its introduced recognition site (purple dot) in the 
chromosome. After homologous recombination at FA or FB regions, the double cross-overs were counter-
selected on the basis of apramycin sensitivity. If the homologous recombination happens at FA region (left 
panel on the bottom), the genotype of the strain reverts to WT. If the homologous recombination happens at 
FB region (right panel on the bottom), the ecf42 gene is successfully deleted form the chromosome. Deletion 
was confirmed by colony PCR and sequencing. 
Exconjugants were were grown on media containing 50 µg/ml thiostrepton at 30 °C. The 
constitutively expressed I-SceI generated double strand breaks at its recognition site in the 
chromosome. After homologous recombination, the double cross-over mutants were 
selected on the basis of apramycin sensitivity before confirmation by colony PCR. Since 
pIJ2742 has a temperature sensitive origin of replication, confirmed Δsven_7131 mutants 
were therefore grown at 37 °C, to promote loss of the plasmid. Once a markerless ECF42 
single deletion mutant TMS0039 (Δsven_7131) was obtained, the ECF42 double deletion 
mutant TMS0044 (Δsven_7131 Δsven_4377) was subsequently obtained by deleting 
sven_4377 gene using the same method of the single deletion mutant (Δsven_7131) 
background. The triple deletion mutant of ECF42 - TMS0050 (Δsven_0747 Δsven_4377 
Δsven_7131) - was then generated by deletion of the third ECF42 gene sven_0747 based on 
the double deletion mutant TMS0044 in the same way. 
2.6.5 Phenotype Microarrays for S. venezuelae 
Biolog Phenotype MicroArrays for phenotypic characterization of microbial cells (Shea et 
al., 2012; Mackie et al., 2014), which is a commercial service provided by Biolog (Biolog, 
Hayward, California), was performed to compare S. venezuelae wild-type and ECF42 triple 
deletion mutant to find the ECF42 related phenotypes. Briefly, S. venezuelae was grown 
overnight on MYM agar medium at 30 °C. After subculture for a second time, cells from the 
agar plate were transferred into a sterile capped tube containing 25 ml of IF-0a medium 
(Biolog, Hayward, California) to obtain a uniform suspension with transmittance of OD590 
value 0.05.  One hundred microliters of cell suspension with Biolog metal ion cocktail was 
then inoculated into the 96 well microplates PM1 to PM20 with different media composition 
in each well, such as different carbon sources, nitrogen sources, chemical reagents and 
antibiotics (more information concerning the plate layouts and media composition can be 
obtained at http://www.biolog.com/products-static/phenotype_ microbial_cells_use.php). 
All PM plates were incubated at 30 °C for 48 hours and metabolic activity was continuously 
monitored in all wells of the arrays.  
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2.6.6 Overexpression of ECF42 σ factors in S. venezuelae 
Three genes (sven_0747, sven_4377 and sven_7131) encoding ECF42 σ factors were 
amplified with primer pairs TM5631 and TM4056, TM5632 and TM4059 and TM5633 and 
TM4062, respectively, and cloned into the vector pIJ10257 (Hong et al., 2005) with NdeI 
and HindIII to generate ECF42 overexpression plasmids pQLS004, pQLS005 and pQLS006 
respectively (Table 2.4). The expression of ECF42 σ factors in S. venezuelae was controlled 
by the constitutive promoter PermE* from vector pIJ10257. A fragment encoding the 3xFLAG 
tag was introduced to the N-terminus of each ECF42 encoding gene through the forward 
primer. Each generated overexpression plasmid was conjugated into S. venezuelae ECF42 
triple deletion mutant TMS0050 to obtain ECF42 overexpression strains TMS0112 
(3xflag_sven_0747), TMS0113 (3xflag_sven_4377) and TMS0114 (3xflag_sven_7131). The 
overexpression of ECF42 σ factors in S. venezuelae was confirmed by Western blot using 
the anti-FLAG antibody as described in the section 2.5.9. 
2.6.7 RNA isolation from S. venezuelae 
For RNA isolation, three independent 30 ml cultures of each S. venezuelae strain were grown 
in MYM supplemented with trace element solution at 30 °C with shaking (initial optical 
density at 450 nm of 0.01). After 10 hours of incubation, cultures were mixed with 20 ml of 
precooled (-20 °C) solution of 60% glycerol and 34% of sodium chloride. The cells were 
then harvested by centrifugation at 8,000 g for 30 min at -20 °C. Cells were resuspended in 
1 ml of RNA TRI reagent (ZYMO RESEARCH) and transferred to a beat-beater tube 
containing glass beads and homogenized with the help of a bead-beater (FastPrep FP120, 
Thermo) for 3 cycles of 30 sec. Two hundred microliters of chloroform were then added to 
the homogenized samples, thoroughly mixed by vortexing and centrifuged at 4 °C, 12,000 g 
for 20 min. The supernatant was transferred to a new tube and mixed with 2.5 volumes of 
pure ethanol and kept at -20 °C for 12 hours.  
Then, the sample was centrifuged at 4 °C, 12,000 g for 20 min. The pellet was washed twice 
with 80% ethanol. The prepared crude nucleic acids were then dissolved in 200 μl 
diethylpyrocarbonate-treated water (DEPC-water) and further purified with Direct-zol RNA 
MiniPrep Plus kit (ZYMO RESEARCH). After that, ribosomal RNA was removed with 
Ribo-Zero rRNA Removal Kit (Gram-Positive Bacteria, Illumina). The remaining RNA was 
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cleaned and concentrated in RNAase-free water by using the RNA Clean & Concentrator-
25 kit (ZYMO RESEARCH). 
2.6.9 RNA-seq and data analysis  
The RNAseq and data analysis was performed at the biotechnology center of TU Dresden. 
Briefly, the mRNA was quantified with Tape Station and 100 ng were chemically 
fragmented using the Ultra II Directional RNA Library Prep Kit (NEB). Next, reverse 
transcription was performed with random hexamers and second strand synthesis was 
performed using dUTP-primer mix. After a XP-bead purification (1.8x) step, the cDNA was 
subjected to end repair and A-tailing before custom adapters were ligated. After ligation, 
adapters were removed by an XP bead purification (Beckman Coulter) adding beads in a 
ratio of 0.9:1. Indexing was done by PCR enrichment (with 6 cycles) using custom 
amplification primers carrying the index sequence. After two more XP bead purifications 
(0.9x), libraries were quantified using the Fragment Analyzer (AATI). For Illumina flow cell 
production, samples were equimolarly pooled and distributed on all lanes used for 75 bp 
single read sequencing on an Illumina NextSeq 500. 
After sequencing, FastQC (v0.11.3; http://www.bioinformatics.babraham.ac.uk/) was used 
to perform a basic quality control check on the sequence data. Reference genome 
(ASM25323v1) and annotation (v36) for S. venezuelae ATCC 10712 were obtained from 
Ensembl Bacteria. Reads were mapped to the S. venezuelae genome using GSNAP (v2017-
08-15). Further quality control on mapped reads, rRNA content and coverage of coding 
genes was performed with RNA-SeQC (v1.1.8). A table of raw readcounts per gene was 
created based on the overlap of the uniquely mapped reads with the S. venezuelae gene 
annotation using featureCounts (v1.5.3). Normalization of the raw readcounts based on the 
library size was performed with the DESeq2 R package (v1.16.1). Principle component 
analysis, sample-to-sample Euclidean distance as well as Pearson's and Spearman's 
correlation coefficients were computed based on the normalized gene expression level. For 
testing differential expression with DESeq2, the count data were fitted to the negative 
binomial distribution and the p-values for the statistical significance of the fold change were 
adjusted for multiple testing with the Benjamini-Hochberg correction for controlling the 
false discovery rate accepting a maximum of 5% false discoveries (adjusted p-value ≤ 0.05). 
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2.6.10 β-Glucuronidase (GusA) assay  
S. venezuelae was grown in liquid MYM medium with shaking for 48 hours at 30 °C. Cells 
were harvested by centrifugation and resuspended in lysis buffer (50 mM phosphate buffer 
at pH 7.0, 0.1% triton X-100 and 0.27% β-mercaptoethanol) for sonication as described in 
section 2.5.3. Cell debris were removed by centrifugation and the protein concentration of 
the supernatant was measured using the Pierce™ BCA Protein Assay Kit (ThermoFisher). 
The activity of β-glucuronidase (GusA) in the cell lysate was measured as described 
previously (Sherwood and Bibb, 2013; Fernandez-Martinez et al., 2015). Briefly, 100 μl of 
cell lysate and 100 μl of Z-buffer (60 mM Na2HPO4, 60 mM NaH2PO4 , 10 mM KCl, 10 mM 
MgSO4, pH7.0) containing PNPG at a final concentration of 4 mg/ml were mixed and 
distributed in a 96-well plate. The plate was immediately incubated in a SynergyTM 
NEOALPHAB multi-mode microplate reader from BioTek® for 2 hours at 30°C. The OD450 
and OD550 were measured in each well. The GusA activity was calculated and expressed as 
miller units per milligram of protein using the following equation: 1000 × (OD420 - 1.75 × 
OD550)/time of reaction (min) × volume of culture assayed × protein concentration (mg/ml). 
2.7 Manipulation of B. subtilis 
2.7.1 Transformation of B. subtilis 
An overnight culture was prepared by inoculating a B. subtilis colony into 4 ml of LB 
medium supplemented with the appropriate antibiotics and incubated at 37 °C with agitation. 
One hundred microliters of the overnight culture was inoculated into 10 ml of MNGE 
medium and incubated at 37 °C with agitation. When the OD600 value of the culture reached 
1.1 to 1.2, four hundred microliters of the culture were incubated with 2 µg of the relevant 
linearized plasmid at 37 °C for 1 hour with agitation. After that, 100 µl of expression mix 
was added and incubation was continued for another hour. Finally, 100 µl of the culture was 
plated on the selective plates. The linearization of pBS3Clux or pBS2E derived plasmids 
(Radeck et al., 2013) was performed by using the restriction enzymes ScaI and BsaI, 
respectively. 
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2.7.2 Luciferase assay with B. subtilis 
For the implementation of ECF42 from S. venezuelae in B. subtilis, ECF42 σ factor and its 
cognate promoter from S. venezuelae were moved to the heterologous host.  Luciferase 
activities of B. subtilis strains harboring Pecf42-lux and PxylA-ecf42 fusions were measured 
using a SynergyTM NEOALPHAB multi-mode microplate reader from BioTek® (Winooski, 
VT, United States). The Bio-reader was controlled using the software Gen5TM (version 2.06). 
One hundred microliter cultures were used per well in 96-well plates (black wall, clear 
bottom, clear lid, Greiner Bio-One). Incubation in the reader occurred at 37 °C with linear 
agitation and luminescence and OD600 were measured every 5 min.  
Briefly, an overnight culture was prepared by inoculating a single colony into 4 ml of MCSE 
medium supplemented with the appropriate antibiotics. Day culture was prepared by diluting 
20 µl of the overnight culture into 10 ml pre-heated MCSEC medium without antibiotics and 
incubated at 37 °C with agitation. When the OD600 reached 0.2, it was diluted to an OD600 of 
0.05 in pre-warmed MCSE medium and distributed into 96-well plate. After incubation in 
the Bio-reader for 1 hour, production of the ECF42 σ factor was induced by the addition of 
xylose to a final concentration of 0.5% (w/v), and the incubation and measurement continued 
for 18 hours. Specific luminescence activity is given in relative luminescence units (RLU) 
normalized by the background corrected cell density (RLU/OD600). 
2.7.3 Pull-down assay of B. subtilis RNAP 
Since the ECF42 σ factors from S. venezuelae were inactive in the heterologous host (B. 
subtilis), a pull-down assay of B. subtilis RNAP was performed to check if ECF42 σ factors 
from S. venezuelae could interact with the B. subtilis RNAP. Two ecf42 genes from S. 
venezuelae (sven_4377 and sven_7131) were codon optimized as described in 2.4.1 for 
expression in B. subtilis and separately cloned into the integrative vector pBS2E_PxylA to 
generated plasmids pQL2E-Pxyl 02 and pQL2E-Pxyl 05 (Table 2.4). The resulting plasmid 
was transformed into B. subtilis 1A774, which contains a 6xHis-tag β´ subunit of the RNAP, 
to generate strains TMB2727 (Sven_4377) and TMB2728 (Sven_7131). The expression of 
genes encoding ECF42 σ factors was controlled by the xylose inducible promoter PxylA and 
both ECF42 σ factors were N-terminally tagged with a 3xFLAG tag. The RNAP pull-down 
assays were performed as described previously (MacLellan et al., 2008). In brief, overnight 
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cultures of TMB2727 or TMB2728 were diluted into 100 mL of fresh LB medium 
supplemented with the appropriate antibiotics and grown at 37 °C with agitation until an 
OD600 of 0.4. Expression of ecf42 genes was induced with 0.5% xylose for 2 hours. Cells 
were harvested by centrifugation at 5,000 g for 10 min and resuspended in lysis buffer (50 
mM phosphate buffer, 100 mM NaCl, 0.1mM PMSF, 5m M imidazole, pH 8.0) for 
sonication as described in the section 2.5.3. The cleared lysate was collected by 
centrifugation (12,000 g, 4 °C for 30 min) and loaded into a column containing 1 mL Ni-
NTA metal affinity beads (Qiagen, Germany). The beads were washed with 10 column 
volumes of lysis buffer containing 5, 10, and 20 mM imidazole. Elution was carried out 
using 0.5 ml lysis buffer with increasing imidazole concentration (50, 100, 250 and 500 mM). 
Protein concentration was quantified by using the Pierce™ BCA Protein Assay Kit 
(ThermoFisher). Twenty microgram samples of cleared lysate, washing steps, and elution 
fractions were submitted to SDS-PAGE for checking the presence of RNAP (by coomassie 
staining) and the 3xFLAG_ECF42 σ factors (by Western blot).  
2.8 Manipulation of E. coli 
2.8.1 Preparation of E. coli competent cells 
E. coli cells were inoculated in 4 ml of LB medium supplemented with the appropriate 
antibiotics when necessary and incubated at 37 °C with shaking. This overnight culture was 
diluted 1:100 in fresh LB medium and incubated at 37 °C with shaking until the OD600 
reached 0.4. The culture was then split into 4 falcon tubes and incubated on ice for 20 min. 
The cells were harvested by centrifugation at 6,000 g for 5 min at 4 °C and resuspended in 
20 ml of 100 mM CaCl2.  After 20 min of incubation on ice, cells were harvested by 
centrifugation as before and resuspended in 4 ml of 15% glycerol containing 100 mM of 
CaCl2. One hundred microliter aliquots were split into 1.5 ml tubes and stored at -80 ℃ until 
use. 
2.8.2 Transformation of E. coli 
Frozen competent cells were incubated on ice for 5 min after which 5 to 10 µl of a ligation 
reaction or 20 ng of pure plasmid DNA was added and mixed gently. After incubation on 
ice for 20 min, cells were subjected to heat shock (90 sec at 42 °C), and placed back on ice 
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for 5 min. After the addition of 600 µl of fresh LB medium the cells were incubated for 1 
hour at 37 °C with shaking. Finally, the cells were plated on LB agar plates supplemented 
with selective antibiotics and incubated overnight at 37 °C. 
2.8.3 Two-hybrid assay in E. coli 
To investigate the interaction between ECF42 σ factors and DGPF proteins or the interaction 
between the N-terminal σ domain and the C-terminal extension of ECF42 σ factors, bacterial 
two-hybrid was performed based on the BACTH System kit (Karimova et al., 1998). For the 
interaction between ECF42 σ factors and DGPF proteins, genes encoding ECF42 σ factors  
(sven_4377 or sven_7131) and DGPF proteins (sven_4376 or sven_7130), were cloned into 
vectors pKT25 or pUT18C to generate the plasmids pQLE035, pQLE035, pQLE036, 
pQLE037, pQLE038, pQLE039, pQLE040 and pQLE041 (Table 2.4). For the interaction 
between the N-terminal and C-terminal of ECF42 (XCC3792), genes encoding the N-
terminal (1 to 178aa) and the C-terminal (179 to 265aa) fragments were cloned into pKT25, 
pKT25N, pUT18 or pUT18C to generate the plasmids pQLE042, pQLE043, pQLE044, 
pQLE045, pQLE046, pQLE047, pQLE048 and pQLE049 (Table 2.4). Plasmids encoding 
the ECF42 σ factor was co-transformed into E. coli BTH101 with plasmids encoding the 
DGPF protein. Plasmids encoding the N-terminal σ region were co-transformed into E. coli 
BTH101 with plasmids carrying genes encoding the C-terminal extension. The pKT25-zip - 
pUT18C-zip plasmid pair was used as positive control. Twenty microliters of co-
transformed cells were plated on LB plates supplemented with IPTG (0.5 mM), X-gal (40 
μg/ml) and the appropriate antibiotics for selection. The plate was incubated at 30 °C for 2 
days before imaging.  
2.8.4 Luciferase assay of E. coli 
Luciferase activity of E. coli MK01 strains harboring level M parts-containing plasmids were 
assayed using SynergyTM NEOALPHAB multi-mode microplate reader from BioTek® 
(Winooski, VT, USA). The reader was controlled by using the Gen5TM software. The day 
cultures were prepared by diluting 40 μl of the overnight cultures into 4 ml of fresh LB 
medium without antibiotics. After incubation at 37 °C with agitation for 2 hours, the cultures 
were diluted to an OD600 of 0.01 in fresh LB medium and transferred to 96-well plates. The 
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plate was incubated in the Bio-reader at 30 °C with agitation. After incubation for 1 hour, 
arabinose to a final concentration of 0.2% was added to induce the expression of the 
truncated or mutated ECF42 σ factor. Cell growth (OD600) and luminescence was monitored 
every 10 min for 6 hours. The relative luminescence output (RLU) was normalized to cell 
density (OD600). The OD600 and RLU values were background-corrected by subtracting the 
respective values measured for wells containing non-inoculated LB medium.  
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3. Results  
3.1 Bioinformatics analysis on ECF42 σ factors 
The initial analysis of genetic phylogenetic distribution and genomic context on group 
ECF42 σ factors in 2009 was based on the dataset containing only 111 ECF42 protein 
sequences (Staron et al., 2009). To account for the huge increase in bacterial genomes 
sequenced within recent decade, we reanalyzed group ECF42 based on 2661 ECF42 protein 
sequences that were extracted from NCBI database. 
3.1.1 Phylogenetic distribution of ECF42 σ factors 
An unrooted phylogenetic tree of ECF42 σ factors in bacteria was constructed based on the 
gapless multiple sequence alignment of 2661 ECF42 protein sequences (Fig. 3.1). ECF42 σ 
factors show a wide taxonomic distribution and proteins of this group can be found in 11 
different phyla, but are predominant in the Actinobacteria (75.5%) and Proteobacteria 
(19.4%) (Table 3.1), which form eight and four separated clusters on the tree, respectively. 
Except one branch of ECF42 σ factors from Proteobacteria that is included in a branch 
otherwise formed by ECF42 σ factors of Actinobacteria, the remaining ECF42 σ factors 
from Bacteroidetes, Acidobacteria, Firmicutes, Planctomycetes, Cyanobacteria, 
Verrucomicrobia, Spirochaetes, Chloroflexi and Gemmatimonadetes form separated 
branches (Fig. 3.1). The 2661 ECF42 σ factors derive from 1003 different species, which 
suggest several of these species harbor more than one copy of the ECF42 gene in their 
genome. This is particularly obvious in the phylum Actinobacteria, which harbors an 
average of more than three ECF42 σ factors per species. However, members of other phyla 
harbor only one or two ECF42 σ factors per species (Table 3.1). 
Based on the predominant distribution of the ECF42 σ factors in the Actinobacteria, we 
chose ECF42 σ factors from S. venezuelae, which is the novel model organism to study 
actinobacterial development, to investigate physiological role, regulatory mechanism and 
target regulons of ECF42 σ factors. 
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Figure 3. 1 Phylogenetic distribution of ECF42 σ factors. The phylogenetic tree of ECF42 σ factors is based 
on a gapless multiple sequence alignment of 2661 ECF42 protein sequences obtained using ClustalW as 
implemented in CLC Main Workbench. The resulting tree was generated using the neighbor-joining method 
and Jukes-Cantor protein distance model. Assignment of sequences to bacterial phyla is indicated in color. The 
position of the three ECF42 σ factors encoded in S. venezuelae (Sven_0747, Sven_4377 and Sven_7131) were 
highlighted with a red dot. 
Table 3. 1 Phylogenetic distribution of ECF42 σ factors 
Phyla 
ECF42 proteins 
in each phylum 
Percentage of            
ECF42 proteins 
Characterized 
species with ECF42 
proteins 
ECF42 
proteins 
per species 
Actinobacteria 2011 75.5 544 3.7 
Proteobacteria 517 19.4 353 1.5 
Bacteroidetes 36 1.4 33 1.1 
Acidobacteria 20 0.8 11 1.8 
Firmicutes 20 0.8 19 1.1 
Planctomycetes 18 0.7 15 1.2 
Cyanobacteria 12 0.5 11 1.1 
Verrucomicrobia 9 0.3 7 1.3 
Spirochaetes 7 0.3 3 2.3 
Chloroflexi 6 0.2 4 1.5 
Gemmatimonadetes 5 0.2 3 1.7 
 
3.1.2 Genomic context of ECF42 
In contrast to most ECF groups defined to date (Pinto and Mascher, 2016b), ECF42 coding 
genes lack neighboring anti-σ factor coding genes. Instead, more than 90% of ecf42 genes 
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are genomically associated with genes encoding DGPF proteins (YciI superfamily, 
COG3795) (Fig. 3.2). In almost 90% of these cases, DGPF coding genes are located closely 
upstream of those encoding ECF42 σ factors, oriented in the same direction and with a short 
intergenic region, which is suggestive of co-transcription. In addition to the DGPF proteins, 
in a few cases proteins from other families are also encoded in the neighborhood: 
glyoxalase/bleomycin resistance protein/dioxygenase (COG-PhnB), acyl-CoA 
dehydrogenases (COG-CaiA), an uncharacterized conserved protein (COG-3832) and a 
ketosteroid isomerase homolog (COG-4319) (Fig. 3.2). 
 
Figure 3. 2  Conserved genomic context of ECF42-encoding genes. Genes are color coded according to their 
COG family number. The number of analyzed species per phylum is indicated in parenthesis. On the left side 
of each genomic context illustration is indicated the ratio between the number of genes with that conserved 
genomic context and the number of ECF42 coding genes identified in all the species of that phylum.   
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3.1.3 Domain architecture of ECF42 σ factors 
ECF σ factors contain only the σ2 and σ4 conserved domains characteristic of the σ70 protein 
family. These are sufficient to ensure interaction with the RNA polymerase and promoter 
recognition. A multiple protein sequence alignment of classical ECF σ factors from different 
organisms and those of group ECF42 revealed a large C-terminal extension containing a 
tetratricopeptide repeat (TPR) conserved protein domain (Fig. 3.3). Such TRP domains are 
known to mediate protein-protein interactions (D'Andrea and Regan, 2003).  
 
Figure 3. 3 Domain architecture of ECF42 σ factors. The multiple sequence alignment of selected classical 
and ECF42 σ factors was constructed using DNAMAN. Identical amino acids at the same position are shaded 
in black, similar amino acids are shaded in pink or in light blue. The σ2 and σ4 domains and the C-terminal 
extension containing the TPR domain are marked on top of the alignment.  
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3.1.4 Prediction of conserved target promoter motif of ECF42 σ factors 
ECF σ factors select promoters with high stringency by combining specific interactions with 
the -10 and -35 promoter elements and hence each ECF group has their own group-specific 
target promoter. Identification of the target promoters of ECF σ factors enables us to predict 
their target regulons, thereby providing a direct access to the physiological role of ECF-
dependent regulation. Generally, the ECF-target promoters can be found at the intergenic 
regions directly upstream of the operon encoding the ECF σ factors, which leads to the 
positive auto-regulation of most them. Therefore, the putative target promoters of ECF42 σ 
factors were predicted using the MEME Suite (Bailey et al., 2009) to search for a conserved 
promoter motif upstream of the operons encoding ECF42 σ factors from different bacterial 
species belonging to different phyla. A conserved putative promoter motif was identified 
with "TGTCGA" in -35 region and "CGTC" in -10 region (Fig. 3.4). 
 
Figure 3. 4 Logo of the putative ECF42 target promoter motif. The logo was generated using the MEME 
motif discovery tool in MEME Suite available at http://meme-suite.org/. The logo graphically represents the 
ECF42 promoter position weight matrix and illustrates the degree of sequence conservation for each nucleotide 
position. The matrix is based on 18 putative promoter sequences found upstream of DGPF- and ECF42 
encoding operons. 
3.2 ECF42 target promoter determination 
3.2.1 Verification of the target promoter of ECF42 σ factors in S. venezuelae 
Since a conserved promoter motif has been found upstream of ECF42 genes, the upstream 
sequences of the operons encoding ECF42 σ factors (sven_0747, sven_4377 and sven_7131) 
in S. venezuelae were run against the ECF42 target promoter motif to identify the presence 
of the same promoter sequence. As expected, sequences matching such bipartite promoter 
motif were found upstream of the three DGPF- and ECF42-encoding operons of 
S. venezuelae (Fig. 3.5 A). 
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Figure 3. 5 ECF42 promoter determination and crosstalk in S. venezuelae. (A) Genomic context of the 
three ECF42 coding genes of S. venezuelae: sven_0747, sven_4377 and sven_7131. DGPF and ECF42 genes 
are shown by light gray and dark gray respectively. The orange square represents the location of the putative 
ECF42 target promoter. The putative -35 and -10 elements are highlighted. (B) DNA fragments containing the 
putative promoters, which start 80 bp upstream of the putative -35 region and end 20 bp downstream of the 
putative -10 region, were inserted into pGUS, which carries a gus reporter gene, generating the plasmids 
pQLS007 (pGUS_Psven0747), pQLS008 (pGUS_Psven4377) and pQLS009 (pGUS_Psven7131). (C) Evaluation of the 
activity of putative ECF42 target promoters in strains overexpressing different ECF42 σ factors. The integrative 
reporter plasmid was transformed into S. venezuelae strains individually overexpressing the ECF42 σ factors 
Sven_0747 (TMS0112), Sven_4377 (TMS0113) and Sven_7131 (TMS0114) as well as in the WT (WT) and 
ECF42 triple deletion mutant (TMS0050) strains. Activity of each promoter and of the empty pGUS vector 
was measured. The activity was expressed as miller units per microgram proteins. (***P﹤0.001, **P﹤0.01 
as compared to the WT). 
Subsequently, the conserved promoter sequences presented upstream of the three DGPF- 
and ECF42-encoding operons was investigated to disclose whether they are in fact the target 
promoters of the ECF42 σ factors. A DNA fragment containing the predicted promoter 
sequence of each ECF42 (Fig. 3.5 A) was fused to the β-glucoronidase (Gus) reporter gene 
in the vector pGUS to generate the plasmids pQLS007 (pGUS_Psven0747), pQLS008 
(pGUS_Psven4377) and pQLS009 (pGUS_Psven7131) (Fig. 3.5 B). Each plasmid was conjugated 
into S. venezuelae and the activity of the promoter was assessed by measuring the Gus 
activity in strains individually overexpressing the three ECF42 σ factors (TMS0112, 
TMS0113 and TMS0114) from the constitutive promoter ermE*p. As shown (Fig. 3.5 C), 
the activity of the sven_0747 promoter (Psven_0747) is approximately ten-fold higher in the 
strain overexpressing Sven_0747 (TMS0112) than in the WT strain, and the sven_4377 
promoter (Psven_4377) has a 5-fold higher activity in the strain overexpressing Sven_4377 
(TMS0113) than in the wild type (Fig. 3.5 C). The activity of the putative sven_7131 
promoter has not been detected in any of the ECF42 overexpression strains (Fig. 3.5 C). 
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However, these results confirm that two of the predicted promoters are targets of ECF42 σ 
factors in S. venezuelae.  
As mentioned above, the genome of S. venezuelae encodes three putative ECF42 σ factors. 
To investigate if there is crosstalk between different ECF42 σ factors and their target 
promoters, the activity of each ECF42 target promoter was also evaluated in strains 
overexpressing the other two ECF42 σ factors. No crosstalk was observed between any of 
the non-cognate ECF-promoter pairs except for the Sven_4377-Psven_0747 pair (Fig. 3.5 C). 
3.2.2 Implementation of ECF42 σ factors from S. venezuelae in B. subtilis 
The genetic manipulations in S. venezuelae is a time-consuming process. Thus, for more 
conveniently investigate the regulatory mechanism of ECF42 σ factors, the σ factors and 
their cognate promoters from S. venezuelae were implemented in a heterologous host, 
B. subtilis 168, which is the Gram-positive model organism characterized by strong genetics 
based on natural competence and the availability of numerous genetic tools including 
standardized vectors suites based on the BioBrick cloning standard (Radeck et al., 2013; 
Popp et al., 2017) developed by our lab.  
Genes encoding ECF42 σ factors (sven_4377 and sven_7131) were codon adapted for 
optimized expression in B. subtilis and cloned into the B. subtilis integrative vector 
pBS2E_PxylA, in which the expression of the ecf42 genes is controlled by the xylose inducible 
promoter PxylA (Fig. 3.6 A). The target promoter sequences of ECF42 σ factors were cloned 
into the integrative vector pBS3Clux upstream of the luciferase reporter gene cluster 
(Fig. 3.6 A). B. subtilis was transformed with both pBS2E_PxylA derived ECF42 
overexpression plasmid and pBS3Clux derived reporter plasmid, then the promoter 
activation by the overexpressed ECF42 σ factors was assessed by monitoring luminescence 
over time. As shown, no activation was not observed in strains overexpressing ECF42 σ 
factors (Sven_4377 or Sven_7131) for neither their natural (NP) nor the adjusted promoters 
(AP), in which the GC content was adapted to B. subtilis. (Fig. 3.6 B). 
Since the lack of activity of these σ factors in B. subtilis has been observed, the expression 
of ECF42 σ factors (Sven_4377 or Sven_7131) was checked by Western blot using an anti-
FLAG antibody and were able to confirm the expression of the codon adapted ecf42 genes 
(Fig. 3.6 C). In addition, the interaction between these ECF42σ factors with the RNAP of 
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B. subtilis was checked by performing a RNAP pull-down assay in B. subtilis strain 1A774, 
which expresses a 6×His-tagged RNAP β´ subunit. The ECF42 σ factors (Sven_4377 or 
Sven_7131) were overexpressed and the RNAP complex from each strain was purified 
(Fig. 3.6 D) through the 6×His-tagged RNAP β´ subunit. The presence of FLAG-tagged 
ECF42 σ factors in the purified complexes was detected by Western blot by using an anti-
FLAG antibody (Fig. 3.6 E). As can be seen by comparing Fig. 3.6 D and Fig. 3.6 E, 
Sven_7131 is pulled-down with the RNAP in a specific way, i.e., higher amounts of RNAP 
seen in the SDS-PAGE loosely correlate with higher amounts of Sven_7131 detected in the 
Western blot. However, Sven_4377 is pulled-down in a non-specific way, i.e., higher 
amounts of RNAP seen in the SDS-PAGE do not correlate with higher amounts of 
Sven_4377 detected in the Western blot; this observation can explain the lack of activity of 
the Sven_4377-PSven_4377 pair in B. subtilis.  
 
Figure 3. 6 Implementation of ECF42 σ factors from S. venezuelae in B. subtilis.  (A) Genes (sven_4377 
and sven_7131) coding ECF42 σ factors were introduced into B. subtilis via the integrative vector pBS2E_PxylA, 
in which the expression of the ECF42 is slaved to the xylose inducible promoter PxylA. The target promoters of 
ECF42 σ factors were cloned into the integrative vector pBS3Clux and drive the expression of the luciferase 
reporter gene cluster. (B) Activity of the natural (NP) and adjusted promoters (AP) was checked by measuring 
the activity of luciferase. ECF41 with its target promoter were constructed in the same way and tested 
simultaneously as positive control. (C) The expression of ECF42 σ factors in B. subtilis was checked by using 
an anti-FLAG antibody. (D) SDS-PAGE analysis of the total (T) protein extract of B. subtilis cells 
overexpressing FLAG-tagged ECF42 σ factors, flow-through (F) from the Ni-NTA column and samples of the 
elution fractions obtained with different concentrations of imidazole (5 to 500 mM). (E) Western Blot detection 
of the FLAG-tagged ECF42 σ factors (Sven_4377 and Sven_7131) co-purified with the RNAP. 
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Collectively, these results indicated that ECF42 σ factors from S. venezuelae are expressed 
in B. subtilis and at least one of them is able to associate with the RNAP of the host. Although 
these ECF σ factor-promoter pairs functions in S. venezuelae, they do not function properly 
in B. subtilis, for reasons that remain elusive at this point.  
3.3 Physiological roles of ECF42 σ factors in S. venezuelae  
3.3.1 Generation of ECF42 triple deletion mutant 
ECF42 σ factors are highly abundant in Actinobacteria, especially in the genus Streptomyces, 
with up to 4 copies per genome. This suggests an important physiological role in these 
organisms. Based on that, the biological role of ECF42 σ factors in S. venezuelae was 
investigated in this study.  
 
Figure 3. 7 Generation of ECF42 triple deletion mutant. (A) Total DNA of the ECF42 triple deletion strain 
(TMS0050) was extracted and analyzed by PCR using three different primer pairs (yellow for sven_0747, green 
for sven_4377 and brown for sven_7131), which bind up- and downstream of the three ECF42 coding genes. 
(B) The amplified fragments encompassing the ECF42 coding genes (1179 bp of sven_0747, 1242 bp of 
sven_4377 and 1977 bp of sven_7131) were obtained by PCR using total DNA from the WT strain in three 
independent PCR reactions with the primer pairs (TM4606 and TM4607 for sven_0747, TM4608 and TM4609 
for sven_4377 and, TM4610 and TM4611 for sven_7131). The amplified fragments were smaller in triple 
deletion mutant TMS0050, confirming the absence of the deleted genes. 
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First, a triple deletion mutant of S. venezuelae (TMS0050) was created by deleting three 
genes (sven_0747, sven_4377 and sven_7131) encoding ECF42 σ factors employing the I-
SceI Meganuclease mediated method (Fernandez-Martinez and Bibb, 2014). The genotype 
of TMS0050 was confirmed by PCR. In brief, total DNA from the strain TMS0050 was 
extracted and analyzed by PCR using three primer pairs (TMS4606 and TM4607 for 
sven_0747, TMS4608 and TM4609 for sven_4377 and, TMS4610 and TM4611 for 
sven_7131), which bind up- and downstream of each of the ECF42 loci (Fig. 3.7 A). In the 
WT of S. venezuelae, these primer pairs generate fragments of 1179, 1242 and 1977 bp, 
respectively (Fig. 3.7 B). In the TMS0050 strain, the same primer pairs generate smaller 
fragments that correspond to the lack of the ECF42 coding genes, confirming their deletion. 
The three loci were sequenced to confirm deletion (Fig. 3.7 B).  
3.3.2 Identification of ECF42-dependent phenotypes by Phenotype Microarrays  
The physiological role of ECF42 σ factors is currently unknown. Identification of the 
ECF42-related phenotype will be helpful to disclose the function of ECF42 σ factors in 
S. venezuelae. Hence, Phenotype Microarrays (PM) analysis, which is a high-throughput 
approach that allows testing hundreds of different physiological conditions in parallel in 
order to identify phenotypes associated with genetic alterations (Bochner, 2003), was 
performed for S. venezuelae and TMS0050 to identify ECF42-dependent phenotypes. 
The PM analysis, commercially provided by Biolog (Hayward CA, USA), on S. venezuelae 
WT and TMS0050 included 960 assays for carbon, nitrogen, phosphorus, and sulfur 
utilization, nutrient stimulation, pH and osmotic stress as well as chemical sensitivity test 
covering 240 different compounds. More information concerning the plate layouts and 
media composition can be obtained at http://www.biolog.com/products-static/phenotype_ 
microbial_cells_use.php. Careful analysis of the PM results shown that the growth of 
S. venezuelae WT and TMS0050 behave in a similar way in all tested conditions (Fig. 3.8 A) 
except for one: in the presence of the dipeptide methionine-histidine (Met-His) as the sole 
nitrogen source the triple deletion mutant showed a slightly higher metabolic activity than 
the WT (Fig. 3.8 A). However, this behavior was not observed in the presence of other 
dipeptides containing methionine (Fig. 3.8 B) or histidine (Fig. 3.8 C) or in the presence of 
the single amino acids as sole nitrogen source. We were therefore not able to identify any 
ECF42-related phenotype. 
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Figure 3. 8 Investigation of ECF42-related phenotype by PM analysis. (A) S. venezuelae WT and ECF42 
triple deletion mutant (TMS0050) were subjected to PM analysis. Each strain was treated with different 
conditions in each well of 20 distinct plates (PM1 to PM20). A statistically significant difference of metabolic 
activity between S. venezuelae WT and TMS0050 was observed in well B12 of PM7 plate, in which growth 
medium had the dipeptide methionine-histidine (Met-His) as the sole nitrogen source. The green area represents 
the metabolic activity of the ECF42 triple deletion mutant (TMS0050) while the red area represents the 
metabolic activity of the WT over time. The overlapped regions are represented in yellow. (B and C) Metabolic 
activity of S. venezuelae WT and TMS0050 in the presence of methionine or methionine containing dipeptides 
as sole nitrogen source (B), and in the presence of histidine or histidine containing dipeptides as sole nitrogen 
source (C).  
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3.3.3 Defining the target regulons of ECF42 σ factors in S. venezuelae by RNAseq 
Since the phenotypic analysis was non-conclusive, we next aimed at unraveling the 
physiological role of ECF42s by identifying their target genes in S. venezuelae. Towards this 
goal, RNAseq analyses were performed on strains overexpressing each of the ECF42 σ 
factors in comparison to the ECF42 triple deletion mutant. 
Overexpression of ECF42 σ factors. Strains overexpressing ECF42 σ factors from the 
constitutive promoter ermE*p in the ECF42 triple deletion mutant background were 
constructed. The growth of S. venezuelae WT, ECF42 triple deletion mutant (TMS0050) and 
of the different ECF42 overexpression strains - TMS0112 (sven_0747), TMS0113 
(sven_4377) and TMS0114 (sven_7131) – was evaluated in MYM medium (Fig. 3.9 A). The 
production of the ECF42 σ factors (Sven_0747, Sven_4377 and Sven_7131) after 8 hours 
(lag phase), 10 hours (log phase) and 12 hours (stationary phase) of growth was investigated 
by Western blot using an anti-FLAG antibody (Fig. 3.9 B). All three ECF42 σ factors were 
successfully produced in all growth phases.  
 
Figure 3. 9 Overexpression of ECF42 σ factors in S. venezuelae. (A) Growth curves of S. venezuelae strains 
in MYM trace element (start cell density of OD450=0.01) at 30 °C with shaking. OD450 was measured every 
hour. (B) The overexpression of the ECF42 σ factors (Sven_0747, Sven_4377 and Sven_7131) at 8, 10 and 12 
hours was checked by Western Blot using an anti-FLAG antibody. 
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Defining the target regulons by RNA-seq. After the ECF42 overexpression strains were 
constructed, total RNA of cells from mid-exponential cultures (10 hours of incubation), 
containing the highest level of ECF42 proteins (Fig. 3.9 B), was extracted by using Direct-
zol RNA MiniPrep Plus kit. Then, the mRNA was purified from total RNA by depleting 
Ribosomal RNA (rRNA) using Ribo-Zero rRNA Removal Kit. After the mRNA was 
fragmented and quantified, it was submitted for reverse transcription and synthesis of the 
second DNA strand to generate the libraries using the Ultra II Directional RNA Library Prep 
Kit (NEB). Then, the generated libraries were quantified and pooled for 75 bp single read 
sequencing on an Illumina NextSeq 500. The transcriptional profiles from the ECF42 σ 
factor overexpression strains were analyzed and compared to that of the ECF42 triple 
deletion mutant. The up-regulated genes (≥ 2-fold, P ≤ 0.005, reads ≥ 300) in each of the 
ECF42 overexpression strains can be found in the appendix (Table A2) and the upregulated 
genes (≥ 2-fold) harboring a target promoter motif of ECF42 are listed in Table 3.2. The 
DGPF protein coding genes sven_0748 and sven_4376, encoded immediately upstream of 
the ECF42-encoding genes sven_0747 and sven_4377 were upregulated more than 16-fold 
(Table 3.2). These results obviously indicated DGPF genes are the target of ECF42 σ factors 
in S. venezuelae. 
Table 3. 2 Genes up-regulated in the ECF42 overexpression strains 
Gene locus Fold-change P value Description 
Strain overexpressing sven_0747 
sven_0748 16.34 1.00945E-23 DGPFAETKE family protein 
Strain overexpressing sven_4377 
sven_3806 643.59 0 DGPFAETKE family protein 
sven_4376 20.97 0 DGPFAETKE family protein 
sven_6046  7.21 5.51978E-25 Molybdate-binding domain of ModE 
sven_3126 2.91 1.98672E-07 Hypothetical protein 
sven_4575  2.83 2.09087E-05 Putative RNA polymerase ECF39 group σ factor 
sven_1017 2.36 1.52519E-12 Hypothetical protein 
sven_0690  2.33 1.53116E-10 Cysteine synthase  
sven_4614  2.19 5.28467E-16 Hypothetical protein 
sven_1219  2.04 4.78931E-25 Iron utilization protein 
Strain overexpressing sven_7131 
sven_2864  4.86 1.75073E-05 Phage major capsid protein 
sven_1613 3.94 1.76361E-08 Aspartate or tyrosine or aromatic aminotransferase 
sven_3169 2.28 1.94133E-14 Molecular chaperone IbpA, HSP20 family 
sven_5840 2 4.73082E-06 Hypothetical protein 
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In addition to genes encoding DGPF proteins or those whose products have no assigned 
function, genes whose products are involved in multi-functions were also upregulated in the 
ECF42 overexpression strains (Table 3.2). For the targets of Sven_0747, the associated 
DGPF proteins Sven_0748 is the only target. For the targets of Sven_4377, (i) Sven_6046 
harbors a Molybdate-binding domain found in ModE protein of E. coli, which is a repressor 
of modABCD operon coding molybdate-specific transport system (Grunden et al., 1996); (ii) 
Sven_4575 belongs to the group of ECF 39 and members in this group are involved in cell 
envelope stress response (Kang et al., 1999) and antibiotics synthesis (Luo et al., 2014); (iii) 
Sven_0690 shows a homolog domain with cysteine synthase, which involved in amino acid 
transport and metabolism; (iv) Sven_1219 is a siderophore interacting protein, which shares 
the domain stricture of the ferredoxin reductase like family, thus involved in iron utilization 
(Catalano-Dupuy et al., 2006). For the targets of Sven_7131, (i) Sven_2864 is a phage major 
capsid protein; (ii) Sven_1613 belongs to the aspartate aminotransferase superfamily, 
members of which are involved in amino acid metabolism; (iii) Sven_3169 is a molecular 
chaperone, which belongs to heat shock protein (HSP) superfamily, members in this family 
are found to be involved in resistances to heat and superoxide stress in E. coli (Kitagawa et 
al., 2000). Although most of the target genes of ECF42 σ factors in S. venezuelae are with 
lower fold changes, putative ECF42 target promoters were identified in the upstream regions 
of all of these genes, suggesting that they are direct targets of ECF42 σ factors (Fig. 3.10 
AB). 
Since the results of RNA-seq had shown DFPG genes upstream of ECF42 genes were the 
significant targets of ECF42 σ factors, we then focused on the expression levels of all the 
DGPF coding genes, identified in the genome of S. venezuelae, to gain further insight into 
their expression patterns (Fig. 3.10 C). Regarding the three DGPF proteins associated with 
ECF42 σ factors, only two of them were overexpressed in the strain producing their 
associated ECF42 σ factors: Sven_0748 in TMS0112 (overexpression of Sven_0747) and 
Sven_4376 in TMS0113 (overexpression of Sven_4377) (Fig. 3.10 C). This is in agreement 
with our data concerning the identification of ECF42 target promoters in S. venezuelae, since 
sven_0748 and sven_4376, but not sven_7130, were active upon overproducing the cognate 
ECF42 σ factor. Additionally, we also observed that the DGPF protein-encoding gene 
sven_0748 is overexpressed in the strain overexpressing Sven_4377. Again, this observation 
is in agreement with our previous observation that the promoter of sven_0748 is active in the 
strain overproducing Sven_4377 (Fig. 3.10 C). Other than the ECF42 associated DGPF 
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genes, one of the three additional genes coding DGPF proteins that is not genomically 
associated with any ECF42 coding gene (sven_3806), was strongly upregulated (643-fold) 
in the Sven_4377 overexpression strain (Fig. 3.10 C). Collectively, our data suggests that 
regulating the expression of the DGPF proteins is the major role of the ECF42 σ factors in 
S. venezuelae.  
 
Figure 3. 10 Identification of ECF42 target regulons in S. venezuelae. (A) Putative promoter sequences in 
the upstream region of the upregulated genes. The promoter sequences harbor the ECF42 target promoter motif 
and are shown accordingly to individual ECF42 overexpression strains. The length of the spacer between -35 
and -10 regions is indicated for each promoter sequence. (B) Logo generated based on the promoter sequences 
listed in panel A. We note that this motif is very similar to the conserved ECF42 promoter motif shown in 
Figure 3.4 although the conservation in positions 7, 8 and 29 is lower. (C) Expression pattern of all DGPF 
protein coding genes identified in the genome of S. venezuelae. In the graph are shown the fold-change on the 
expression of the DGPF protein coding genes (sven_0748, sven_4376, sven_7130, sven_3806, sven_5447 and 
sven_6405) in the S. venezuelae ECF42 overexpression strains TMS0012 (Sven_0747), TMS0113 (Sven_4377) 
and TMS0114 (Sven_7131) in reference to the triple deletion mutant TMS0050. (***P﹤0.001) 
3.3.5 Interaction between DGPF and RibD 
DGPF genes were identified as the main target of ECF42 regulation in S. venezuelae, thus 
elucidation of the function of DGPF might be important to disclose the physiological roles 
of ECF42 σ factors. Currently, the exact function of DGPF proteins is unknown, although 
the structure of members of the same protein family has been determined (Willis et al., 2005) 
and one of them has been characterized as a dehydrochlorinase (Hayes et al., 2013). 
Additionally, the Escherichia coli DGPF protein (YciI) was found to interact with RibD, a 
deaminase/reductase of the riboflavin biosynthetic pathway (Hu et al., 2009). Based on this 
information, the interaction between DGPF protein (Sven_3806) and RibD (Sven_1041) 
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from S. venezuelae was initially investigated by pull-down in E. coli to further explore the 
physiological role of ECF42 σ factors. 
Both codon-optimized genes encoding DGPF protein (Sven_3806) and RibD protein 
(Sven_1041) were cloned into the overexpression vector pETduet1 separately or in tandem 
(Fig. 3.11 A). A 10xHis tag was introduced into the N-terminus of RibD (37.8 kDa) and a 
Strep tag was introduced into the C-terminus of the DGPF protein (15.9 kDa). The capture 
of the DGPF-Strep protein was performed using the magnetic Strep beads (Fig. 3.11 B) and 
the co-purification of 10xHis_RibD protein was investigated by Western blot using an anti-
His antibody (Fig. 3.11 C).  
 
Figure 3. 11 Pull-down analysis of the interaction between DGPF and RibD protein. (A) Codon optimized 
genes encoding RibD (sven_1041) and DGPF (sven_3806) proteins from S. venezuelae were cloned into the 
pETDuet1 vector separately or in tandem to generate these three overexpression plasmids. Expression of the 
proteins was independently driven by the IPTG inducible T7 promoter. A 10xHis tag was introduced into the 
N-terminus of RibD (37.8 kDa) and a Strep tag was introduced into the C-terminus of the DGPF protein (15.9 
kDa). (B) SDS-PAGE of the total soluble proteins (T) from the strains overexpressing 10xHis_RibD, 
DGPF_Strep or both with (+) or without (-) IPTG induction. "Pull" represents the protein fractions recovered 
from the pull-down samples using the magnetic Strep beads. (C) Western blot analysis of the same samples as 
in (B) using an anti His antibody. The protein samples and the order in each lane are as the same as in (B). 
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The 10xHis_RibD protein was detected in the total soluble extract of strains overexpressing 
10xHis_RibD and 10xHis _RibD and DGPF_Strep. However, the 10xHis_RibD was not 
detected in the DGPF_Strep pull-down sample from the strains co-overexpressing 
10xHis_RibD and DGPF_Strep (Fig. 3.11 C). These results show that despite being 
successfully expressed in E. coli, both 10xHis_RibD and DGPF_Strep proteins do not 
interact with each other. 
3.4 Regulation of ECF42 σ factor activity 
3.4.1 Regulatory role of DGPF proteins  
Generally, the activity of ECF σ factors are controlled by their cognate anti-σ factor located 
in the their same operons. However, the conserved features of the genetic context in the 
ECF42 group (Fig. 3.2) indicate that ECF42 lack a cognate anti-σ factor. Instead, they are 
associated and putatively co-expressed with genes encoding DGPF proteins of unknown 
function (Fig. 3.5). The crystal structure of a member of this protein family (COG3795), 
YciI from Haemophilus influenzae, was solved and contains a putative active site, but no 
enzymatic activity was observed in a subsequent screen (Willis et al., 2005).  
Based on the available data, we hypothesized that DGPF protein plays a regulatory role on 
ECF42 σ factors (Fig. 3.12). In the absence of stimulus, ECF42 σ factors are inactive, either 
by intramolecular interactions or by oligomerization mediated by the TPR-repeat containing 
C-terminal extension. The YciI-like (DGPF) proteins might function as sensors in a partner-
switching mechanism: upon activation, DGPF might change their confirmation and bind the 
TPR-domain, thereby releasing the ECF σ domain from inhibition (Fig. 3.12 A). 
Alternatively, DGPF proteins and ECF42 σ factors might form a protein-protein interaction 
complex reminiscent of a typical σ and anti-σ pair in the absence of a suitable stimulus. Once 
activated, this interaction would then be disrupted, for example by a conformational change 
of the DGPF proteins, thereby releasing ECF42 σ factors to initiate gene expression from 
their target promoters (Fig. 3.12 B). 
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Figure 3. 12 Putative regulation mechanism of DGPF proteins on ECF42 σ factors activation. (A) ECF42 
σ factors are inactive in the absence of stimulus. Once the stimulus is perceived by the DGPF protein, it induces 
a conformational change and it is then bound by the TPR-domain, thereby releasing the ECF σ domain from 
inhibition. (B) In the absence of an inducible stimulus, the DGPF protein and the ECF42 σ factor form a 
complex reminiscent of a σ and anti-σ complex. Under activating conditions, this interaction is disrupted, 
thereby releasing the ECF42 σ factor to initiate transcription. 
3.4.1.1 Interaction between ECF42 and DGPF proteins in two-hybrid assay 
No matter the DGPF protein plays the negative or positive regulatory role on the activity of 
ECF42 σ factor as we hypothesized, DGPF needs to interact with ECF42 σ factor to execute 
its regulatory functions. Thus, the interaction between the DGPF protein and the ECF42 σ 
factor was initially investigated by two-hybrid (BACTH) assays in E. coli.  
The BACTH system is based on the interaction-mediated reconstitution of the adenylate 
cyclase (Karimova et al., 1998). It exploits the fact that the catalytic domain of adenylate 
cyclase (CyaA) from Bordetella pertussis (Goyard et al., 1993) consists of two 
complementary fragments –  T25 and T18 –  that are not active when physically separated. 
When these two fragments are brought together by interacting proteins (here, DGPF and 
ECF42 σ factor), it results in functional complementation between T25 and T18 fragments 
and, therefore leads the generation of cyclic AMP (cAMP). The generated cAMP then binds 
to the catabolite activator protein (CAP) to form the cAMP/CAP complex, which is a 
pleiotropic regulator of gene transcription in E. coli. Amongst other targets, it induces the 
expression of the β-galactosidase gene. In this way, blue colonies on LB-IPTG-X-gal plate 
are indicative of protein-protein interactions. 
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The codon-optimized DGPF genes (sven_4376 and sven_7130) and the genes encoding 
ECF42 σ factors (sven_4377 and sven_7131) were cloned into pTK25 and pUT18C vectors. 
pTK25 and pUT18C derivatives were co-transformed into E. coli BTH101. The 
transformants were plated on LB-IPTG-X-gal plates and incubated at 30 °C for 2 days. Only 
an interaction between the positive control plasmids – pTK25-Zip and pUT18C-Zip – was 
detected, but no additional interactions were observed for any other pair (Fig. 3.13). These 
results suggested that there is no direct interaction between ECF42 σ factors and their 
cognate DGPF proteins. 
 
Figure 3. 13 Interaction between ECF42 σ factors and DGPF proteins. Genes encoding ECF42 σ factors 
(sven_4377 or sven_7131) and DGPF proteins (sven_4376 or sven_7130) were cloned into pKT25 and pUT18C 
vectors to generate two sets of plasmids. Each pKT25 derived plasmid (ECF42 σ factor or DGPF protein) was 
co-transformed with each of pUT18C derived plasmid (ECF42 σ factor or DGPF protein) into E. coli BTH101. 
Twenty microliters of co-transformed cells were dropped on a LB-agar plate supplemented with IPTG (0.5 
mM), X-gal (40 μg/ml), ampicillin (100 μg/ml) and kanamycin (50 μg/ml). The plate was incubated at 30 °C 
for 2 days. 
Results 
71 
3.4.1.2 Effect of DGPF on promoter activation of ECF42 σ factor 
Other than the interaction between DGPF and ECF42 σ factors, the effect of the DGPF 
protein on the activity of the ECF42 σ factors was investigated subsequently. The genes 
encoding the ECF42 σ factor (XCC3792) and its cognate DGPF proteins (XCC3790) of 
Xanthomonas campestris were placed under the control of the arabinose inducible promoter 
(PBAD) and the anhydrotetracycline inducible promoter (PTet), respectively (Fig. 3.14 A). The 
luxCDABE reporter cassette was placed under the control of the ECF42-target promoter. 
These three transcription units were assembled into one plasmid using the Moclo system 
(Fig. 3.14 A). E. coli was transformed with this generated plasmid and the activity of the 
ECF42 σ factor was evaluated by measuring the luminescence output. Induction of ECF42 
σ factor expression by arabinose results in a 10-fold increase in the Pecf42 promoter activity 
(Fig. 3.14 B). However, the activity of Pecf42 in the presence of ECF42 σ factor is not 
influenced by the DGPF protein (Fig. 3.14 B). Expression of both ECF42 σ factor and DGPF 
proteins was confirmed by Western blot. Together with the results of the two-hybrid assay, 
the collective data indicates that the DGPF protein is not involved directly in the regulation 
of ECF42 activity. 
 
Figure 3. 14 Influence of the DGPF protein on the activity of the ECF42 σ factor. (A) Genes encoding the 
ECF42 σ factor and its cognate DGPF proteins of X. campestris were placed under the control of the arabinose 
inducible promoter (PBAD) and the anhydrotetracycline inducible promoter (PTet), respectively. The luxCDABE 
reporter cassette was placed under the control of the ECF42 σ factor target promoter. All these three 
transcription units were assembled using the MoClo cloning method. T shapes represent terminators and the 
gray squares represent the genetic insulators, preventing the transcriptional interference of the transcription 
units. (B) The activity of Pecf42 was evaluated by measuring luminescence in the presence (+) or absence (-) of 
the ECF42 σ factor and the DGPF protein. (C) Western blot analysis of FLAG-tagged ECF42 σ factors and 
DGPF proteins from the strains induced with the different inducers as the same order as shown above. 
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3.4.2 Regulatory role of the C-terminal extension of ECF42 σ factor 
In addition to being putatively co-expressed with a conserved neighboring gene encoding a 
DGPF protein, ECF42 σ factors are characterized by the presence of a large C-terminal 
extension containing a conserved TPR domain (Fig. 3.3). Generally, ECF σ factors require 
their cognate anti-σ factors, locating in the same operon of ECF σ factors, to keep them 
inactive as long as non-inducing conditions prevail. However, given that no anti-σ factors 
was identified for ECF42 σ factors, this negative function might reside either on the C-
terminal extension and/or on the partner proteins (DGPF). Our data shows that the DGPF 
protein does not interact with the σ factor (Fig. 3.13) and that its activity is not affected by 
the DGPF protein (Fig. 3.14). We therefore propose a regulatory role of the C-terminal 
extension of ECF42 σ factors, which might serve as an anti-σ like function that directly 
interacts with the N-terminal σ domain to block the activity of the ECF42 σ factor (Fig. 3.15). 
 
Figure 3. 15 Putative regulatory role of the C-terminal extension of ECF42 σ factors. The C-terminal 
extension interacts with the N-terminal σ domain and acts as an anti-σ factor in absence of a suitable stimulus. 
Once triggered, this interaction is then disrupted (probably by a conformational change), thereby releasing 
ECF42 σ factor to initiate transcription. 
3.4.2.1 Prediction of the interaction surfaces between the σ region and the C-terminal 
extension of ECF42 σ factor 
As we hypothesized, the C-terminal extension of ECF42 σ factor might interact with its N-
terminal σ domains and play the role of anti-σ factor. Thus, the direct coupling analysis 
(DCA) (Weigt et al., 2009; Ekeberg et al., 2013) was initially applied to identify the direct 
residue contacts between the σ region and the C-terminal extension of ECF42 σ factor. DCA 
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is a statistical inference framework used to infer direct co-evolutionary couplings among 
residue pairs in multiple sequence alignments. In this case, the DCA was employed for the 
conserved N-terminal σ domain and the C-terminal extension of ECF42 σ factors and five 
co-variable amino acid pairs were identified between the σ4 domain and the C-terminal 
extension of ECF42 σ factors (XCC3790) from X. campestris: R132 - S191, T136 - V195, 
G141 - I199, A151 - N201 and A147 - R214 (Fig. 3.16). This direct-coupling-analysis 
between N- and C- terminal domains of ECF42 σ factors was performed by our collaborators 
Hao and Georg (unpublished data). 
 
Figure 3. 16 Prediction of interaction between the N-terminal σ domain and the C-terminal extension of 
X. campestris ECF42 σ factor. (A) Five potential interacting residues between the C-terminal extension and 
the N-terminal domain of the ECF42 σ factor from X. campestris were identified by DCA. (B) The positions 
and residues of the co-variable amino acid pairs between the N-terminal σ region and the C-terminal extension. 
(C) Position of the co-variable amino acids in the sequence of the σ4 region and in the C-terminal extension. 
3.4.2.2 Alanine-scanning mutagenesis of the co-variable residues in the C-terminal 
extension decreases the activity of the ECF42 σ factor 
Since we hypothesized that the C-terminal extension plays a regulatory role and five co-
variable amino acid pairs were identified between the C-terminal extension and σ4 domain 
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by DCA, the influence of these amino acids to the activity of ECF42 σ factor was 
subsequently investigated by site-directed mutagenesis (Fig. 3.17).  
 
Figure 3. 17 Mutation on the predicted co-variable residues on the C-terminal extension decrease the 
activity of ECF42 σ factor. (A) The genes encoding ECF42 σ factor WT and the different mutants M01 
(S191A), M02 (V195A), M03 (I199A), M04 (N201A) and M05 (R214A), were placed under the control of the 
arabinose inducible promoter PBAD, while the target promoter of ECF42 σ factor is controlling the expression 
of the luxCDABE reporter cassette. Both transcription units were carried in the same plasmid. T shapes 
represent terminators and the gray squares represent the genetic insulators, preventing the transcriptional 
interference of the transcription units from their both sides.  (B) Activity of different ECF42 σ factor variants 
as measured by their ability to activate their target promoter. (C) Western blot detection of the FLAG-tagged 
ECF42 variants. 
Each residue in the C-terminal extension was substituted by alanine to generate different 
ECF42 alleles: M01 (S191A), M02 (V195A), M03 (I199A), M04 (N201A) and M05 
(R214A). Genes encoding the different ECF42 variants were placed under the control of the 
arabinose-inducible promoter PBAD and the target promoter of the ECF42 σ factor was used 
to drive the expression of the luxCDABE reporter gene (Fig. 3.17 A). The activity of the 
different variants of the ECF42 σ factor was evaluated by measuring luminescence in E. coli. 
All variants – except for M05 (R214A) – show a reduction in activity of 20 to 80% relative 
to the wild type (Fig. 3.17 B). 
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Next, another variant was generated in which all four relevant mutations were combined 
(M07 - S191A V195A I199A N201A), to investigate if the effects of the single mutations 
on the activity of ECF42 σ factor are cumulative. Indeed, the activity of the M07 variant is 
dramatically reduced almost to non-induced levels (Fig. 3.17 B). This effect was not due to 
a reduced production level of the mutated alleles of ECF42 σ factor, as demonstrated by 
Western blot (Fig. 3.17 C). These results indicate that the postulated contact between the N-
terminal σ region and the C-terminal extension, most likely mediated by the co-variable 
residues, plays a positive regulatory role on the activity of ECF42 σ factor. 
3.4.2.3 Interaction of the N-terminal σ domain and the C-terminal extension of ECF42 
σ factors in two-hybrid assay 
Although the mutations on the contact sites of the C-terminal reduced the activity of ECF42 
σ factor, the contact between the C-terminal extension and N-terminal σ domain was still a 
prediction of DCA analysis. Thus, two-hybrid assay was performed to experimentally verify 
the interaction between the N-terminal σ domain and the C-terminal extension of the ECF42 
σ factor (XCC3792).  
DNA fragments encoding N-terminus or C-terminus were cloned into the pKT25, pKNT25, 
pUT18 and pUT18C vectors (Fig. 3.18 A). E. coli BTH101 was co-transformed with each 
generated T25 fragment containing plasmid and T18 fragment containing plasmid. The 
empty vectors and the plasmids containing DNA fragment coding leucine zipper (Zip), 
which are known to form the homodimer (O'Shea et al., 1991), were used as negative and 
positive control, respectively. The transformants were plated on LB-X-Gal-IPTG plates for 
screening. As shown (Fig. 3.18 B), except for the positive control (pUT18C_zip and 
pKT25_zip), no other blue colonies were observed. These results argue against an interaction 
between the different domains of the ECF42 σ factor. 
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Figure 3. 18 Investigation of the interaction between the N-terminal σ domain and the C-terminal 
extension of the ECF42 σ factor. (A) Gene fragments encoding the N-terminal (N) or C-terminal (C) domains 
were cloned into T25 and T18 fragments containing vectors. The empty vector and the plasmids (pUT18C_zip 
and pKT25_zip) containing Zip, which are known to form a homodimer, were used as negative and positive 
controls, respectively. (B) Twenty µl of co-transformed cell were dropped on LB plates supplemented with 
IPTG (0.5 mM) and X-gal (40 μg/ml). Blue color represents interaction between the hybrid proteins.  
3.4.2.4 In vitro cross-linking assays to study the interaction between the N-terminal σ 
region and the C-terminal extension of ECF42 σ factor  
Since no interaction between N-terminal σ domain and C-terminal extension was observed 
in two-hybrid assay, which might be caused by the misfolding of the each part of proteins in 
E. coli, the in vitro cross-linking assay thus was performed to further investigate the potential 
interaction between N-terminus and C-terminus of ECF 42 σ factor subsequently. Both 
fragments were overexpressed in E. coli under the control of an IPTG inducible promoter, 
however, they were both expressed insolubly (Fig. 3.19 A). Therefore, both of the protein 
fragments were refolded in vitro before submitting for purification. The N-terminus and C-
terminus of ECF42 σ factor were purified after refolding based on their introduced tags 
respectively (10×His-σ_domain and C-terminal_extension-Strep; Fig. 3.19 BC). Equal 
molar amounts of the purified N-terminal σ domain and C-terminal extension were mixed 
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together and crosslinked by the addition of formaldehyde. The crosslinked samples were 
analyzed by SDS-PAGE (Fig. 3.19 D). The alcohol dehydrogenase (ThaADH), which is 
known to form a homodimer, was used as positive control (Fig. 3.19 E). As the results shown, 
unfortunately, we were again unable to observe any interaction between the different 
domains of ECF42 proteins in the cross-linking assay (Fig. 3.19 D).  
Taken together, some potentially contact sites between N-terminal σ domain and C-terminal 
extension were identified by the DCA prediction, and mutation on the contact sites of C-
terminal extension significantly reduced the activity of ECF42 σ factor. However, interaction 
between N and C-terminal domains were not observed in either two-hybrid assay or in vitro 
cross-linking assay. 
 
Figure 3. 19 Investigation of the interaction between the N-terminal σ domain and the C-terminal 
extension of ECF42 σ factor by in vitro crosslinking. (A) Fragments encoding the N-terminal σ domain and 
the C-terminal extension of ECF42 σ factor were cloned into pETDuet-1 overexpression vector, under the 
control of an IPTG inducible promoter. The expression of both proteins in E. coli with (+) or without (-) 
induction by IPTG was analyzed by SDS-PAGE. The arrows indicate the over-expressed proteins. (B) The 10 
× His tagged N-terminal σ domain of ECF42 σ factor (arrow) was purified by using His-Trap HP column. 
Different fractions eluted from column were analyzed by SDS-PAGE. (C) The Strep tagged C-terminal 
extension of ECF42 σ factor (arrow) was purified by using Strep-Tactin XT Superflow cartridge. Different 
fractions eluted from column were analyzed by SDS-PAGE. (D) Crosslinking of the N-terminal σ domain (N) 
and the C-terminal extension (C) of ECF42 σ factor. Equal amounts of the proteins were mixed as indicated 
above each lane. The mixture was incubated at room temperature for 5 min and treated with formaldehyde (+) 
or 20 mM HEPES buffer (-). The arrow indicated the expected position of the dimers. (E) Positive control of 
the crosslinking experiment. The alcohol dehydrogenase (ThaADH), which is known to form a homodimer, 
was successfully crosslinked. 
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3.4.2.5 The regulatory role of the C-terminal extension on the activity of ECF42 σ factor 
Generally, ECF σ factor harbors only the σ2 domains and σ4 domains, which is sufficient 
for their functions: assembling with RNAP and initiating the transcription from their target 
promoters. Interestingly, proteins in ECF42 group are characterized by a long C-terminal 
extension in addition to σ domains. Such a C-terminal extension with group specificity has 
also been found in some other groups of ECF σ factors (Pinto and Mascher, 2016b). The 
function and regulatory role of the C-terminal extension in ECF σ factors has rarely been 
investigated so far. However, the C-terminal extension of ECF41 has been reported plays 
both a positive and negative role on the activity of ECF41, which means a shorter truncation 
of the C-terminal extension increase the activity of ECF41, but the whole truncation of the 
C-terminal extension results in the complete loss of ECF41 activity (Wecke et al., 2012). 
Based on this information, the regulatory role of the C-terminal extension of ECF42 was 
investigated by the sequential deletion analysis.  
First, the activity of different C-terminal truncations of the ECF42 σ factor (XCC3790) of X. 
campestris was analyzed in E. coli (Fig. 3.20 ABC). Genes coding for the full-length (WT) 
and C-terminally truncated ECF42 σ factor were cloned under the control of the arabinose 
inducible promoter PBAD and the ECF42 promoter sequence Pecf42 was responsible to drive 
the expression of the luxCDABE reporter cassette. Both transcription units were assembled 
into one plasmid (Fig. 3.20 B), which was then transformed into E. coli for the evaluation.  
After induction with arabinose, the WT ECF42 σ factor shows a seven-fold higher activity 
than in the absence of arabinose (Fig. 3.20 C). Compared to the WT, all C-terminally 
truncated versions of ECF42 σ factor significantly decreased the activity on the promoter 
activation. The longest version (T4, 1-355aa) retained some activity showing a 5-fold 
increase in activity in relation to the non-induced sample. However, the T3 (1-294aa), T2 
(1-232aa) and T1 (1-180aa) have completely lost activity (Fig. 3.20 C). This behavior was 
not due to a reduced production level of the truncated alleles, as demonstrated by Western 
blot (Fig. 3.20 D).  
Second, the activity of C-terminally truncated ECF42 from S. venezuelae was also evaluated 
in vivo. Gene encoding WT and a series of C-terminally truncated ECF42 σ factor (ven_4377) 
were cloned into the integrative vector pIJ10257 under the control of the constitutive 
promoter PermE*
 (Fig. 3.20 E). The target promoter of ECF42 σ factor was cloned upstream 
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Figure 3. 20 Investigation of the regulatory role of the C-terminal extension of ECF42 σ factor. (A) 
Schematic representation of the protein domain architecture of classical and ECF42 σ factors and positions of 
the constructed truncations. (B) Genes encoding different C-terminally truncated and WT versions of ECF42 
σ factor (XCC3790) from X. campestris were expressed from an arabinose inducible promoter. The target 
promoter of ECF42 σ factor drives the luxCDABE reporter cassette. Both transcription units were assembled 
in one plasmid. (C) The activity of different C-terminally truncated and WT ECF42 σ factors from 
X. campestris were evaluated in E. coli with or without induction by arabinose. (D) Western blot detection of 
the FLAG-tagged ECF42 alleles with an anti-FLAG antibody. (E) Genes encoding WT and different C-
terminally truncated ECF42 σ factor (Sven_4377) from S. venezuelae were cloned into an integrative vector 
pIJ10257. Production of WT or different truncated ECF42 σ factor was achieved from a strong constitutive 
promoter PermE*. The target promoter of ECF42 σ factor was responsible for the expression of the Gus reporter 
gene placed in another integrative vector pGUS. Both generated plasmids were transformed into S. venezuelae 
and integrated into the phage φBT1 and φC31 integration sites. (F) Activity of the sven_4377 promoter in 
strains expressing the WT and different alleles of ECF42 σ factors. The sven_4377 promoter was cloned into 
the integrative pGUS reporter vector and transformed into S. venezuelae strains overexpressing truncated 
FLAG-tagged ECF42 σ factors T1 (1-179 aa), T2 (1-230 aa), T3 (1-287 aa) and T4 (1-353 aa) (X-axis). The 
activity of the promoter in the different strains was determined by β-glucoronidase assays (gray bars). The 
activity of the sven_4377 promoter was also evaluated in the ECF42 triple deletion mutant of S. venezuelae as 
the negative control (white bars). The activity was expressed as miller units per microgram of protein 
(munits/mg) (Y-axis). (G) Production of all ECF42 truncated alleles in S. venezuelae was verified by Western 
blot using a FLAG-tag specific antibody. 
of the gene coding for the β-glucuronidase (Gus) in the vector pGUS (Fig. 3.20 E). Both 
integrative plasmids were transformed into S. venezuelae by conjugation. The activity of WT 
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and the C-terminally truncated ECF42 σ factor was evaluated by measuring the Gus activity. 
All our truncations resulted in a severe decrease in the activity of the ECF42 σ factor relative 
to its full-length allele (WT), as judged by its target promoter activity (Fig. 3.20 F). This 
behavior was not due to a reduced production level of the truncated alleles, as demonstrated 
by Western blot (Fig. 3.20 G).  
Taken together, the results obtained with all C-terminal truncations of ECF42 of 
X. campestris and S. venezuelae suggest that the C-terminal extension of ECF42 is necessary 
for its activity, as seen previously for ECF41 (Wecke et al., 2012). However, in contrast to 
the situation for ECF41 σ factor, the complete ECF42 C-terminal extension is necessary for 
activity, since even the shortest truncation of the C-terminal extension (T4) leads to a 
significant loss of σ factor activity. 
3.4.2.6 The role of C-terminal extension on the interaction with the RNAP 
As demonstrated above, the C-terminal extension is necessary for ECF42 σ factor activity, 
as its truncation abolish ECF activity. One possible mechanism to explain this behavior is 
that the deletion of the C-terminal extension impaired the interaction between ECF42 σ 
factor and RNAP, which would prevent transcription initiation from ECF42 target promoter. 
Therefore, immunoprecipitation (IP) of RNAP in E. coli was performed to investigate the 
effect of C-terminal truncation on the interaction between ECF42 σ factor and RNAP.  
The shortest truncated allele T1 (1-133aa), in which the whole C-terminus was truncated and 
that only contain σ2 and σ4 regions of ECF42 σ factor (XCC3790) (Fig. 3.21 A), was 
overexpressed in E. coli under the control of PBAD promoter. After production of ECF42-T1 
induced by arabinose, the RNAP complex was isolated by using the anti-E. coli RNA 
polymerase ( subunit) immune affinity resin. The protein fractions eluted from the affinity 
resin were analyzed for the presence of RNAP by SDS-PAGE. As the result shown, the 
RNAP was successfully purified from the cell lysate (Fig. 3.21 B). Meanwhile, the presence 
of the FLAG-tagged ECF42-T1 in the RNAP complex was investigated by Western blot 
using an anti-FLAG antibody (Fig. 3.21 C). Both ECF42 WT and ECF42-T1 were detected 
in the purified RNAP fractions, suggesting that the C-terminal extension of the ECF42 σ 
factor is not necessary to mediate the interaction with RNAP.  
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Figure 3. 21 C-terminal extension is not necessary for ECF42 σ factor interaction with RNAP. (A) 
Schematic representation of the protein domain architecture of classical and ECF42 σ factors and the relative 
position of the ECF42-T1 truncation. (B) SDS-PAGE of total soluble cell lysate (Total) or purified RNAP 
(Elution) from E. coli overexpressed FLAG-tagged ECF42 WT or ECF42-T1. ’ and  subunits of the RNA 
polymerase are indicated on the SDS-PAGE gel. (C) Western blot detection of the FLAG-tagged ECF42 WT 
or ECF42-T1 in total soluble cell lysate (Total) or in purified RNAP protein fractions (Elution) using anti-
FLAG antibody. 
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4. Discussion 
4.1 Phylogenetic distribution and ECF42 abundance 
In this study, we provide the very first detailed characterization of members of the novel 
group of ECF42 proteins with regard to their phylogenetic distribution, physiological role, 
target promoter sequence, regulons, and the regulatory role of the C-terminal extension and 
of the conserved co-transcribed DGPF proteins.  
The novel group of ECF42 σ factors was initially defined and described in the first 
comprehensive analysis on ECF σ factors in 2009 (Staron et al., 2009). As a huge increase 
in available bacterial genome sequences occurred over the last decade, the characteristics of 
this novel group of ECF42 σ factors, regarding phylogenetic distribution and genomic 
context, were reanalyzed based on more ECF42 protein sequences. Our analysis showed that 
proteins in the group of ECF42 show a wide taxonomic distribution, being present in 11 
different phyla but predominantly in the Actinobacteria (Fig. 3.1) with about four copies per 
genome (Table 3.1), which is in accordance with the initial analysis (Staron et al., 2009).  
The number of ECF σ factors positively correlates with genome size, thus larger genomes 
harbor more ECF σ factors (Huang et al., 2015). Another hypothesis for the large number of 
ECF σ in a genome is that they provide a regulatory advantage for bacteria having complex 
developmental features or living in complex and rapidly changing environments. These 
might contribute to an increase ability to perceive their environment and integrate stimulus 
from different sources, allowing for more complex cognitive behavior (Pinto and Mascher, 
2016a).  
Following this line of thought, it is not surprising that ECF42 σ factors are so abundant in 
Actinobacteria, which are characterized by large genomes and a remarkably complex 
developmental process (Flardh and Buttner, 2009).  Alternatively or additionally, the high 
numbers of ECF42 σ factors in Actinobacteria also suggests that they might play an 
important physiological role in these bacteria. 
On the other hand, the over-representation of these ECF σ factors in Actinobacteria, which 
encode several ECF42 copies per genome on average (Table 3.1) might indicate a functional 
redundancy. But this interpretation is in contrast to our data that indicates they might work 
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independently, since we have observed little cross-talk between the ECF-promoter pairs, 
with the minor exception of the non-cognate pair Sven_4377 - Psven_0747 (Fig. 3.5 C). This is 
in agreement with our RNAseq data, showing that each of the three ECF42 proteins activates 
a different set of genes without any overlap between them (Table 3.2). The analysis of the 
putative ECF42 binding sites in the upstream regions of the genes controlled by each ECF42 
σ factor did not reveal any obvious sequence determinants in the core -10 and -35 promoter 
regions (Fig. 3.5 A). However, we cannot exclude that less conserved residues in the spacer 
region will contribute or determine this specificity, as demonstrated for other ECF promoters 
in B. subtilis (Gaballa et al., 2018b). Unfortunately, the limited number of ECF42 target 
genes in S. venezuelae – indicative of small regulons – currently prevents the identification 
of such residues. 
4.2 The physiological role of ECF42 σ factors in S. venezuelae  
The genome of S. venezuelae encodes three ECF42 σ factors, to avoid the complementarily 
function to each other, the ECF42 triple deletion mutant of S. venezuelae was generated and 
used in a MicroArray Phenotype assay to identify ECF42-related phenotypes. In addition, 
RNAseq was performed to identify the regulons of ECF42 σ factors, thereby hoping for 
some indication as deduced by the (predicted) function of ECF42 target genes. Both of these 
approaches unfortunately gave very little information concerning their functions in 
S. venezuelae. 
For MicroArray Phenotype assay, the slight increase in metabolic activity of the ECF42 
triple deletion mutant in the presence of the Met-His dipeptide as sole nitrogen source 
(Fig. 3.8) was surprising, since it implies a negative effect of these ECF σ factors on 
metabolism. There are two ways in which this mechanism can envisioned: 
First, a direct effect of the ECF42 σ factors on genes whose products are involved in the 
import or utilization of this dipeptide could be postulated. Indeed, a conserved ECF42 
promoter signature can be found in the antisense orientation of the 5’-untranslated region of 
the operon encoding the methionine ABC transporter (sven_1158, sven_1157 and sven_1156) 
as shown in Fig. 4.1. This would suggest that ECF42 σ factors negatively regulate the 
expression of this operon by transcriptional interference. However, the RNAseq data show 
only a slight downregulation of genes in this operon in the strains overexpressing Sven_0747 
or Sven_4377 (between 0.8- and 0.57-fold). In addition, the activity of the promoter of this 
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gene cluster (PMet) was checked in individual S. venezuelae strains overexpressing ECF42 σ 
factors and compared to that in wild type and ECF42 triple deletion mutant. However, the 
activity of PMet under normal growth conditions was undetectable in all strains when using 
the mCherry fluorescent protein as a reporter (data not shown). This observation might be 
due to the low transcriptional level of methionine ABC transporter gene cluster – a situation 
reminiscent to E. coli, where this operon was only activated if methionine or methionine-
related substrates were present as sole nitrogen sources (Kadner and Watson, 1974). It might 
therefore be worthy to look for suitable growth conditions for S. venezuelae, in which the 
activity of PMet is strong and then compare the behavior of the wild type and the ECF42 triple 
mutant. Nevertheless, the putative negative effect of ECF42 σ factors on methionine 
utilization through downregulation of the methionine ABC transporter gene cluster still 
requires further investigations.  
 
Figure 4. 1 Putative binding site of ECF42 σ factor promoter motif in methionine ABC transporter gene 
cluster of S. venezuelae. A putative promoter motif of ECF42 σ factor indicated as a purple square in the 
chromosome has been found in the methionine ABC transporter gene cluster of S. venezuelae. The ECF42 
putative promoter region is zoomed in from the chromosomal DNA and the core -35 and -10 regions are 
highlighted by a black frame. The putative ECF42 target promoter is located downstream of the transcriptional 
start site (green square in the chromosome) of the methionine ABC transporter gene cluster. The direction of 
the ECF42 dependent transcription is contrary to that of the ABC transporter gene cluster. 
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Second, we could hypothesize an indirect effect of the ECF42 σ factors mediated by their 
target, the DGPF proteins, as identified by the RNAseq analysis. Proteins of this family have 
been shown to interact with RibD, a deaminase/reductase of the riboflavin biosynthetic 
pathway (Hu et al., 2009). Riboflavin is involved in the production of methionine from 
homocysteine via folate. The interaction of the DGPF with RibD could to some extent 
interfere with this process. Unfortunately, the interaction between DGPF protein 
(Sven_3806) and RibD protein (Sven_1041) could not be verified by pulldown assays 
(Fig. 3.11). 
In addition to the Phenotype Microarray assays, RNAseq was performed to identify the 
regulons of ECF42 σ factors in S. venezuelae and in this way disclosing their physiological 
roles. However, few significant target genes were identified, except for the DGPF genes 
located in the same operon as the ECF42 σ factor coding genes (Table A2). This observation 
suggests that they are to some extent independently self-controlled systems in S. venezuelae. 
Such kind of self-contained ECF regulons that work independently have already been 
reported in S. coelicolor (Kao et al., 2018). In the reported case, the artificial overexpression 
of the ECF σ factor activates the transcription of genes in the same ECF-contained genomic 
island. The authors claim that the ECF σ factor and its regulon are a self-contained 
transcriptional unit, which was presumably acquired by horizontal gene transfer because of 
the typical characteristics of a genomic island (Kao et al., 2018). Indeed, the transcription 
units of an ECF σ factor and its contiguous regulon has been reported to be transferrable by 
horizontal gene transfer in bacteria (Grass et al., 2000; Tibazarwa et al., 2000). Taken 
together, we were not able to identify a solid ECF42-related phenotype. RNAseq analysis at 
least identified the solid target protein (DGPF) of ECF42 σ factors in S. venezuelae despite 
their function being unknown. Thus, further research on the function of DGPF proteins will 
be necessary to explore the physiological role of ECF42 σ factors. 
4.3 Target promoter determination of ECF42 σ factors in S. venezuelae 
Each group of ECF σ factors has their own group-specific target promoter. Hence, 
identification of the target promoter of ECF σ factors enables us to predict their target genes, 
thereby providing a direct access to the physiological role of ECF-dependent regulation. 
Generally, ECF σ factors are positively auto-regulated, which means the target promoter of 
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the ECF σ factors are usually found upstream of their encoding operons and can be activated 
and transcribed by the ECF σ factors themselves (Mascher, 2013). In agreement with 
previous analyses of the ECF42 target promoter motif of ECF42 (Rhodius et al., 2013; Pinto 
and Mascher, 2016b), the search for over-represented motifs in the upstream regions of 
operons encoding ECF42 σ factors identified a conserved promoter motif with "TGTCGA" 
in the -35 region and "CGTC" in the -10 region (Fig. 3.4). This finding strongly suggests 
this conserved motif is most likely the target promoter motif of ECF42 σ factors in 
S. venezuelae as well. 
Following this identification of the conserved promoter motif, the activity of the upstream 
conserved promoters (Psven_0747, Psven_4377 and Psven_7131) from three ECF42 encoding operons 
of S. venezuelae were tested in S. venezuelae overexpressing their cognate ECF42 σ factor. 
Two ECF42 σ factor/promoter pairs (Sven_0747-Psven_0747 and Sven_4377-Psven_4377) showed 
significant activity (Fig. 3.5), strongly supporting the notion that the predicted promoter 
motif indeed is the target promoter of ECF42 σ factor and that they are positively regulated 
as described for other ECF σ factors. This conclusion was also supported by the RNAseq 
data, in which the DGPF-encoding genes sven_0748 and sven_4376 – located in the ECF42 
operons of sven_0747 and sven_4376 – were highly upregulated in S. venezuelae 
overexpressing sven_0747 and sven_4376, respectively (Table 3.2).  
However, one ECF42 σ factor/promoter pair – Sven_7131-Psven_7131 – was not active. This 
result made sense in light of the observation that the most likely promoter sequence of 
ECF42 σ factor we can find upstream of sven_7131 (Fig. 3.5 A) was not very similar to the 
conserved ECF42 promoter motif (Fig. 3.4). Additionally, the ECF42 σ factor encoded by 
sven_7131 is much longer than the other two and contains an additional phage integrase N-
terminal SAM-like domain (PF02899), which is known to be involved in DNA 
recombination (Kwon et al., 1997). Remarkably, overproduction of Sven_7131 only resulted 
in reduced fold-change differences in gene expression (Table A2), which suggests that 
Sven_7131 might not act as a σ factor at all. In conclusion, we experimentally verified the 
target promoter motif of ECF42 σ factors in S. venezuelae and the presence of the target 
promoter upstream of the ECF42 σ factors encoding operons suggests they are auto-
regulated.  
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4.4 Genomic context conservation and domain architecture of ECF42 σ 
factors 
ECF42 σ factors deviate in a number of characteristics from classical ECF σ factors. Genes 
encoding ECF σ factors are usually co-transcribed with their cognate anti-σ factors, which 
are required as negative regulators of the activity of ECF σ factors and keep them inactive 
in the absence of inducing conditions. However, the genomic context analysis of ECF42 
coding genes did not reveal any obvious anti-σ factor coding genes but instead genes 
encoding DGPF (COG3795) proteins of unknown function (Fig. 3.2). Additionally, ECF42 
σ factors are characterized by the presence of long C-terminal extensions containing TPR 
domains that is often involved in mediating protein-protein interactions (D'Andrea and 
Regan, 2003). In contrast, classical ECF σ factors normally contain only the two σ2 and σ4 
conserved domains (Fig. 1.1).  
Based on this conserved genomic context and architectures of ECF42 proteins, we initially 
proposed that both DGPF proteins and the C-terminal extension of ECF42 σ factors are 
possibly involved in the regulation of ECF42-dependent gene expression. This assumption 
led to three central hypotheses:  
(i) In the absence of inducing conditions, ECF42 σ factors might be kept inactive due to the 
formation of a protein-protein interaction complex between the DGPF protein and the 
ECF42 σ factor, similarly to the σ - anti-σ pair of typical ECF σ factors. Once triggered by 
a suitable stimulus, the ECF42 σ factor would then be released from the DGPF protein to 
initiate gene expression from its target promoters (Fig 3.12 B).  
(ii) Alternatively, ECF42 σ factors might be kept inactive by intramolecular interactions or 
by oligomerization mediated by their own C-terminal TPR domains in the absence of 
suitable stimulus. In this case, the DGPF protein might function as a sensor, which changes 
its conformation in the presence of an inducing stimulus and binds the TPR domain located 
in the C-terminal of ECF42 σ factor, thereby releasing the N-terminal σ domain of ECF42 σ 
factor from inhibition (Fig 3.12 A).  
(iii) The third hypothesis postulated a regulatory mechanism independent of the DGPF 
protein: The activity of ECF42 σ factor might be inhibited by its C-terminal extension in the 
absence of a stimulus, while the ECF42 σ factor could be activated by self-cleavage of the 
C-terminal extension once the suitable stimulus occurs. This hypothesis is in line with a 
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previous study on ECF41 σ factors (Wecke et al., 2012), which also lack an anti-σ factor but 
harbor a conserved C-terminal extension. Here, partial truncation of the C-terminal extension 
increases the activity of the ECF41 σ factor.  
Taken together, the bioinformatics analysis, provide us with the first testable hypothesis for 
the regulatory mechanism of ECF42 σ factors. 
4.5 Regulation mechanism of ECF42 σ factors 
As described above, the regulatory function governing the activity of ECF42 σ factors might 
reside either in the associated DGFP proteins and/or in the conserved C-terminal extension 
of these proteins. To verify the role of the DGPF protein as either a repressor or an activator 
of ECF42 σ factor, interaction between DGPF proteins and ECF42 σ factors from 
S. venezuelae was initially investigated by two-hybrid assay in E. coli and no interaction was 
observed (Fig. 3.13). In agreement with this, the activity of ECF42 σ factor of X. campestris 
(XCC3792) was not affected by the presence of the cognate DGPF protein (XCC3792) 
(Fig. 3.14). All results from our study suggested that the DGPF protein are not involved in 
the regulation of ECF42 proteins. Given that the ECF42 operons in S. venezuelae, which 
include the DGPF-encoding gene, are positively auto-regulated (Fig. 3.5) and DGPF 
proteins do not seem to harbor a regulatory function, they seem to be just the main target of 
ECF42 σ factors. This is in agreement with the results from the RNAseq analysis, in which 
an additional DGPF-encoding gene (sven_3806) located separately from ECF42 genes was 
significantly upregulated by 643-fold in the S. venezuelae overexpressing Sven_4377 (Fig. 
3.10).  
For classical ECF σ/anti-σ pairs, the regulation is based on specific protein-protein 
interactions between the partner proteins that prevent the activity of the ECF σ factor in the 
absence of inducing conditions (Helmann, 2002). The presence of TPR domains, known to 
be responsible for protein-protein interactions (D'Andrea and Regan, 2003), in the C-
terminal extension of ECF42 σ factors suggested a regulatory role of this domain, in line 
with recent evidences on the regulatory role of other C-terminal extensions of ECF groups, 
ECF41 (Wecke et al., 2012) and ECF44 (Marcos-Torres et al., 2016). In the case of ECF41 
σ factors, it was demonstrated that the extension has both an activating and a repressing role 
on σ factor activity, while the extension of ECF44 coordinates a metal ion and determines 
the specificity of the σ factor (Marcos-Torres et al., 2016). 
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Initially, we hypothesized that the C-terminal extension plays the role of an anti-σ factor 
binding to the σ domain of the ECF42 σ factor in the absence of inducing conditions. In line 
with this hypothesis, five interacting amino acid pair between the σ domain and the C-
terminal extension were identified using a direct coupling analysis (DCA). Surprisingly, the 
activity of ECF42 σ factor was reduced or completely lost when the putative interaction 
residues located in the C-terminal extension were changed to alanine (Fig. 3.17). These 
results suggest that the interaction between N-terminal σ domain and the C-terminal 
extension is necessary for ECF42 σ factor's activity. Unfortunately, we were unable to verify 
the interaction both in an in vivo two-hybrid assay (Fig. 3.18) and in an in vitro cross-linking 
assay (Fig. 3.19). Whether this suggests that the N- and C-terminal portions of the σ factor 
do not interact directly and that those residues might be important for other interactions or 
that their mutations disturb the correct folding of the σ factor remains to be investigated.  
Alternatively, experimental limitations might also lead to the observed result: both the N-
terminal and the C-terminal portions of the σ factor are insoluble when overexpressed in 
E. coli (Fig. 3.19 A). This behavior might contribute to the negative results in bacterial two-
hybrid assay;  the absence of interaction observed in cross-linking assay could be caused 
by protein misfolding in vitro; or the interaction is too transient or not strong enough once 
the two portions are no linker connected within the some protein to be detected by these 
assays. Hence, the interaction between N- and C-terminal domains will require further 
investigations.   
The TPR domain-containing proteins (Cdc16p, Cdc23p and Cdc27p) of Saccharomyces 
cerevisiae have been reported to be able to form homodimers (Lamb et al., 1994). Thus, it is 
possible that the activity of ECF42 σ factor is inhibited by its self-dimerization mediated by 
its C-terminal TPR domains under non-induced conditions. Once triggered by suitable 
stimuli, the interaction between the TPR domains could be broken, e.g. by the competitive 
binding of the TPR domain to an unknown signal molecules, thereby releasing the ECF42 σ 
factors. Although the hypothesis that the TPR domain could play an inhibitory role sounds 
reasonable, our data from the sequential deletion analysis suggested that the TPR containing 
C-terminal extension of ECF42 σ factors is instead essential for its activity (Fig. 3.20). One 
possible explanation for this behavior would be to postulate a role of the C-terminal 
extension of ECF42 σ factor in the assemble of the RNAP-ECF42 holoenzyme. In this case, 
deletion or disturbance of the C-terminal domain would disable the ECF42 σ factor assembly 
with RNAP, as has been demonstrated previously for ECF41 σ factors, another ECF group 
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containing a C-terminal extension (Wecke et al., 2012). But such a mechanism contradicts 
our RNAP pull-down results, which demonstrated that even a complete deletion of the C-
terminal extension did not decrease the affinity of ECF42 σ factor for RNAP (Fig. 3.21).  
Another possible explanation might be that the TPR-containing C-terminal extension is 
involved in promoter recognition via an unknown mechanism, in which case truncation of 
the C-terminal extension would reduce or abolish the ability of ECF42 σ factor to recognize 
and/or bind its target promoter, thereby preventing transcription initiation. Further studies 
on the affinity of wild type or C-terminally truncated ECF42 σ factor to the target promoter 
need to be performed in order to challenge this hypothesis.  
Collectively, our data suggests that the full C-terminal extension of ECF42 σ factor is 
essential for its activity. We hypothesize that any disturbance of the TPR protein-protein 
interaction domain will render the ECF σ factor inactive. But the exact mechanism by which 
this effect is exerted will require further investigations. While this question needs to be 
answered in the future, this work – as presented in this thesis – provides a first 
comprehensive analysis of a novel and widely distributed ECF group.  
We have identified the ECF42 target promoters in S. venezuelae and shown that the main 
target genes of these σ factors are encoding DGPF proteins. Together, these results provide 
the first insights into the function and mechanism of one of the most abundant, but previously 
untouched groups of ECF σ factors. I hope that these results will inspire subsequent studies 
on ECF42 σ factors from different bacterial species to ultimately unravel both the 
physiological role as well as the exact mechanism of ECF42-dependent stimulus perception 
and σ factor activation. 
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Table A 1. Oligonucleotides used in this study 
Name Sequence (5′ → 3′) 
TM4364 AAATTAAGCTTCCGAGCCGCCGCCCGCCGGG 
TM4365 AAATTGGATCCTCCGTGACGGTGGGCGGCACGCCG 
TM4366 AAATTGGATCCCCCGCCCGCGGCCCCCGCTCCGC 
TM4367 AAATTGGTACCCGGGCAGCGGGGCCGGTGCGGC 
TM4368 AAATTAAGCTTAGATGGACCCGGCCGTCGGGGGCCG 
TM4369 AAATTGGATCCACGTCCGCCGCGGACTCGTGCAGCAC 
TM4370 AAATTGGATCCGCCGGAGGGGGCGGGCGACGGCTC 
TM4371 AAATTGGTACCAAGGACTCGAGGGCGGCCTTGGTGAAGACC 
TM4452 AAATTAAGCTTCCAAGCCCGACCTGCGGTCGCTGCC 
TM4453 AAATTGAATTCGCTTGCCTCGCTGCTCCTCGGCTCTGG 
TM4454 AAATTGAATTCGGGGAGCTTCCGCGGGCCCAGGTG 
TM4455 AAATTGGTACCAGGGGCCCTCGCCGAAGAAGCCGGGG 
TM4606 GATGGTCATCGACGTCGACGGCTAC 
TM4607 CGATGAACCACTGCCTGGCCCAGATC 
TM4608 GAGTACCTGGCCAGCTTCTACCTG 
TM4609 TGAGAAGGAGCGACGAGTACTGTG 
TM4610 CTGATCGAGGTCCGGTCCAAGGAGG 
TM4611 CAGGGACGAACGCACGCGTCTGTG 
TM5631 
AAATTCATATGGACTACAAGGACCACGACGGCGACTACAAGGACCACGACAT
CGACTACAAGGACGATGACGACAAGACCCCTTCGATGGACGAGGTCCTGCTC 
TM4056 AAATTAAGCTTTCAGCGCCCCTCCTCGTCGCCGCCGCCGC 
TM5632 
AAATTCATATGGACTACAAGGACCACGACGGCGACTACAAGGACCACGACAT
CGACTACAAGGACGATGACGACAAGACCGGCCCCGCCGAGGTCGAGGACCT 
TM4059 AAATTAAGCTTTCAGCCCAACCGCCGCGCCCGCTCGGTG 
TM5633 
AAATTCATATGGACTACAAGGACCACGACGGCGACTACAAGGACCACGACAT
CGACTACAAGGACGATGACGACAAGCCCGAGCCGGACACCCGCCGTACGGT 
TM4062 AAATTAAGCTTTCAGGGCCGGGGCTTGAGCTGACGCAAGG 
TM5631 AAATTAAGCTTTCAGTCCTCCCCCGCGGGCAGCGCG 
TM4056 AAATTAAGCTTTCAGTCCTCGGGCACCAGCCGGTGG 
TM5632 AAATTAAGCTTTCACCCCCGGGGCAGGGTGCGGCTG 
TM4059 AAATTAAGCTTTCAGAGCAGCGCGAGCCCGGCCGCGG 
TM6090 AAATTTCTAGACGGCTCCCGCTTCGCCACCGACGG 
TM6091 AAATTGGTACCGGTGTCTCTCCTCGGTTCCGTGC 
TM6092 AAATTTCTAGAAGCGGCCGGCCGGGCCGGAAG 
TM6093 AAATTGGTACC CCGTGGGGTGACTGCCCGCCTC 
TM4718 AAATTTCTAGAGTGGGCGGTCCGTCCCCTCGAATC 
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TM4719 AAATTGGTACCCTCGGGTGTCCTCCCCGTCCCG 
TM4732 ACCGCGATGCTGTTGTGGGC 
TM4733 GCGACCTTGCCCCTCCAACG 
TM4734 CGATCACGGCACGATCATCGTG 
TM4735 CGGTCGAGGCTGAACGCCCAC 
TM4530 GTGCTGCAAGGCGATTAAGTTG 
TM4531 CACAGGAAACAGCTATGACATG 
TM5590 
AAATTGAAGACAAAATGGATTATAAGGATCATGATGGTGATTATAAGGATCAT
GATATCGACTACAAAGACGATGACGACAAGATGGCAGCAACCGATATTAGCG 
TM5591 AAATTGAAGACAACGAATTATGCAGGCAGACCGCTACAT 
TM5714 AAATTGAAGACAAAAGCTTAACCACGCGGAACTTCAAACGGAAC 
TM5715 AAATTGAAGACAAAAGCTTATGCGGTCGGCATCTGCTCTGCCAG 
TM5716 AAATTGAAGACAAAAGCTTATTCACCGCCACCCAGCTGCTGTGC 
TM5717 AAATTGAAGACAAAAGCTTAGTGGCGCAGTGCACTATCCTGCTG 
TM5611 CTTTGAGTGAGCTGATACCG 
TM5612 CCACCTGACGTCTAAGAAAC 
TM5613 GTTTACCCGCCAATATATCCTG 
TM5614 CAAAGGAGATCCTGATCTGAC 
TM5619 AAATT GAAGACAAAATGGATTATAAGGATCATG 
TM5620 AAATTGAAGACAAAAGCTTATGCAGGCAGACCGCTACAT 
TM5670 AAATTGAAGACAAAATGGCAGCAACCGATATTAG 
TM5671 TGCCAGACGTGCATGACG 
TM5672 CGTCATGCACGTCTGGCAGCAGTTCTGGAAGTTCTGTATC 
TM5673 
CGTCATGCACGTCTGGCAAGCGTTCTGGAAGCACTGTATCTGATTTTTAACGA
AGGC 
TM5674 
CGTCATGCACGTCTGGCAAGCGTTCTGGAAGTTCTGTATCTGGCATTTAACGA
AGGCTATGCAGCC 
TM5675 
CGTCATGCACGTCTGGCAAGCGTTCTGGAAGTTCTGTATCTGATTTTTGCAGAA
GGCTATGCAGCCAGTG 
TM5676 CTGGGCATCATCACCATCAC 
TM5677 GTGATGGTGATGATGCCCAGGCACCGGCTCTGTGTCATGAAGC 
TM5856 AAATTGAAGACGCTGCCAGACGTGCATGACGTTC 
TM5857 
AAATTGAAGACCTGGCAGCAGTTCTGGAAGCACTGTATCTGGCATTTGCAGAA
GGCTATGCAGCCAGTGATGGTG 
TM3707 
AATTCGCGGCCGCTTCTAGAGCGCCGGAAAAAAGCTCGGCCGGTGATGTCGA
GAATCCGCGTCCTGCTCCGTCCCCGGGGAGATA  
TM3708 
CTAGTATCTCCCCGGGGACGGAGCAGGACGCGGATTCTCGACATCACCGGCCG
AGCTTTTTTCCGGCGCTCTAGAAGCGGCCGCG 
TM3709 
AATTCGCGGCCGCTTCTAGAGAAGCACATTAAAATATAACGTTTTTTGTCGAA
ACTCCGTTTTCTCTCTCGTCATATAAGTGAATA 
TM3710 
CTAGTATTCACTTATATGACGAGAGAGAAAACGGAGTTTCGACAAAAAACGTT
ATATTTTAATGTGCTT CTCTAGAAGCGGCCGCG 
TM3711 
AATTCGCGGCCGCTTCTAGAGAACTTTCGAAGATCGCCGTCGGGGATGTCGAG
GACGCCCCGCCGGCTCCGACCGAGGGGTGA TA 
TM3712 
CTAGTATCACCCCTCGGTCGGAGCCGGCGGGGCGTCCTCGACATCCCCGACGG
CGATCTTCGAAAGTT CTCTAGAAGCGGCCGCG 
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TM3713 
AATTCGCGGCCGCTTCTAGAGAAGCACATTAAAATATAACGTTTTTTGTCGAA
ACTCCGTTTTCTCTCTCGACATATAAGTGAA TA 
TM3714 
CTAGTATTCACTTATATGTCGAGAGAGAAAACGGAGTTTCGACAAAAAACGTT
ATATTTTAATGTGCTT CTCTAGAAGCGGCCGCG 
TM3715 
AATTCGCGGCCGCTTCTAGAGATCGAACTGGCCCGCCGCTTCCGCAGGATCGT
CGGCGACGGCGAGAGCGTGGTCCAGCAGG TA  
TM3716 
CTAGTACCTGCTGGACCACGCTCTCGCCGTCGCCGACGATCCTGCGGAAGCGG
CGGGCCAGTTCGAT CTCTAGAAGCGGCCGCG  
TM3717 
AATTCGCGGCCGCTTCTAGAGAAGCACATTAAAATATAACGTTTTTGGATCGT
CGGCGACGGCGAGAGCGTG ATATAAGTGAA TA  
TM3718 
CTAGTATTCACTTATATCACGCTCTCGCCGTCGCCGACGATCCAAAAACGTTAT
ATTTTAATGTGCTT CTCTAGAAGCGGCCGCG 
TM3731 
AAATTGAATTCGCGGCCGCtTCTAGAAAGGAGGTGGCCGGCATGACAGGTCCA
GCTGAAGTTGAAG 
TM3732 
AAATTCTGCAGCGGCCGCTACTAGTATTAACCGGTTCAACCCAAACGACGAGC
ACGTTCTG 
TM3735 
AAATTGAATTCGCGGCCGCtTCTAGAAAGGAGGTGGCCGGCATGCCAGAACCT
GATACACGTCGTA 
TM3736 
AAATTCTGCAGCGGCCGCTACTAGTATTAACCGGTTCATGGACGTGGTTTAAG
TTGACGCAA 
TM6134 
AAATTCCATGGGCCATCATCATCATCATCATCATCATCATCACGTTGCACAGC
AGGCAGATATTAC 
TM6135 AAATTGGATCCTTATGCACCTTTCAGTGTGGCGG 
TM6136 AAATTCATATGAAGTATCTGGTGATGGTGCAAG 
TM6137 AAATTGGTACCTTATTTTTCGAACTGCGGGTGGCTCCA  
 
Table A 2. Upregulated genes (fold ≥ 2, P ≤ 0.005, reads ≥ 300) in ECF42 overexpression S. venezuelae 
strains compared to ECF42 triple deletion mutant. 
Locus 
log2-fold 
Change 
P-value Description 
S. venezuelae overexpressing sven_0747 
SVEN_0747 18.79 8.62E-54 Putative RNA polymerase sigma factor 
SVEN_0748 4.03 1.12E-90 Hypothetical protein 
SVEN_4522 3.5 0 Putative integral membrane protein 
SVEN_4523 1.67 4.63E-62 Oligopeptide binding protein 
SVEN_3779 1.49 0.0073 Transcriptional regulator, MarR family 
SVEN_t8 1.31 4.78E-12 tRNA 
SVEN_t59 1.15 2.26E-07 tRNA 
SVEN_t46 1.11 5.60E-09 tRNA 
SVEN_4219 1.08 1.07E-10 Putative integral membrane protein 
SVEN_t7 1.07 5.90E-08 tRNA 
SVEN_t37 1 0.0033 tRNA 
SVEN_t37 1 0.0033 tRNA 
S. venezuelae overexpressing sven_4377 
SVEN_4377 15.97 8.4E-107 RNA polymerase sigma-70 factor, ECF subfamily 
SVEN_3806 9.33 0 Hypothetical protein 
SVEN_3805 6.15 0 GCN5-related N-acetyltransferase 
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SVEN_4376 4.39 0 DGPFAETKE family protein 
SVEN_4522 3.16 0 Putative integral membrane protein 
SVEN_6046 2.85 5.52E-25 Molybdate-binding domain of ModE 
SVEN_6659 1.74 5.11E-06 Xylulose kinase 
SVEN_4040 1.72 3.63E-19 Hypothetical protein 
SVEN_3036 1.68 2.49E-22 Hypothetical protein 
SVEN_4476 1.59 5.09E-11 Putative secreted lipase 
SVEN_3356 1.55 7.37E-17 Hypothetical protein 
SVEN_3924 1.55 4.71E-22 Putative integral membrane protein 
SVEN_3126 1.54 1.99E-07 Hypothetical protein 
SVEN_6100 1.53 2.42E-19 Hypothetical protein 
SVEN_4523 1.52 3.21E-54 Oligopeptide binding protein 
SVEN_4575 1.5 2.09E-05 Putative RNA polymerase ECF-subfamily sigma factor 
SVEN_3534 1.5 7.29E-16 ABC-type multidrug transport system, ATPase component 
SVEN_6957 1.45 6.37E-32 MarR-family transcriptional regulator 
SVEN_3714 1.44 5.88E-34 Cytochrome d ubiquinol oxidase subunit II 
SVEN_0961 1.44 9.71E-12 Hypothetical protein 
SVEN_2147 1.41 2.33E-15 HNH endonuclease 
SVEN_3526 1.4 3.14E-19 Hypothetical protein 
SVEN_0718 1.39 1.14E-16 Possible sugar kinase 
SVEN_2257 1.37 1.59E-13 Ferredoxin reductase 
SVEN_4229 1.3 3.05E-16 RNA polymerase ECF-subfamily sigma factor 
SVEN_3531 1.28 6.93E-14 Universal stress protein family 
SVEN_1867 1.26 8.87E-27 Arsenate reductase 
SVEN_0260 1.26 3.76E-14 GCN5-related N-acetyltransferase 
SVEN_2571 1.26 6.01E-13 Desferrioxamine E biosynthesis protein DesB 
SVEN_5883 1.25 7.15E-13 Glyoxalase family protein 
SVEN_1017 1.24 1.53E-12 Hypothetical protein 
SVEN_0690 1.22 1.53E-10 Putative lyase 
SVEN_0322 1.19 3.26E-09 Hypothetical protein 
SVEN_1503 1.18 2.18E-13 Penicillin amidase family protein 
SVEN_6081 1.18 0.000184 LPXTG-motif cell wall anchor domain protein 
SVEN_3715 1.17 1.17E-25 Transport ATP-binding protein CydCD 
SVEN_2672 1.15 3.49E-17 ATP-dependent Clp protease adaptor protein ClpS 
SVEN_4981 1.15 1.71E-20 Transcriptional regulator, MarR family 
SVEN_0273 1.15 3.15E-10 Putative regulatory protein 
SVEN_4614 1.13 5.28E-16 Hypothetical protein 
SVEN_2241 1.12 3.29E-23 Organic hydroperoxide resistance transcriptional regulator 
SVEN_3697 1.12 3.08E-09 Hypothetical protein 
SVEN_2058 1.12 2.75E-06 Putative integral membrane protein 
SVEN_1504 1.11 2.67E-12 Putative acetyltransferase 
SVEN_2406 1.08 9.16E-18 Putative membrane protein 
SVEN_2487 1.08 3.73E-07 Hypothetical protein 
SVEN_1911 1.08 5.27E-08 Hypothetical protein 
SVEN_4062 1.07 2.08E-10 Hypothetical protein 
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SVEN_0838 1.07 2.77E-16 Hypothetical protein 
SVEN_2188 1.06 8.99E-06 LrgA-associated membrane protein LrgB 
SVEN_1241 1.05 8.14E-15 Putative ferredoxin 
SVEN_2607 1.05 2.56E-09 Transcriptional regulator, IclR family 
SVEN_1177 1.05 2.02E-15 Prolyl endopeptidase 
SVEN_0837 1.05 5.49E-12 Putative membrane protein 
SVEN_1787 1.04 2.96E-15 Hypothetical protein 
SVEN_3532 1.04 3.14E-07 Lyase 
SVEN_4689 1.04 1.71E-11 Hypothetical protein 
SVEN_1219 1.03 4.79E-25 Iron utilization protein 
SVEN_1401 1.03 2.39E-16 Ribosyl nicotinamide transporter, PnuC 
SVEN_4751 1.03 1.65E-10 Hypothetical protein 
SVEN_0001 1.03 0.000393 Hypothetical protein 
SVEN_3361 1.03 1.72E-13 Hypothetical protein 
SVEN_4295 1.02 3.39E-08 Hypothetical protein 
SVEN_3415 1.01 7.20E-08 Transcriptional regulator, GntR family 
S. venezuelae overexpressing sven_7131 
SVEN_4522 3.86 0 Putative integral membrane protein 
SVEN_2864 2.28 1.75E-05 Phage major capsid protein 
SVEN_1613 1.98 1.76E-08 Aspartate or tyrosine or aromatic aminotransferase 
SVEN_2991 1.88 1.14E-08 Hypothetical protein 
SVEN_2992 1.66 2.31E-18 L-lysine permease 
SVEN_4523 1.59 4.16E-59 Oligopeptide binding protein 
SVEN_1612 1.58 6.47E-17 Transcriptional regulator, HxlR family 
SVEN_4977 1.42 6.01E-16 ATP-dependent protease La Type I 
SVEN_1615 1.32 4.13E-23 Hypothetical protein 
SVEN_5837 1.3 1.28E-07 Secreted protein 
SVEN_1614 1.29 3.01E-14 Hypothetical protein 
SVEN_3169 1.19 1.94E-14 Hsp18_3 
SVEN_5838 1.18 1.44E-05 Hypothetical protein 
SVEN_5836 1.17 8.44E-08 Hypothetical protein 
SVEN_5839 1.11 7.25E-07 Hypothetical protein 
SVEN_3298 1.05 5.4E-17 Hypothetical protein 
SVEN_1595 1.05 1.08E-14 Integral membrane protein TerC 
SVEN_3297 1.04 1.21E-15 Hypothetical protein 
SVEN_0065 1.01 2.24E-09 Extracellular alkaline serine protease 2 
SVEN_5840 1 4.73E-06 Hypothetical protein 
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